#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Load-Dependent Hyperdeactivation of the Default Mode Network in People With Schizophrenia
#Text=Schizophrenia is associated with impairment in a range of cognitive functions.
1-1	0-14	Load-Dependent	_	
1-2	15-32	Hyperdeactivation	_	
1-3	33-35	of	_	
1-4	36-39	the	_	
1-5	40-47	Default	_	
1-6	48-52	Mode	_	
1-7	53-60	Network	_	
1-8	61-63	in	_	
1-9	64-70	People	_	
1-10	71-75	With	_	
1-11	76-89	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-12	90-103	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-13	104-106	is	_	
1-14	107-117	associated	_	
1-15	118-122	with	_	
1-16	123-133	impairment	_	
1-17	134-136	in	_	
1-18	137-138	a	_	
1-19	139-144	range	_	
1-20	145-147	of	_	
1-21	148-157	cognitive	_	
1-22	158-167	functions	_	
1-23	167-168	.	_	

#Text=Neuroimaging studies have reported lower, but also higher, task-induced activation accompanying impaired performance.
2-1	169-181	Neuroimaging	_	
2-2	182-189	studies	_	
2-3	190-194	have	_	
2-4	195-203	reported	_	
2-5	204-209	lower	_	
2-6	209-210	,	_	
2-7	211-214	but	_	
2-8	215-219	also	_	
2-9	220-226	higher	_	
2-10	226-227	,	_	
2-11	228-240	task-induced	_	
2-12	241-251	activation	_	
2-13	252-264	accompanying	_	
2-14	265-273	impaired	_	
2-15	274-285	performance	_	
2-16	285-286	.	_	

#Text=Differences in task-load and the ability of people with schizophrenia (PSZ) to stay engaged in the cognitive operations probed appear to underlie such discrepancies.
3-1	287-298	Differences	_	
3-2	299-301	in	_	
3-3	302-311	task-load	_	
3-4	312-315	and	_	
3-5	316-319	the	_	
3-6	320-327	ability	_	
3-7	328-330	of	_	
3-8	331-337	people	_	
3-9	338-342	with	_	
3-10	343-356	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
3-11	357-358	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
3-12	358-361	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
3-13	361-362	)	_	
3-14	363-365	to	_	
3-15	366-370	stay	_	
3-16	371-378	engaged	_	
3-17	379-381	in	_	
3-18	382-385	the	_	
3-19	386-395	cognitive	_	
3-20	396-406	operations	_	
3-21	407-413	probed	_	
3-22	414-420	appear	_	
3-23	421-423	to	_	
3-24	424-432	underlie	_	
3-25	433-437	such	_	
3-26	438-451	discrepancies	_	
3-27	451-452	.	_	

#Text=Similarly, task-induced deactivation of the default mode network (DMN) was weaker in PSZ relative to healthy control subjects (HCS) in most studies, but some reported greater deactivation.
4-1	453-462	Similarly	_	
4-2	462-463	,	_	
4-3	464-476	task-induced	_	
4-4	477-489	deactivation	_	
4-5	490-492	of	_	
4-6	493-496	the	_	
4-7	497-504	default	_	
4-8	505-509	mode	_	
4-9	510-517	network	_	
4-10	518-519	(	_	
4-11	519-522	DMN	_	
4-12	522-523	)	_	
4-13	524-527	was	_	
4-14	528-534	weaker	_	
4-15	535-537	in	_	
4-16	538-541	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
4-17	542-550	relative	_	
4-18	551-553	to	_	
4-19	554-561	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
4-20	562-569	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
4-21	570-578	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
4-22	579-580	(	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
4-23	580-583	HCS	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
4-24	583-584	)	_	
4-25	585-587	in	_	
4-26	588-592	most	_	
4-27	593-600	studies	_	
4-28	600-601	,	_	
4-29	602-605	but	_	
4-30	606-610	some	_	
4-31	611-619	reported	_	
4-32	620-627	greater	_	
4-33	628-640	deactivation	_	
4-34	640-641	.	_	

#Text=An inability to stay engaged in the cognitive operations could account for these discrepancies, too, as it would lead to more time off-task and consequently less deactivation of DMN functions.
5-1	642-644	An	_	
5-2	645-654	inability	_	
5-3	655-657	to	_	
5-4	658-662	stay	_	
5-5	663-670	engaged	_	
5-6	671-673	in	_	
5-7	674-677	the	_	
5-8	678-687	cognitive	_	
5-9	688-698	operations	_	
5-10	699-704	could	_	
5-11	705-712	account	_	
5-12	713-716	for	_	
5-13	717-722	these	_	
5-14	723-736	discrepancies	_	
5-15	736-737	,	_	
5-16	738-741	too	_	
5-17	741-742	,	_	
5-18	743-745	as	_	
5-19	746-748	it	_	
5-20	749-754	would	_	
5-21	755-759	lead	_	
5-22	760-762	to	_	
5-23	763-767	more	_	
5-24	768-772	time	_	
5-25	773-781	off-task	_	
5-26	782-785	and	_	
5-27	786-798	consequently	_	
5-28	799-803	less	_	
5-29	804-816	deactivation	_	
5-30	817-819	of	_	
5-31	820-823	DMN	_	
5-32	824-833	functions	_	
5-33	833-834	.	_	

#Text=The present study employed a change detection paradigm with small to moderate set sizes (SSs) of 1, 2, and 4 items.
6-1	835-838	The	_	
6-2	839-846	present	_	
6-3	847-852	study	_	
6-4	853-861	employed	_	
6-5	862-863	a	_	
6-6	864-870	change	_	
6-7	871-880	detection	_	
6-8	881-889	paradigm	_	
6-9	890-894	with	_	
6-10	895-900	small	_	
6-11	901-903	to	_	
6-12	904-912	moderate	_	
6-13	913-916	set	_	
6-14	917-922	sizes	_	
6-15	923-924	(	_	
6-16	924-927	SSs	_	
6-17	927-928	)	_	
6-18	929-931	of	_	
6-19	932-933	1	_	
6-20	933-934	,	_	
6-21	935-936	2	_	
6-22	936-937	,	_	
6-23	938-941	and	_	
6-24	942-943	4	_	
6-25	944-949	items	_	
6-26	949-950	.	_	

#Text=Task training prior to fMRI scanning abolished the group difference in no-response trials.
7-1	951-955	Task	_	
7-2	956-964	training	_	
7-3	965-970	prior	_	
7-4	971-973	to	_	
7-5	974-978	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
7-6	979-987	scanning	_	
7-7	988-997	abolished	_	
7-8	998-1001	the	_	
7-9	1002-1007	group	_	
7-10	1008-1018	difference	_	
7-11	1019-1021	in	_	
7-12	1022-1033	no-response	_	
7-13	1034-1040	trials	_	
7-14	1040-1041	.	_	

#Text=Task-positive regions of interest (ROIs) displayed greater activation with increasing SS in both groups.
8-1	1042-1055	Task-positive	_	
8-2	1056-1063	regions	_	
8-3	1064-1066	of	_	
8-4	1067-1075	interest	_	
8-5	1076-1077	(	_	
8-6	1077-1081	ROIs	_	
8-7	1081-1082	)	_	
8-8	1083-1092	displayed	_	
8-9	1093-1100	greater	_	
8-10	1101-1111	activation	_	
8-11	1112-1116	with	_	
8-12	1117-1127	increasing	_	
8-13	1128-1130	SS	_	
8-14	1131-1133	in	_	
8-15	1134-1138	both	_	
8-16	1139-1145	groups	_	
8-17	1145-1146	.	_	

#Text=PSZ showed greater activation relative to HCS at SSs 1 and 2.
9-1	1147-1150	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
9-2	1151-1157	showed	_	
9-3	1158-1165	greater	_	
9-4	1166-1176	activation	_	
9-5	1177-1185	relative	_	
9-6	1186-1188	to	_	
9-7	1189-1192	HCS	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
9-8	1193-1195	at	_	
9-9	1196-1199	SSs	_	
9-10	1200-1201	1	_	
9-11	1202-1205	and	_	
9-12	1206-1207	2	_	
9-13	1207-1208	.	_	

#Text=DMN ROIs displayed greater deactivation with increasing SS in PSZ, but not in HCS, and PSZ tended to hyperdeactivate DMN regions at SS 4.
10-1	1209-1212	DMN	_	
10-2	1213-1217	ROIs	_	
10-3	1218-1227	displayed	_	
10-4	1228-1235	greater	_	
10-5	1236-1248	deactivation	_	
10-6	1249-1253	with	_	
10-7	1254-1264	increasing	_	
10-8	1265-1267	SS	_	
10-9	1268-1270	in	_	
10-10	1271-1274	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
10-11	1274-1275	,	_	
10-12	1276-1279	but	_	
10-13	1280-1283	not	_	
10-14	1284-1286	in	_	
10-15	1287-1290	HCS	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
10-16	1290-1291	,	_	
10-17	1292-1295	and	_	
10-18	1296-1299	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
10-19	1300-1306	tended	_	
10-20	1307-1309	to	_	
10-21	1310-1325	hyperdeactivate	_	
10-22	1326-1329	DMN	_	
10-23	1330-1337	regions	_	
10-24	1338-1340	at	_	
10-25	1341-1343	SS	_	
10-26	1344-1345	4	_	
10-27	1345-1346	.	_	

#Text=No hypodeactivation was observed in PSZ.
11-1	1347-1349	No	_	
11-2	1350-1366	hypodeactivation	_	
11-3	1367-1370	was	_	
11-4	1371-1379	observed	_	
11-5	1380-1382	in	_	
11-6	1383-1386	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
11-7	1386-1387	.	_	

#Text=In conclusion, when minimizing differences in task-engagement, PSZ tend to over-recruit task-positive regions during low-load operations, and hyperdeactivate DMN functions at higher load, perhaps reflecting heightened non-specific vigilance or effort when dealing with cognitive challenges.
12-1	1388-1390	In	_	
12-2	1391-1401	conclusion	_	
12-3	1401-1402	,	_	
12-4	1403-1407	when	_	
12-5	1408-1418	minimizing	_	
12-6	1419-1430	differences	_	
12-7	1431-1433	in	_	
12-8	1434-1449	task-engagement	_	
12-9	1449-1450	,	_	
12-10	1451-1454	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
12-11	1455-1459	tend	_	
12-12	1460-1462	to	_	
12-13	1463-1475	over-recruit	_	
12-14	1476-1489	task-positive	_	
12-15	1490-1497	regions	_	
12-16	1498-1504	during	_	
12-17	1505-1513	low-load	_	
12-18	1514-1524	operations	_	
12-19	1524-1525	,	_	
12-20	1526-1529	and	_	
12-21	1530-1545	hyperdeactivate	_	
12-22	1546-1549	DMN	_	
12-23	1550-1559	functions	_	
12-24	1560-1562	at	_	
12-25	1563-1569	higher	_	
12-26	1570-1574	load	_	
12-27	1574-1575	,	_	
12-28	1576-1583	perhaps	_	
12-29	1584-1594	reflecting	_	
12-30	1595-1605	heightened	_	
12-31	1606-1618	non-specific	_	
12-32	1619-1628	vigilance	_	
12-33	1629-1631	or	_	
12-34	1632-1638	effort	_	
12-35	1639-1643	when	_	
12-36	1644-1651	dealing	_	
12-37	1652-1656	with	_	
12-38	1657-1666	cognitive	_	
12-39	1667-1677	challenges	_	
12-40	1677-1678	.	_	

#Text=This speaks against an inability to down-regulate task-independent thought processes as a primary mechanism underlying cognitive impairment in schizophrenia.
13-1	1679-1683	This	_	
13-2	1684-1690	speaks	_	
13-3	1691-1698	against	_	
13-4	1699-1701	an	_	
13-5	1702-1711	inability	_	
13-6	1712-1714	to	_	
13-7	1715-1728	down-regulate	_	
13-8	1729-1745	task-independent	_	
13-9	1746-1753	thought	_	
13-10	1754-1763	processes	_	
13-11	1764-1766	as	_	
13-12	1767-1768	a	_	
13-13	1769-1776	primary	_	
13-14	1777-1786	mechanism	_	
13-15	1787-1797	underlying	_	
13-16	1798-1807	cognitive	_	
13-17	1808-1818	impairment	_	
13-18	1819-1821	in	_	
13-19	1822-1835	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
13-20	1835-1836	.	_	

#Text=Introduction
#Text=Schizophrenia is associated with impairment in a range of cognitive functions.
14-1	1837-1849	Introduction	_	
14-2	1850-1863	Schizophrenia	_	
14-3	1864-1866	is	_	
14-4	1867-1877	associated	_	
14-5	1878-1882	with	_	
14-6	1883-1893	impairment	_	
14-7	1894-1896	in	_	
14-8	1897-1898	a	_	
14-9	1899-1904	range	_	
14-10	1905-1907	of	_	
14-11	1908-1917	cognitive	_	
14-12	1918-1927	functions	_	
14-13	1927-1928	.	_	

#Text=Accompanying activation differences in task-specific brain areas have been studied extensively.
15-1	1929-1941	Accompanying	_	
15-2	1942-1952	activation	_	
15-3	1953-1964	differences	_	
15-4	1965-1967	in	_	
15-5	1968-1981	task-specific	_	
15-6	1982-1987	brain	_	
15-7	1988-1993	areas	_	
15-8	1994-1998	have	_	
15-9	1999-2003	been	_	
15-10	2004-2011	studied	_	
15-11	2012-2023	extensively	_	
15-12	2023-2024	.	_	

#Text=Recently, the focus has widened to include task-related deactivations.
16-1	2025-2033	Recently	_	
16-2	2033-2034	,	_	
16-3	2035-2038	the	_	
16-4	2039-2044	focus	_	
16-5	2045-2048	has	_	
16-6	2049-2056	widened	_	
16-7	2057-2059	to	_	
16-8	2060-2067	include	_	
16-9	2068-2080	task-related	_	
16-10	2081-2094	deactivations	_	
16-11	2094-2095	.	_	

#Text=A relatively consistent set of brain regions has been shown to deactivate during various external processing tasks relative to rest.
17-1	2096-2097	A	_	
17-2	2098-2108	relatively	_	
17-3	2109-2119	consistent	_	
17-4	2120-2123	set	_	
17-5	2124-2126	of	_	
17-6	2127-2132	brain	_	
17-7	2133-2140	regions	_	
17-8	2141-2144	has	_	
17-9	2145-2149	been	_	
17-10	2150-2155	shown	_	
17-11	2156-2158	to	_	
17-12	2159-2169	deactivate	_	
17-13	2170-2176	during	_	
17-14	2177-2184	various	_	
17-15	2185-2193	external	_	
17-16	2194-2204	processing	_	
17-17	2205-2210	tasks	_	
17-18	2211-2219	relative	_	
17-19	2220-2222	to	_	
17-20	2223-2227	rest	_	
17-21	2227-2228	.	_	

#Text=These areas, termed the default mode network (DMN) of resting brain function, are thought to subserve stimulus-independent thought processes such as mind-wandering when the individual is not engaged in external stimulus processing.
18-1	2229-2234	These	_	
18-2	2235-2240	areas	_	
18-3	2240-2241	,	_	
18-4	2242-2248	termed	_	
18-5	2249-2252	the	_	
18-6	2253-2260	default	_	
18-7	2261-2265	mode	_	
18-8	2266-2273	network	_	
18-9	2274-2275	(	_	
18-10	2275-2278	DMN	_	
18-11	2278-2279	)	_	
18-12	2280-2282	of	_	
18-13	2283-2290	resting	_	
18-14	2291-2296	brain	_	
18-15	2297-2305	function	_	
18-16	2305-2306	,	_	
18-17	2307-2310	are	_	
18-18	2311-2318	thought	_	
18-19	2319-2321	to	_	
18-20	2322-2330	subserve	_	
18-21	2331-2351	stimulus-independent	_	
18-22	2352-2359	thought	_	
18-23	2360-2369	processes	_	
18-24	2370-2374	such	_	
18-25	2375-2377	as	_	
18-26	2378-2392	mind-wandering	_	
18-27	2393-2397	when	_	
18-28	2398-2401	the	_	
18-29	2402-2412	individual	_	
18-30	2413-2415	is	_	
18-31	2416-2419	not	_	
18-32	2420-2427	engaged	_	
18-33	2428-2430	in	_	
18-34	2431-2439	external	_	
18-35	2440-2448	stimulus	_	
18-36	2449-2459	processing	_	
18-37	2459-2460	.	_	

#Text=Down-regulation of DMN activity appears to be necessary for successful cognitive performance (e.g.).
19-1	2461-2476	Down-regulation	_	
19-2	2477-2479	of	_	
19-3	2480-2483	DMN	_	
19-4	2484-2492	activity	_	
19-5	2493-2500	appears	_	
19-6	2501-2503	to	_	
19-7	2504-2506	be	_	
19-8	2507-2516	necessary	_	
19-9	2517-2520	for	_	
19-10	2521-2531	successful	_	
19-11	2532-2541	cognitive	_	
19-12	2542-2553	performance	_	
19-13	2554-2555	(	_	
19-14	2555-2558	e.g	_	
19-15	2558-2559	.	_	
19-16	2559-2560	)	_	
19-17	2560-2561	.	_	

#Text=Functional Magnetic Resonance Imaging (fMRI) studies of cognition reported less pronounced task-induced DMN deactivation in people with schizophrenia (PSZ) than in healthy control subjects (HCS).
20-1	2562-2572	Functional	_	
20-2	2573-2581	Magnetic	_	
20-3	2582-2591	Resonance	_	
20-4	2592-2599	Imaging	_	
20-5	2600-2601	(	_	
20-6	2601-2605	fMRI	_	
20-7	2605-2606	)	_	
20-8	2607-2614	studies	_	
20-9	2615-2617	of	_	
20-10	2618-2627	cognition	_	
20-11	2628-2636	reported	_	
20-12	2637-2641	less	_	
20-13	2642-2652	pronounced	_	
20-14	2653-2665	task-induced	_	
20-15	2666-2669	DMN	_	
20-16	2670-2682	deactivation	_	
20-17	2683-2685	in	_	
20-18	2686-2692	people	_	
20-19	2693-2697	with	_	
20-20	2698-2711	schizophrenia	_	
20-21	2712-2713	(	_	
20-22	2713-2716	PSZ	_	
20-23	2716-2717	)	_	
20-24	2718-2722	than	_	
20-25	2723-2725	in	_	
20-26	2726-2733	healthy	_	
20-27	2734-2741	control	_	
20-28	2742-2750	subjects	_	
20-29	2751-2752	(	_	
20-30	2752-2755	HCS	_	
20-31	2755-2756	)	_	
20-32	2756-2757	.	_	

#Text=Such findings led to suggestions that an inability to down-regulate task-independent thought processes may contribute to cognitive impairment in PSZ.
21-1	2758-2762	Such	_	
21-2	2763-2771	findings	_	
21-3	2772-2775	led	_	
21-4	2776-2778	to	_	
21-5	2779-2790	suggestions	_	
21-6	2791-2795	that	_	
21-7	2796-2798	an	_	
21-8	2799-2808	inability	_	
21-9	2809-2811	to	_	
21-10	2812-2825	down-regulate	_	
21-11	2826-2842	task-independent	_	
21-12	2843-2850	thought	_	
21-13	2851-2860	processes	_	
21-14	2861-2864	may	_	
21-15	2865-2875	contribute	_	
21-16	2876-2878	to	_	
21-17	2879-2888	cognitive	_	
21-18	2889-2899	impairment	_	
21-19	2900-2902	in	_	
21-20	2903-2906	PSZ	_	
21-21	2906-2907	.	_	

#Text=There are, however, discrepant reports of DMN hyperdeactivation in PSZ, with support also from a study employing constrained principle component analysis.
22-1	2908-2913	There	_	
22-2	2914-2917	are	_	
22-3	2917-2918	,	_	
22-4	2919-2926	however	_	
22-5	2926-2927	,	_	
22-6	2928-2938	discrepant	_	
22-7	2939-2946	reports	_	
22-8	2947-2949	of	_	
22-9	2950-2953	DMN	_	
22-10	2954-2971	hyperdeactivation	_	
22-11	2972-2974	in	_	
22-12	2975-2978	PSZ	_	
22-13	2978-2979	,	_	
22-14	2980-2984	with	_	
22-15	2985-2992	support	_	
22-16	2993-2997	also	_	
22-17	2998-3002	from	_	
22-18	3003-3004	a	_	
22-19	3005-3010	study	_	
22-20	3011-3020	employing	_	
22-21	3021-3032	constrained	_	
22-22	3033-3042	principle	_	
22-23	3043-3052	component	_	
22-24	3053-3061	analysis	_	
22-25	3061-3062	.	_	

#Text=These three studies have in common that performance of PSZ displayed no clear impairment relative to HCS, whereas PSZ performed significantly worse in most studies reporting hypodeactivation. employed extensive task practice prior to scanning, which eliminated the group difference in the number of no-response trials and appeared to equate the time spent “off-task”.
23-1	3063-3068	These	_	
23-2	3069-3074	three	_	
23-3	3075-3082	studies	_	
23-4	3083-3087	have	_	
23-5	3088-3090	in	_	
23-6	3091-3097	common	_	
23-7	3098-3102	that	_	
23-8	3103-3114	performance	_	
23-9	3115-3117	of	_	
23-10	3118-3121	PSZ	_	
23-11	3122-3131	displayed	_	
23-12	3132-3134	no	_	
23-13	3135-3140	clear	_	
23-14	3141-3151	impairment	_	
23-15	3152-3160	relative	_	
23-16	3161-3163	to	_	
23-17	3164-3167	HCS	_	
23-18	3167-3168	,	_	
23-19	3169-3176	whereas	_	
23-20	3177-3180	PSZ	_	
23-21	3181-3190	performed	_	
23-22	3191-3204	significantly	_	
23-23	3205-3210	worse	_	
23-24	3211-3213	in	_	
23-25	3214-3218	most	_	
23-26	3219-3226	studies	_	
23-27	3227-3236	reporting	_	
23-28	3237-3253	hypodeactivation	_	
23-29	3253-3254	.	_	
23-30	3255-3263	employed	_	
23-31	3264-3273	extensive	_	
23-32	3274-3278	task	_	
23-33	3279-3287	practice	_	
23-34	3288-3293	prior	_	
23-35	3294-3296	to	_	
23-36	3297-3305	scanning	_	
23-37	3305-3306	,	_	
23-38	3307-3312	which	_	
23-39	3313-3323	eliminated	_	
23-40	3324-3327	the	_	
23-41	3328-3333	group	_	
23-42	3334-3344	difference	_	
23-43	3345-3347	in	_	
23-44	3348-3351	the	_	
23-45	3352-3358	number	_	
23-46	3359-3361	of	_	
23-47	3362-3373	no-response	_	
23-48	3374-3380	trials	_	
23-49	3381-3384	and	_	
23-50	3385-3393	appeared	_	
23-51	3394-3396	to	_	
23-52	3397-3403	equate	_	
23-53	3404-3407	the	_	
23-54	3408-3412	time	_	
23-55	3413-3418	spent	_	
23-56	3419-3420	“	_	
23-57	3420-3428	off-task	_	
23-58	3428-3429	”	_	
23-59	3429-3430	.	_	

#Text=This suggests that difficulty managing the cognitive operations and maintaining task engagement may have contributed to findings of DMN hypodeactivation in other studies.
24-1	3431-3435	This	_	
24-2	3436-3444	suggests	_	
24-3	3445-3449	that	_	
24-4	3450-3460	difficulty	_	
24-5	3461-3469	managing	_	
24-6	3470-3473	the	_	
24-7	3474-3483	cognitive	_	
24-8	3484-3494	operations	_	
24-9	3495-3498	and	_	
24-10	3499-3510	maintaining	_	
24-11	3511-3515	task	_	
24-12	3516-3526	engagement	_	
24-13	3527-3530	may	_	
24-14	3531-3535	have	_	
24-15	3536-3547	contributed	_	
24-16	3548-3550	to	_	
24-17	3551-3559	findings	_	
24-18	3560-3562	of	_	
24-19	3563-3566	DMN	_	
24-20	3567-3583	hypodeactivation	_	
24-21	3584-3586	in	_	
24-22	3587-3592	other	_	
24-23	3593-3600	studies	_	
24-24	3600-3601	.	_	

#Text=These considerations are reminiscent of the neuroimaging literature on working memory (WM).
25-1	3602-3607	These	_	
25-2	3608-3622	considerations	_	
25-3	3623-3626	are	_	
25-4	3627-3638	reminiscent	_	
25-5	3639-3641	of	_	
25-6	3642-3645	the	_	
25-7	3646-3658	neuroimaging	_	
25-8	3659-3669	literature	_	
25-9	3670-3672	on	_	
25-10	3673-3680	working	_	
25-11	3681-3687	memory	_	
25-12	3688-3689	(	_	
25-13	3689-3691	WM	_	
25-14	3691-3692	)	_	
25-15	3692-3693	.	_	

#Text=While early studies overwhelmingly supported lower prefrontal cortex (PFC) activation in PSZ, several subsequent studies reported equal or even greater activation.
26-1	3694-3699	While	_	
26-2	3700-3705	early	_	
26-3	3706-3713	studies	_	
26-4	3714-3728	overwhelmingly	_	
26-5	3729-3738	supported	_	
26-6	3739-3744	lower	_	
26-7	3745-3755	prefrontal	_	
26-8	3756-3762	cortex	_	
26-9	3763-3764	(	_	
26-10	3764-3767	PFC	_	
26-11	3767-3768	)	_	
26-12	3769-3779	activation	_	
26-13	3780-3782	in	_	
26-14	3783-3786	PSZ	_	
26-15	3786-3787	,	_	
26-16	3788-3795	several	_	
26-17	3796-3806	subsequent	_	
26-18	3807-3814	studies	_	
26-19	3815-3823	reported	_	
26-20	3824-3829	equal	_	
26-21	3830-3832	or	_	
26-22	3833-3837	even	_	
26-23	3838-3845	greater	_	
26-24	3846-3856	activation	_	
26-25	3856-3857	.	_	

#Text=This may reflect the inverted-U relationship between WM load and PFC activation.
27-1	3858-3862	This	_	
27-2	3863-3866	may	_	
27-3	3867-3874	reflect	_	
27-4	3875-3878	the	_	
27-5	3879-3889	inverted-U	_	
27-6	3890-3902	relationship	_	
27-7	3903-3910	between	_	
27-8	3911-3913	WM	_	
27-9	3914-3918	load	_	
27-10	3919-3922	and	_	
27-11	3923-3926	PFC	_	
27-12	3927-3937	activation	_	
27-13	3937-3938	.	_	

#Text=Greater load increases activation, but when it exceeds an individual’s capacity, activation decreases.
28-1	3939-3946	Greater	_	
28-2	3947-3951	load	_	
28-3	3952-3961	increases	_	
28-4	3962-3972	activation	_	
28-5	3972-3973	,	_	
28-6	3974-3977	but	_	
28-7	3978-3982	when	_	
28-8	3983-3985	it	_	
28-9	3986-3993	exceeds	_	
28-10	3994-3996	an	_	
28-11	3997-4007	individual	_	
28-12	4007-4008	’	_	
28-13	4008-4009	s	_	
28-14	4010-4018	capacity	_	
28-15	4018-4019	,	_	
28-16	4020-4030	activation	_	
28-17	4031-4040	decreases	_	
28-18	4040-4041	.	_	

#Text=Thus, when imposing task demands manageable for HCS but exceeding the capacity of PSZ, PFC activation would be lower in PSZ.
29-1	4042-4046	Thus	_	
29-2	4046-4047	,	_	
29-3	4048-4052	when	_	
29-4	4053-4061	imposing	_	
29-5	4062-4066	task	_	
29-6	4067-4074	demands	_	
29-7	4075-4085	manageable	_	
29-8	4086-4089	for	_	
29-9	4090-4093	HCS	_	
29-10	4094-4097	but	_	
29-11	4098-4107	exceeding	_	
29-12	4108-4111	the	_	
29-13	4112-4120	capacity	_	
29-14	4121-4123	of	_	
29-15	4124-4127	PSZ	_	
29-16	4127-4128	,	_	
29-17	4129-4132	PFC	_	
29-18	4133-4143	activation	_	
29-19	4144-4149	would	_	
29-20	4150-4152	be	_	
29-21	4153-4158	lower	_	
29-22	4159-4161	in	_	
29-23	4162-4165	PSZ	_	
29-24	4165-4166	.	_	

#Text=Indeed, across studies, larger performance deficits of PSZ tend to be associated with greater hypofrontality.
30-1	4167-4173	Indeed	_	
30-2	4173-4174	,	_	
30-3	4175-4181	across	_	
30-4	4182-4189	studies	_	
30-5	4189-4190	,	_	
30-6	4191-4197	larger	_	
30-7	4198-4209	performance	_	
30-8	4210-4218	deficits	_	
30-9	4219-4221	of	_	
30-10	4222-4225	PSZ	_	
30-11	4226-4230	tend	_	
30-12	4231-4233	to	_	
30-13	4234-4236	be	_	
30-14	4237-4247	associated	_	
30-15	4248-4252	with	_	
30-16	4253-4260	greater	_	
30-17	4261-4275	hypofrontality	_	
30-18	4275-4276	.	_	

#Text=In contrast, greater activation can be observed in PSZ at lower WM loads, which are manageable but more challenging to PSZ than to HCS.
31-1	4277-4279	In	_	
31-2	4280-4288	contrast	_	
31-3	4288-4289	,	_	
31-4	4290-4297	greater	_	
31-5	4298-4308	activation	_	
31-6	4309-4312	can	_	
31-7	4313-4315	be	_	
31-8	4316-4324	observed	_	
31-9	4325-4327	in	_	
31-10	4328-4331	PSZ	_	
31-11	4332-4334	at	_	
31-12	4335-4340	lower	_	
31-13	4341-4343	WM	_	
31-14	4344-4349	loads	_	
31-15	4349-4350	,	_	
31-16	4351-4356	which	_	
31-17	4357-4360	are	_	
31-18	4361-4371	manageable	_	
31-19	4372-4375	but	_	
31-20	4376-4380	more	_	
31-21	4381-4392	challenging	_	
31-22	4393-4395	to	_	
31-23	4396-4399	PSZ	_	
31-24	4400-4404	than	_	
31-25	4405-4407	to	_	
31-26	4408-4411	HCS	_	
31-27	4411-4412	.	_	

#Text=The present fMRI study compared WM load-dependent activation of typical task-positive regions, and deactivation of the DMN, between PSZ and HCS.
32-1	4413-4416	The	_	
32-2	4417-4424	present	_	
32-3	4425-4429	fMRI	_	
32-4	4430-4435	study	_	
32-5	4436-4444	compared	_	
32-6	4445-4447	WM	_	
32-7	4448-4462	load-dependent	_	
32-8	4463-4473	activation	_	
32-9	4474-4476	of	_	
32-10	4477-4484	typical	_	
32-11	4485-4498	task-positive	_	
32-12	4499-4506	regions	_	
32-13	4506-4507	,	_	
32-14	4508-4511	and	_	
32-15	4512-4524	deactivation	_	
32-16	4525-4527	of	_	
32-17	4528-4531	the	_	
32-18	4532-4535	DMN	_	
32-19	4535-4536	,	_	
32-20	4537-4544	between	_	
32-21	4545-4548	PSZ	_	
32-22	4549-4552	and	_	
32-23	4553-4556	HCS	_	
32-24	4556-4557	.	_	

#Text=Load was varied as the number of items maintained in a Change Detection Task (CDT).
33-1	4558-4562	Load	_	
33-2	4563-4566	was	_	
33-3	4567-4573	varied	_	
33-4	4574-4576	as	_	
33-5	4577-4580	the	_	
33-6	4581-4587	number	_	
33-7	4588-4590	of	_	
33-8	4591-4596	items	_	
33-9	4597-4607	maintained	_	
33-10	4608-4610	in	_	
33-11	4611-4612	a	_	
33-12	4613-4619	Change	_	
33-13	4620-4629	Detection	_	
33-14	4630-4634	Task	_	
33-15	4635-4636	(	_	
33-16	4636-4639	CDT	_	
33-17	4639-4640	)	_	
33-18	4640-4641	.	_	

#Text=Reduced WM capacity in PSZ has been shown in similar paradigms; however, by keeping the set size (SS) modest and providing extensive practice prior to scanning, we aimed at evoking at most minimally impaired performance and comparable task engagement in PSZ and HCS.
34-1	4642-4649	Reduced	_	
34-2	4650-4652	WM	_	
34-3	4653-4661	capacity	_	
34-4	4662-4664	in	_	
34-5	4665-4668	PSZ	_	
34-6	4669-4672	has	_	
34-7	4673-4677	been	_	
34-8	4678-4683	shown	_	
34-9	4684-4686	in	_	
34-10	4687-4694	similar	_	
34-11	4695-4704	paradigms	_	
34-12	4704-4705	;	_	
34-13	4706-4713	however	_	
34-14	4713-4714	,	_	
34-15	4715-4717	by	_	
34-16	4718-4725	keeping	_	
34-17	4726-4729	the	_	
34-18	4730-4733	set	_	
34-19	4734-4738	size	_	
34-20	4739-4740	(	_	
34-21	4740-4742	SS	_	
34-22	4742-4743	)	_	
34-23	4744-4750	modest	_	
34-24	4751-4754	and	_	
34-25	4755-4764	providing	_	
34-26	4765-4774	extensive	_	
34-27	4775-4783	practice	_	
34-28	4784-4789	prior	_	
34-29	4790-4792	to	_	
34-30	4793-4801	scanning	_	
34-31	4801-4802	,	_	
34-32	4803-4805	we	_	
34-33	4806-4811	aimed	_	
34-34	4812-4814	at	_	
34-35	4815-4822	evoking	_	
34-36	4823-4825	at	_	
34-37	4826-4830	most	_	
34-38	4831-4840	minimally	_	
34-39	4841-4849	impaired	_	
34-40	4850-4861	performance	_	
34-41	4862-4865	and	_	
34-42	4866-4876	comparable	_	
34-43	4877-4881	task	_	
34-44	4882-4892	engagement	_	
34-45	4893-4895	in	_	
34-46	4896-4899	PSZ	_	
34-47	4900-4903	and	_	
34-48	4904-4907	HCS	_	
34-49	4907-4908	.	_	

#Text=We hypothesized that, under these conditions, both activation of task-positive and deactivation of DMN regions would be equal or greater in PSZ relative to HCS, but not reduced.
35-1	4909-4911	We	_	
35-2	4912-4924	hypothesized	_	
35-3	4925-4929	that	_	
35-4	4929-4930	,	_	
35-5	4931-4936	under	_	
35-6	4937-4942	these	_	
35-7	4943-4953	conditions	_	
35-8	4953-4954	,	_	
35-9	4955-4959	both	_	
35-10	4960-4970	activation	_	
35-11	4971-4973	of	_	
35-12	4974-4987	task-positive	_	
35-13	4988-4991	and	_	
35-14	4992-5004	deactivation	_	
35-15	5005-5007	of	_	
35-16	5008-5011	DMN	_	
35-17	5012-5019	regions	_	
35-18	5020-5025	would	_	
35-19	5026-5028	be	_	
35-20	5029-5034	equal	_	
35-21	5035-5037	or	_	
35-22	5038-5045	greater	_	
35-23	5046-5048	in	_	
35-24	5049-5052	PSZ	_	
35-25	5053-5061	relative	_	
35-26	5062-5064	to	_	
35-27	5065-5068	HCS	_	
35-28	5068-5069	,	_	
35-29	5070-5073	but	_	
35-30	5074-5077	not	_	
35-31	5078-5085	reduced	_	
35-32	5085-5086	.	_	

#Text=Materials and Methods
#Text=Participants
#Text=Twenty-two medicated (detail in Supplement) outpatients meeting DSM-IV criteria for schizophrenia (N=21) or schizoaffective disorder (N=1), and 20 HCS, all right-handed, completed this study.
36-1	5087-5096	Materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
36-2	5097-5100	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
36-3	5101-5108	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[3]	
36-4	5109-5121	Participants	_	
36-5	5122-5132	Twenty-two	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-6	5133-5142	medicated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-7	5143-5144	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-8	5144-5150	detail	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-9	5151-5153	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-10	5154-5164	Supplement	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-11	5164-5165	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-12	5166-5177	outpatients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-13	5178-5185	meeting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-14	5186-5192	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-15	5193-5201	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-16	5202-5205	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-17	5206-5219	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
36-18	5220-5221	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-19	5221-5222	N	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-20	5222-5223	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-21	5223-5225	21	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-22	5225-5226	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-23	5227-5229	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-24	5230-5245	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[6]	
36-25	5246-5254	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[6]	
36-26	5255-5256	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-27	5256-5257	N	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-28	5257-5258	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-29	5258-5259	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-30	5259-5260	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-31	5260-5261	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-32	5262-5265	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-33	5266-5268	20	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-34	5269-5272	HCS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[7]	
36-35	5272-5273	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-36	5274-5277	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-37	5278-5290	right-handed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-38	5290-5291	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-39	5292-5301	completed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-40	5302-5306	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-41	5307-5312	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
36-42	5312-5313	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	

#Text=Data from four HCS and one PSZ were excluded because they appeared to be asleep during parts of the scan.
37-1	5314-5318	Data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-2	5319-5323	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-3	5324-5328	four	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-4	5329-5332	HCS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[9]	
37-5	5333-5336	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-6	5337-5340	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-7	5341-5344	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[10]	
37-8	5345-5349	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-9	5350-5358	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-10	5359-5366	because	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-11	5367-5371	they	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-12	5372-5380	appeared	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-13	5381-5383	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-14	5384-5386	be	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-15	5387-5393	asleep	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-16	5394-5400	during	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-17	5401-5406	parts	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-18	5407-5409	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-19	5410-5413	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-20	5414-5418	scan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
37-21	5418-5419	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=Demographic information of the remaining participants is summarized in Table 1.
38-1	5420-5431	Demographic	_	
38-2	5432-5443	information	_	
38-3	5444-5446	of	_	
38-4	5447-5450	the	_	
38-5	5451-5460	remaining	_	
38-6	5461-5473	participants	_	
38-7	5474-5476	is	_	
38-8	5477-5487	summarized	_	
38-9	5488-5490	in	_	
38-10	5491-5496	Table	_	
38-11	5497-5498	1	_	
38-12	5498-5499	.	_	

#Text=Groups did not differ in age, sex, ethnicity, or parental education.
39-1	5500-5506	Groups	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-2	5507-5510	did	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-3	5511-5514	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-4	5515-5521	differ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-5	5522-5524	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-6	5525-5528	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-7	5528-5529	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-8	5530-5533	sex	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-9	5533-5534	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-10	5535-5544	ethnicity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-11	5544-5545	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-12	5546-5548	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-13	5549-5557	parental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-14	5558-5567	education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
39-15	5567-5568	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=PSZ tended to have fewer years of education (P<0.1) and scored lower on neuropsychological tests of cognition.
40-1	5569-5572	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
40-2	5573-5579	tended	_	
40-3	5580-5582	to	_	
40-4	5583-5587	have	_	
40-5	5588-5593	fewer	_	
40-6	5594-5599	years	_	
40-7	5600-5602	of	_	
40-8	5603-5612	education	_	
40-9	5613-5614	(	_	
40-10	5614-5615	P	_	
40-11	5615-5616	<	_	
40-12	5616-5619	0.1	_	
40-13	5619-5620	)	_	
40-14	5621-5624	and	_	
40-15	5625-5631	scored	_	
40-16	5632-5637	lower	_	
40-17	5638-5640	on	_	
40-18	5641-5659	neuropsychological	_	
40-19	5660-5665	tests	_	
40-20	5666-5668	of	_	
40-21	5669-5678	cognition	_	
40-22	5678-5679	.	_	

#Text=Because blood pressure can affect BOLD responses to neuronal activation, we compared groups on systolic (P>0.6) and diastolic blood pressure (P>0.3).
41-1	5680-5687	Because	_	
41-2	5688-5693	blood	_	
41-3	5694-5702	pressure	_	
41-4	5703-5706	can	_	
41-5	5707-5713	affect	_	
41-6	5714-5718	BOLD	_	
41-7	5719-5728	responses	_	
41-8	5729-5731	to	_	
41-9	5732-5740	neuronal	_	
41-10	5741-5751	activation	_	
41-11	5751-5752	,	_	
41-12	5753-5755	we	_	
41-13	5756-5764	compared	_	
41-14	5765-5771	groups	_	
41-15	5772-5774	on	_	
41-16	5775-5783	systolic	_	
41-17	5784-5785	(	_	
41-18	5785-5786	P	_	
41-19	5786-5787	>	_	
41-20	5787-5790	0.6	_	
41-21	5790-5791	)	_	
41-22	5792-5795	and	_	
41-23	5796-5805	diastolic	_	
41-24	5806-5811	blood	_	
41-25	5812-5820	pressure	_	
41-26	5821-5822	(	_	
41-27	5822-5823	P	_	
41-28	5823-5824	>	_	
41-29	5824-5827	0.3	_	
41-30	5827-5828	)	_	
41-31	5828-5829	.	_	

#Text=Participants provided informed consent for a protocol approved by the Institutional Review Boards of the University of Maryland, Baltimore, and the National Institute on Drug Abuse – Intramural Research Program.
42-1	5830-5842	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-2	5843-5851	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-3	5852-5860	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-4	5861-5868	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-5	5869-5872	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-6	5873-5874	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-7	5875-5883	protocol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-8	5884-5892	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-9	5893-5895	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-10	5896-5899	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-11	5900-5913	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-12	5914-5920	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-13	5921-5927	Boards	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-14	5928-5930	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-15	5931-5934	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-16	5935-5945	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-17	5946-5948	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-18	5949-5957	Maryland	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-19	5957-5958	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-20	5959-5968	Baltimore	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-21	5968-5969	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-22	5970-5973	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-23	5974-5977	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-24	5978-5986	National	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-25	5987-5996	Institute	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-26	5997-5999	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-27	6000-6004	Drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-28	6005-6010	Abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-29	6011-6012	–	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-30	6013-6023	Intramural	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-31	6024-6032	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-32	6033-6040	Program	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
42-33	6040-6041	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	

#Text=Procedure
#Text=During an initial training session, participants received task instructions, performed the full-length tasks on a PC, and completed neuropsychological testing.
43-1	6042-6051	Procedure	_	
43-2	6052-6058	During	_	
43-3	6059-6061	an	_	
43-4	6062-6069	initial	_	
43-5	6070-6078	training	_	
43-6	6079-6086	session	_	
43-7	6086-6087	,	_	
43-8	6088-6100	participants	_	
43-9	6101-6109	received	_	
43-10	6110-6114	task	_	
43-11	6115-6127	instructions	_	
43-12	6127-6128	,	_	
43-13	6129-6138	performed	_	
43-14	6139-6142	the	_	
43-15	6143-6154	full-length	_	
43-16	6155-6160	tasks	_	
43-17	6161-6163	on	_	
43-18	6164-6165	a	_	
43-19	6166-6168	PC	_	
43-20	6168-6169	,	_	
43-21	6170-6173	and	_	
43-22	6174-6183	completed	_	
43-23	6184-6202	neuropsychological	_	
43-24	6203-6210	testing	_	
43-25	6210-6211	.	_	

#Text=Training performance data from one PSZ was lost due to recording errors.
44-1	6212-6220	Training	_	
44-2	6221-6232	performance	_	
44-3	6233-6237	data	_	
44-4	6238-6242	from	_	
44-5	6243-6246	one	_	
44-6	6247-6250	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
44-7	6251-6254	was	_	
44-8	6255-6259	lost	_	
44-9	6260-6263	due	_	
44-10	6264-6266	to	_	
44-11	6267-6276	recording	_	
44-12	6277-6283	errors	_	
44-13	6283-6284	.	_	

#Text=Scans were always performed on a separate day to avoid exhaustion.
45-1	6285-6290	Scans	_	
45-2	6291-6295	were	_	
45-3	6296-6302	always	_	
45-4	6303-6312	performed	_	
45-5	6313-6315	on	_	
45-6	6316-6317	a	_	
45-7	6318-6326	separate	_	
45-8	6327-6330	day	_	
45-9	6331-6333	to	_	
45-10	6334-6339	avoid	_	
45-11	6340-6350	exhaustion	_	
45-12	6350-6351	.	_	

#Text=Participants performed two tasks while undergoing fMRI: first a stimulus detection task, reported elsewhere, then the CDT described below.
46-1	6352-6364	Participants	_	
46-2	6365-6374	performed	_	
46-3	6375-6378	two	_	
46-4	6379-6384	tasks	_	
46-5	6385-6390	while	_	
46-6	6391-6401	undergoing	_	
46-7	6402-6406	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
46-8	6406-6407	:	_	
46-9	6408-6413	first	_	
46-10	6414-6415	a	_	
46-11	6416-6424	stimulus	_	
46-12	6425-6434	detection	_	
46-13	6435-6439	task	_	
46-14	6439-6440	,	_	
46-15	6441-6449	reported	_	
46-16	6450-6459	elsewhere	_	
46-17	6459-6460	,	_	
46-18	6461-6465	then	_	
46-19	6466-6469	the	_	
46-20	6470-6473	CDT	_	
46-21	6474-6483	described	_	
46-22	6484-6489	below	_	
46-23	6489-6490	.	_	

#Text=An anatomical scan was obtained between tasks.
47-1	6491-6493	An	_	
47-2	6494-6504	anatomical	_	
47-3	6505-6509	scan	_	
47-4	6510-6513	was	_	
47-5	6514-6522	obtained	_	
47-6	6523-6530	between	_	
47-7	6531-6536	tasks	_	
47-8	6536-6537	.	_	

#Text=The CDT was preceded by four blocks of a visuomotor control task, not reported here.
48-1	6538-6541	The	_	
48-2	6542-6545	CDT	_	
48-3	6546-6549	was	_	
48-4	6550-6558	preceded	_	
48-5	6559-6561	by	_	
48-6	6562-6566	four	_	
48-7	6567-6573	blocks	_	
48-8	6574-6576	of	_	
48-9	6577-6578	a	_	
48-10	6579-6589	visuomotor	_	
48-11	6590-6597	control	_	
48-12	6598-6602	task	_	
48-13	6602-6603	,	_	
48-14	6604-6607	not	_	
48-15	6608-6616	reported	_	
48-16	6617-6621	here	_	
48-17	6621-6622	.	_	

#Text=The CDT
#Text=The design was first described by.
49-1	6623-6626	The	_	
49-2	6627-6630	CDT	_	
49-3	6631-6634	The	_	
49-4	6635-6641	design	_	
49-5	6642-6645	was	_	
49-6	6646-6651	first	_	
49-7	6652-6661	described	_	
49-8	6662-6664	by	_	
49-9	6664-6665	.	_	

#Text=Participants viewed a 200-ms encoding array of 1, 2, or 4 colored squares, circles, or triangles (each participant was allocated one shape) against a black background (Figure 1A).
50-1	6666-6678	Participants	_	
50-2	6679-6685	viewed	_	
50-3	6686-6687	a	_	
50-4	6688-6691	200	_	
50-5	6691-6692	-	_	
50-6	6692-6694	ms	_	
50-7	6695-6703	encoding	_	
50-8	6704-6709	array	_	
50-9	6710-6712	of	_	
50-10	6713-6714	1	_	
50-11	6714-6715	,	_	
50-12	6716-6717	2	_	
50-13	6717-6718	,	_	
50-14	6719-6721	or	_	
50-15	6722-6723	4	_	
50-16	6724-6731	colored	_	
50-17	6732-6739	squares	_	
50-18	6739-6740	,	_	
50-19	6741-6748	circles	_	
50-20	6748-6749	,	_	
50-21	6750-6752	or	_	
50-22	6753-6762	triangles	_	
50-23	6763-6764	(	_	
50-24	6764-6768	each	_	
50-25	6769-6780	participant	_	
50-26	6781-6784	was	_	
50-27	6785-6794	allocated	_	
50-28	6795-6798	one	_	
50-29	6799-6804	shape	_	
50-30	6804-6805	)	_	
50-31	6806-6813	against	_	
50-32	6814-6815	a	_	
50-33	6816-6821	black	_	
50-34	6822-6832	background	_	
50-35	6833-6834	(	_	
50-36	6834-6840	Figure	_	
50-37	6841-6843	1A	_	
50-38	6843-6844	)	_	
50-39	6844-6845	.	_	

#Text=After a 1100-ms blank-screen delay, one of the shape stimuli reappeared for 2000 ms.
51-1	6846-6851	After	_	
51-2	6852-6853	a	_	
51-3	6854-6858	1100	_	
51-4	6858-6859	-	_	
51-5	6859-6861	ms	_	
51-6	6862-6874	blank-screen	_	
51-7	6875-6880	delay	_	
51-8	6880-6881	,	_	
51-9	6882-6885	one	_	
51-10	6886-6888	of	_	
51-11	6889-6892	the	_	
51-12	6893-6898	shape	_	
51-13	6899-6906	stimuli	_	
51-14	6907-6917	reappeared	_	
51-15	6918-6921	for	_	
51-16	6922-6926	2000	_	
51-17	6927-6929	ms	_	
51-18	6929-6930	.	_	

#Text=The task was to make an index finger response if the shape that had been presented at this location changed color, and a middle finger response if the color stayed the same (50% probability).
52-1	6931-6934	The	_	
52-2	6935-6939	task	_	
52-3	6940-6943	was	_	
52-4	6944-6946	to	_	
52-5	6947-6951	make	_	
52-6	6952-6954	an	_	
52-7	6955-6960	index	_	
52-8	6961-6967	finger	_	
52-9	6968-6976	response	_	
52-10	6977-6979	if	_	
52-11	6980-6983	the	_	
52-12	6984-6989	shape	_	
52-13	6990-6994	that	_	
52-14	6995-6998	had	_	
52-15	6999-7003	been	_	
52-16	7004-7013	presented	_	
52-17	7014-7016	at	_	
52-18	7017-7021	this	_	
52-19	7022-7030	location	_	
52-20	7031-7038	changed	_	
52-21	7039-7044	color	_	
52-22	7044-7045	,	_	
52-23	7046-7049	and	_	
52-24	7050-7051	a	_	
52-25	7052-7058	middle	_	
52-26	7059-7065	finger	_	
52-27	7066-7074	response	_	
52-28	7075-7077	if	_	
52-29	7078-7081	the	_	
52-30	7082-7087	color	_	
52-31	7088-7094	stayed	_	
52-32	7095-7098	the	_	
52-33	7099-7103	same	_	
52-34	7104-7105	(	_	
52-35	7105-7108	50%	_	
52-36	7109-7120	probability	_	
52-37	7120-7121	)	_	
52-38	7121-7122	.	_	

#Text=Trials were separated by a 1000-ms intertrial interval.
53-1	7123-7129	Trials	_	
53-2	7130-7134	were	_	
53-3	7135-7144	separated	_	
53-4	7145-7147	by	_	
53-5	7148-7149	a	_	
53-6	7150-7154	1000	_	
53-7	7154-7155	-	_	
53-8	7155-7157	ms	_	
53-9	7158-7168	intertrial	_	
53-10	7169-7177	interval	_	
53-11	7177-7178	.	_	

#Text=The larger a participant’s WM capacity, the more items are encoded, and the greater the probability of a correct response.
54-1	7179-7182	The	_	
54-2	7183-7189	larger	_	
54-3	7190-7191	a	_	
54-4	7192-7203	participant	_	
54-5	7203-7204	’	_	
54-6	7204-7205	s	_	
54-7	7206-7208	WM	_	
54-8	7209-7217	capacity	_	
54-9	7217-7218	,	_	
54-10	7219-7222	the	_	
54-11	7223-7227	more	_	
54-12	7228-7233	items	_	
54-13	7234-7237	are	_	
54-14	7238-7245	encoded	_	
54-15	7245-7246	,	_	
54-16	7247-7250	and	_	
54-17	7251-7254	the	_	
54-18	7255-7262	greater	_	
54-19	7263-7266	the	_	
54-20	7267-7278	probability	_	
54-21	7279-7281	of	_	
54-22	7282-7283	a	_	
54-23	7284-7291	correct	_	
54-24	7292-7300	response	_	
54-25	7300-7301	.	_	

#Text=While ceiling effects are likely at SS 1 and 2, SS 4 somewhat exceeds the capacity of most participants and thus is sensitive to group differences in WM capacity.
55-1	7302-7307	While	_	
55-2	7308-7315	ceiling	_	
55-3	7316-7323	effects	_	
55-4	7324-7327	are	_	
55-5	7328-7334	likely	_	
55-6	7335-7337	at	_	
55-7	7338-7340	SS	_	
55-8	7341-7342	1	_	
55-9	7343-7346	and	_	
55-10	7347-7348	2	_	
55-11	7348-7349	,	_	
55-12	7350-7352	SS	_	
55-13	7353-7354	4	_	
55-14	7355-7363	somewhat	_	
55-15	7364-7371	exceeds	_	
55-16	7372-7375	the	_	
55-17	7376-7384	capacity	_	
55-18	7385-7387	of	_	
55-19	7388-7392	most	_	
55-20	7393-7405	participants	_	
55-21	7406-7409	and	_	
55-22	7410-7414	thus	_	
55-23	7415-7417	is	_	
55-24	7418-7427	sensitive	_	
55-25	7428-7430	to	_	
55-26	7431-7436	group	_	
55-27	7437-7448	differences	_	
55-28	7449-7451	in	_	
55-29	7452-7454	WM	_	
55-30	7455-7463	capacity	_	
55-31	7463-7464	.	_	

#Text=Dependent variables were accuracy, reflecting the percentage of correct choices (chance being 50%), average reaction time over all responses, and no-response trials, reflecting the percentage of trials in which participants failed to respond.
56-1	7465-7474	Dependent	_	
56-2	7475-7484	variables	_	
56-3	7485-7489	were	_	
56-4	7490-7498	accuracy	_	
56-5	7498-7499	,	_	
56-6	7500-7510	reflecting	_	
56-7	7511-7514	the	_	
56-8	7515-7525	percentage	_	
56-9	7526-7528	of	_	
56-10	7529-7536	correct	_	
56-11	7537-7544	choices	_	
56-12	7545-7546	(	_	
56-13	7546-7552	chance	_	
56-14	7553-7558	being	_	
56-15	7559-7562	50%	_	
56-16	7562-7563	)	_	
56-17	7563-7564	,	_	
56-18	7565-7572	average	_	
56-19	7573-7581	reaction	_	
56-20	7582-7586	time	_	
56-21	7587-7591	over	_	
56-22	7592-7595	all	_	
56-23	7596-7605	responses	_	
56-24	7605-7606	,	_	
56-25	7607-7610	and	_	
56-26	7611-7622	no-response	_	
56-27	7623-7629	trials	_	
56-28	7629-7630	,	_	
56-29	7631-7641	reflecting	_	
56-30	7642-7645	the	_	
56-31	7646-7656	percentage	_	
56-32	7657-7659	of	_	
56-33	7660-7666	trials	_	
56-34	7667-7669	in	_	
56-35	7670-7675	which	_	
56-36	7676-7688	participants	_	
56-37	7689-7695	failed	_	
56-38	7696-7698	to	_	
56-39	7699-7706	respond	_	
56-40	7706-7707	.	_	

#Text=The task was presented in 26-s blocks of 6 trials each (3 change, 3 no-change).
57-1	7708-7711	The	_	
57-2	7712-7716	task	_	
57-3	7717-7720	was	_	
57-4	7721-7730	presented	_	
57-5	7731-7733	in	_	
57-6	7734-7736	26	_	
57-7	7736-7737	-	_	
57-8	7737-7738	s	_	
57-9	7739-7745	blocks	_	
57-10	7746-7748	of	_	
57-11	7749-7750	6	_	
57-12	7751-7757	trials	_	
57-13	7758-7762	each	_	
57-14	7763-7764	(	_	
57-15	7764-7765	3	_	
57-16	7766-7772	change	_	
57-17	7772-7773	,	_	
57-18	7774-7775	3	_	
57-19	7776-7785	no-change	_	
57-20	7785-7786	)	_	
57-21	7786-7787	.	_	

#Text=All trials within a block were of the same SS (block design analysis).
58-1	7788-7791	All	_	
58-2	7792-7798	trials	_	
58-3	7799-7805	within	_	
58-4	7806-7807	a	_	
58-5	7808-7813	block	_	
58-6	7814-7818	were	_	
58-7	7819-7821	of	_	
58-8	7822-7825	the	_	
58-9	7826-7830	same	_	
58-10	7831-7833	SS	_	
58-11	7834-7835	(	_	
58-12	7835-7840	block	_	
58-13	7841-7847	design	_	
58-14	7848-7856	analysis	_	
58-15	7856-7857	)	_	
58-16	7857-7858	.	_	

#Text=Eight scan runs (each 178 s, or 89 TRs) were separated by rest periods during which the scanner was turned off.
59-1	7859-7864	Eight	_	
59-2	7865-7869	scan	_	
59-3	7870-7874	runs	_	
59-4	7875-7876	(	_	
59-5	7876-7880	each	_	
59-6	7881-7884	178	_	
59-7	7885-7886	s	_	
59-8	7886-7887	,	_	
59-9	7888-7890	or	_	
59-10	7891-7893	89	_	
59-11	7894-7897	TRs	_	
59-12	7897-7898	)	_	
59-13	7899-7903	were	_	
59-14	7904-7913	separated	_	
59-15	7914-7916	by	_	
59-16	7917-7921	rest	_	
59-17	7922-7929	periods	_	
59-18	7930-7936	during	_	
59-19	7937-7942	which	_	
59-20	7943-7946	the	_	
59-21	7947-7954	scanner	_	
59-22	7955-7958	was	_	
59-23	7959-7965	turned	_	
59-24	7966-7969	off	_	
59-25	7969-7970	.	_	

#Text=Each run contained one block of each SS, one 26-s rest block during which participants fixated a central cross, and two blocks in which either one relevant and one irrelevant, or two relevant and two irrelevant shapes were presented.
60-1	7971-7975	Each	_	
60-2	7976-7979	run	_	
60-3	7980-7989	contained	_	
60-4	7990-7993	one	_	
60-5	7994-7999	block	_	
60-6	8000-8002	of	_	
60-7	8003-8007	each	_	
60-8	8008-8010	SS	_	
60-9	8010-8011	,	_	
60-10	8012-8015	one	_	
60-11	8016-8018	26	_	
60-12	8018-8019	-	_	
60-13	8019-8020	s	_	
60-14	8021-8025	rest	_	
60-15	8026-8031	block	_	
60-16	8032-8038	during	_	
60-17	8039-8044	which	_	
60-18	8045-8057	participants	_	
60-19	8058-8065	fixated	_	
60-20	8066-8067	a	_	
60-21	8068-8075	central	_	
60-22	8076-8081	cross	_	
60-23	8081-8082	,	_	
60-24	8083-8086	and	_	
60-25	8087-8090	two	_	
60-26	8091-8097	blocks	_	
60-27	8098-8100	in	_	
60-28	8101-8106	which	_	
60-29	8107-8113	either	_	
60-30	8114-8117	one	_	
60-31	8118-8126	relevant	_	
60-32	8127-8130	and	_	
60-33	8131-8134	one	_	
60-34	8135-8145	irrelevant	_	
60-35	8145-8146	,	_	
60-36	8147-8149	or	_	
60-37	8150-8153	two	_	
60-38	8154-8162	relevant	_	
60-39	8163-8166	and	_	
60-40	8167-8170	two	_	
60-41	8171-8181	irrelevant	_	
60-42	8182-8188	shapes	_	
60-43	8189-8193	were	_	
60-44	8194-8203	presented	_	
60-45	8203-8204	.	_	

#Text=These two conditions tapped specific hypotheses about mechanisms of selective attention in PSZ and were modeled but not further analyzed for the purposes of this study.
61-1	8205-8210	These	_	
61-2	8211-8214	two	_	
61-3	8215-8225	conditions	_	
61-4	8226-8232	tapped	_	
61-5	8233-8241	specific	_	
61-6	8242-8252	hypotheses	_	
61-7	8253-8258	about	_	
61-8	8259-8269	mechanisms	_	
61-9	8270-8272	of	_	
61-10	8273-8282	selective	_	
61-11	8283-8292	attention	_	
61-12	8293-8295	in	_	
61-13	8296-8299	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
61-14	8300-8303	and	_	
61-15	8304-8308	were	_	
61-16	8309-8316	modeled	_	
61-17	8317-8320	but	_	
61-18	8321-8324	not	_	
61-19	8325-8332	further	_	
61-20	8333-8341	analyzed	_	
61-21	8342-8345	for	_	
61-22	8346-8349	the	_	
61-23	8350-8358	purposes	_	
61-24	8359-8361	of	_	
61-25	8362-8366	this	_	
61-26	8367-8372	study	_	
61-27	8372-8373	.	_	

#Text=Magnetic resonance imaging
#Text=A 3 Tesla Siemens Tim Trio scanner (Erlangen, Germany) acquired whole-brain EPI images for measuring T2*-weighted BOLD effects [4-mm oblique (30º) axial slices, 64×64 matrix, FOV=22×22 cm, TR=2 s, TE=27 ms].
62-1	8374-8382	Magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[13]	
62-2	8383-8392	resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[13]	
62-3	8393-8400	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[13]	
62-4	8401-8402	A	_	
62-5	8403-8404	3	_	
62-6	8405-8410	Tesla	_	
62-7	8411-8418	Siemens	_	
62-8	8419-8422	Tim	_	
62-9	8423-8427	Trio	_	
62-10	8428-8435	scanner	_	
62-11	8436-8437	(	_	
62-12	8437-8445	Erlangen	_	
62-13	8445-8446	,	_	
62-14	8447-8454	Germany	_	
62-15	8454-8455	)	_	
62-16	8456-8464	acquired	_	
62-17	8465-8476	whole-brain	_	
62-18	8477-8480	EPI	_	
62-19	8481-8487	images	_	
62-20	8488-8491	for	_	
62-21	8492-8501	measuring	_	
62-22	8502-8504	T2	_	
62-23	8504-8505	*	_	
62-24	8505-8506	-	_	
62-25	8506-8514	weighted	_	
62-26	8515-8519	BOLD	_	
62-27	8520-8527	effects	_	
62-28	8528-8529	[	_	
62-29	8529-8530	4	_	
62-30	8530-8531	-	_	
62-31	8531-8533	mm	_	
62-32	8534-8541	oblique	_	
62-33	8542-8543	(	_	
62-34	8543-8546	30º	_	
62-35	8546-8547	)	_	
62-36	8548-8553	axial	_	
62-37	8554-8560	slices	_	
62-38	8560-8561	,	_	
62-39	8562-8564	64	_	
62-40	8564-8565	×	_	
62-41	8565-8567	64	_	
62-42	8568-8574	matrix	_	
62-43	8574-8575	,	_	
62-44	8576-8579	FOV	_	
62-45	8579-8580	=	_	
62-46	8580-8582	22	_	
62-47	8582-8583	×	_	
62-48	8583-8585	22	_	
62-49	8586-8588	cm	_	
62-50	8588-8589	,	_	
62-51	8590-8592	TR	_	
62-52	8592-8593	=	_	
62-53	8593-8594	2	_	
62-54	8595-8596	s	_	
62-55	8596-8597	,	_	
62-56	8598-8600	TE	_	
62-57	8600-8601	=	_	
62-58	8601-8603	27	_	
62-59	8604-8606	ms	_	
62-60	8606-8607	]	_	
62-61	8607-8608	.	_	

#Text=An axial T1-weighted image (MPRAGE) provided anatomical reference (1-mm3 voxels, TR=1.9 s, TE=3.51 ms, FA=9º).
63-1	8609-8611	An	_	
63-2	8612-8617	axial	_	
63-3	8618-8620	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[14]	
63-4	8620-8621	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[14]	
63-5	8621-8629	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[14]	
63-6	8630-8635	image	_	
63-7	8636-8637	(	_	
63-8	8637-8643	MPRAGE	_	
63-9	8643-8644	)	_	
63-10	8645-8653	provided	_	
63-11	8654-8664	anatomical	_	
63-12	8665-8674	reference	_	
63-13	8675-8676	(	_	
63-14	8676-8677	1	_	
63-15	8677-8678	-	_	
63-16	8678-8681	mm3	_	
63-17	8682-8688	voxels	_	
63-18	8688-8689	,	_	
63-19	8690-8692	TR	_	
63-20	8692-8693	=	_	
63-21	8693-8696	1.9	_	
63-22	8697-8698	s	_	
63-23	8698-8699	,	_	
63-24	8700-8702	TE	_	
63-25	8702-8703	=	_	
63-26	8703-8707	3.51	_	
63-27	8708-8710	ms	_	
63-28	8710-8711	,	_	
63-29	8712-8714	FA	_	
63-30	8714-8715	=	_	
63-31	8715-8717	9º	_	
63-32	8717-8718	)	_	
63-33	8718-8719	.	_	

#Text=Data were processed using AFNI.
64-1	8720-8724	Data	_	
64-2	8725-8729	were	_	
64-3	8730-8739	processed	_	
64-4	8740-8745	using	_	
64-5	8746-8750	AFNI	_	
64-6	8750-8751	.	_	

#Text=Each volume was registered to a base volume.
65-1	8752-8756	Each	_	
65-2	8757-8763	volume	_	
65-3	8764-8767	was	_	
65-4	8768-8778	registered	_	
65-5	8779-8781	to	_	
65-6	8782-8783	a	_	
65-7	8784-8788	base	_	
65-8	8789-8795	volume	_	
65-9	8795-8796	.	_	

#Text=For each subject, a composite motion index was calculated from the six motion correction parameters (Yang et al., 2005).
66-1	8797-8800	For	_	
66-2	8801-8805	each	_	
66-3	8806-8813	subject	_	
66-4	8813-8814	,	_	
66-5	8815-8816	a	_	
66-6	8817-8826	composite	_	
66-7	8827-8833	motion	_	
66-8	8834-8839	index	_	
66-9	8840-8843	was	_	
66-10	8844-8854	calculated	_	
66-11	8855-8859	from	_	
66-12	8860-8863	the	_	
66-13	8864-8867	six	_	
66-14	8868-8874	motion	_	
66-15	8875-8885	correction	_	
66-16	8886-8896	parameters	_	
66-17	8897-8898	(	_	
66-18	8898-8902	Yang	_	
66-19	8903-8905	et	_	
66-20	8906-8908	al	_	
66-21	8908-8909	.	_	
66-22	8909-8910	,	_	
66-23	8911-8915	2005	_	
66-24	8915-8916	)	_	
66-25	8916-8917	.	_	

#Text=These scores did not differ between HCS and PSZ [t(32)=1.66, P>0.1].
67-1	8918-8923	These	_	
67-2	8924-8930	scores	_	
67-3	8931-8934	did	_	
67-4	8935-8938	not	_	
67-5	8939-8945	differ	_	
67-6	8946-8953	between	_	
67-7	8954-8957	HCS	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
67-8	8958-8961	and	_	
67-9	8962-8965	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
67-10	8966-8967	[	_	
67-11	8967-8968	t	_	
67-12	8968-8969	(	_	
67-13	8969-8971	32	_	
67-14	8971-8972	)	_	
67-15	8972-8973	=	_	
67-16	8973-8977	1.66	_	
67-17	8977-8978	,	_	
67-18	8979-8980	P	_	
67-19	8980-8981	>	_	
67-20	8981-8984	0.1	_	
67-21	8984-8985	]	_	
67-22	8985-8986	.	_	

#Text=TRs with >0.5 mm displacement or >0.5° rotation relative to the preceding TR were censored out of the time series.
68-1	8987-8990	TRs	_	
68-2	8991-8995	with	_	
68-3	8996-8997	>	_	
68-4	8997-9000	0.5	_	
68-5	9001-9003	mm	_	
68-6	9004-9016	displacement	_	
68-7	9017-9019	or	_	
68-8	9020-9021	>	_	
68-9	9021-9024	0.5	_	
68-10	9024-9025	°	_	
68-11	9026-9034	rotation	_	
68-12	9035-9043	relative	_	
68-13	9044-9046	to	_	
68-14	9047-9050	the	_	
68-15	9051-9060	preceding	_	
68-16	9061-9063	TR	_	
68-17	9064-9068	were	_	
68-18	9069-9077	censored	_	
68-19	9078-9081	out	_	
68-20	9082-9084	of	_	
68-21	9085-9088	the	_	
68-22	9089-9093	time	_	
68-23	9094-9100	series	_	
68-24	9100-9101	.	_	

#Text=The number of censored TRs did not differ between groups [t(35)=0.60, P>0.5].
69-1	9102-9105	The	_	
69-2	9106-9112	number	_	
69-3	9113-9115	of	_	
69-4	9116-9124	censored	_	
69-5	9125-9128	TRs	_	
69-6	9129-9132	did	_	
69-7	9133-9136	not	_	
69-8	9137-9143	differ	_	
69-9	9144-9151	between	_	
69-10	9152-9158	groups	_	
69-11	9159-9160	[	_	
69-12	9160-9161	t	_	
69-13	9161-9162	(	_	
69-14	9162-9164	35	_	
69-15	9164-9165	)	_	
69-16	9165-9166	=	_	
69-17	9166-9170	0.60	_	
69-18	9170-9171	,	_	
69-19	9172-9173	P	_	
69-20	9173-9174	>	_	
69-21	9174-9177	0.5	_	
69-22	9177-9178	]	_	
69-23	9178-9179	.	_	

#Text=The time series was analyzed by voxel-wise multiple regression.
70-1	9180-9183	The	_	
70-2	9184-9188	time	_	
70-3	9189-9195	series	_	
70-4	9196-9199	was	_	
70-5	9200-9208	analyzed	_	
70-6	9209-9211	by	_	
70-7	9212-9222	voxel-wise	_	
70-8	9223-9231	multiple	_	
70-9	9232-9242	regression	_	
70-10	9242-9243	.	_	

#Text=Five 26-s boxcar regressors, corresponding to blocks with 1, 2, and 4 item trials, and to the two blocks involving distractors (see 2.3), were convolved with a model hemodynamic response function.
71-1	9244-9248	Five	_	
71-2	9249-9251	26	_	
71-3	9251-9252	-	_	
71-4	9252-9253	s	_	
71-5	9254-9260	boxcar	_	
71-6	9261-9271	regressors	_	
71-7	9271-9272	,	_	
71-8	9273-9286	corresponding	_	
71-9	9287-9289	to	_	
71-10	9290-9296	blocks	_	
71-11	9297-9301	with	_	
71-12	9302-9303	1	_	
71-13	9303-9304	,	_	
71-14	9305-9306	2	_	
71-15	9306-9307	,	_	
71-16	9308-9311	and	_	
71-17	9312-9313	4	_	
71-18	9314-9318	item	_	
71-19	9319-9325	trials	_	
71-20	9325-9326	,	_	
71-21	9327-9330	and	_	
71-22	9331-9333	to	_	
71-23	9334-9337	the	_	
71-24	9338-9341	two	_	
71-25	9342-9348	blocks	_	
71-26	9349-9358	involving	_	
71-27	9359-9370	distractors	_	
71-28	9371-9372	(	_	
71-29	9372-9375	see	_	
71-30	9376-9379	2.3	_	
71-31	9379-9380	)	_	
71-32	9380-9381	,	_	
71-33	9382-9386	were	_	
71-34	9387-9396	convolved	_	
71-35	9397-9401	with	_	
71-36	9402-9403	a	_	
71-37	9404-9409	model	_	
71-38	9410-9421	hemodynamic	_	
71-39	9422-9430	response	_	
71-40	9431-9439	function	_	
71-41	9439-9440	.	_	

#Text=The six motion parameter curves were included as regressors of no interest.
72-1	9441-9444	The	_	
72-2	9445-9448	six	_	
72-3	9449-9455	motion	_	
72-4	9456-9465	parameter	_	
72-5	9466-9472	curves	_	
72-6	9473-9477	were	_	
72-7	9478-9486	included	_	
72-8	9487-9489	as	_	
72-9	9490-9500	regressors	_	
72-10	9501-9503	of	_	
72-11	9504-9506	no	_	
72-12	9507-9515	interest	_	
72-13	9515-9516	.	_	

#Text=All correlations between any of three regressors of interest and any of the motion regressors were near zero (all Ps >0.9), and the groups did not differ in average stimulus-correlated motion [t(35)=0.50, P>0.6].
73-1	9517-9520	All	_	
73-2	9521-9533	correlations	_	
73-3	9534-9541	between	_	
73-4	9542-9545	any	_	
73-5	9546-9548	of	_	
73-6	9549-9554	three	_	
73-7	9555-9565	regressors	_	
73-8	9566-9568	of	_	
73-9	9569-9577	interest	_	
73-10	9578-9581	and	_	
73-11	9582-9585	any	_	
73-12	9586-9588	of	_	
73-13	9589-9592	the	_	
73-14	9593-9599	motion	_	
73-15	9600-9610	regressors	_	
73-16	9611-9615	were	_	
73-17	9616-9620	near	_	
73-18	9621-9625	zero	_	
73-19	9626-9627	(	_	
73-20	9627-9630	all	_	
73-21	9631-9633	Ps	_	
73-22	9634-9635	>	_	
73-23	9635-9638	0.9	_	
73-24	9638-9639	)	_	
73-25	9639-9640	,	_	
73-26	9641-9644	and	_	
73-27	9645-9648	the	_	
73-28	9649-9655	groups	_	
73-29	9656-9659	did	_	
73-30	9660-9663	not	_	
73-31	9664-9670	differ	_	
73-32	9671-9673	in	_	
73-33	9674-9681	average	_	
73-34	9682-9701	stimulus-correlated	_	
73-35	9702-9708	motion	_	
73-36	9709-9710	[	_	
73-37	9710-9711	t	_	
73-38	9711-9712	(	_	
73-39	9712-9714	35	_	
73-40	9714-9715	)	_	
73-41	9715-9716	=	_	
73-42	9716-9720	0.50	_	
73-43	9720-9721	,	_	
73-44	9722-9723	P	_	
73-45	9723-9724	>	_	
73-46	9724-9727	0.6	_	
73-47	9727-9728	]	_	
73-48	9728-9729	.	_	

#Text=For each subject, the voxel-wise average amplitude of signal change produced by each of the three SSs relative to rest blocks was determined.
74-1	9730-9733	For	_	
74-2	9734-9738	each	_	
74-3	9739-9746	subject	_	
74-4	9746-9747	,	_	
74-5	9748-9751	the	_	
74-6	9752-9762	voxel-wise	_	
74-7	9763-9770	average	_	
74-8	9771-9780	amplitude	_	
74-9	9781-9783	of	_	
74-10	9784-9790	signal	_	
74-11	9791-9797	change	_	
74-12	9798-9806	produced	_	
74-13	9807-9809	by	_	
74-14	9810-9814	each	_	
74-15	9815-9817	of	_	
74-16	9818-9821	the	_	
74-17	9822-9827	three	_	
74-18	9828-9831	SSs	_	
74-19	9832-9840	relative	_	
74-20	9841-9843	to	_	
74-21	9844-9848	rest	_	
74-22	9849-9855	blocks	_	
74-23	9856-9859	was	_	
74-24	9860-9870	determined	_	
74-25	9870-9871	.	_	

#Text=These maps were re-sampled to a 1-μL resolution, converted to a standard coordinate system, and spatially blurred.
75-1	9872-9877	These	_	
75-2	9878-9882	maps	_	
75-3	9883-9887	were	_	
75-4	9888-9898	re-sampled	_	
75-5	9899-9901	to	_	
75-6	9902-9903	a	_	
75-7	9904-9905	1	_	
75-8	9905-9906	-	_	
75-9	9906-9908	μL	_	
75-10	9909-9919	resolution	_	
75-11	9919-9920	,	_	
75-12	9921-9930	converted	_	
75-13	9931-9933	to	_	
75-14	9934-9935	a	_	
75-15	9936-9944	standard	_	
75-16	9945-9955	coordinate	_	
75-17	9956-9962	system	_	
75-18	9962-9963	,	_	
75-19	9964-9967	and	_	
75-20	9968-9977	spatially	_	
75-21	9978-9985	blurred	_	
75-22	9985-9986	.	_	

#Text=Second-level analyses:
#Text=For visualization of SS-dependent activity within PSZ and within HCS, a Gaussian 5-mm root mean square (RMS) isotropic kernel was adopted.
76-1	9987-9999	Second-level	_	
76-2	10000-10008	analyses	_	
76-3	10008-10009	:	_	
76-4	10010-10013	For	_	
76-5	10014-10027	visualization	_	
76-6	10028-10030	of	_	
76-7	10031-10043	SS-dependent	_	
76-8	10044-10052	activity	_	
76-9	10053-10059	within	_	
76-10	10060-10063	PSZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
76-11	10064-10067	and	_	
76-12	10068-10074	within	_	
76-13	10075-10078	HCS	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject	
76-14	10078-10079	,	_	
76-15	10080-10081	a	_	
76-16	10082-10090	Gaussian	_	
76-17	10091-10092	5	_	
76-18	10092-10093	-	_	
76-19	10093-10095	mm	_	
76-20	10096-10100	root	_	
76-21	10101-10105	mean	_	
76-22	10106-10112	square	_	
76-23	10113-10114	(	_	
76-24	10114-10117	RMS	_	
76-25	10117-10118	)	_	
76-26	10119-10128	isotropic	_	
76-27	10129-10135	kernel	_	
76-28	10136-10139	was	_	
76-29	10140-10147	adopted	_	
76-30	10147-10148	.	_	

#Text=Whole-brain voxel-wise multiple linear regression was performed within each separate group, with SS as the regressor of interest.
77-1	10149-10160	Whole-brain	_	
77-2	10161-10171	voxel-wise	_	
77-3	10172-10180	multiple	_	
77-4	10181-10187	linear	_	
77-5	10188-10198	regression	_	
77-6	10199-10202	was	_	
77-7	10203-10212	performed	_	
77-8	10213-10219	within	_	
77-9	10220-10224	each	_	
77-10	10225-10233	separate	_	
77-11	10234-10239	group	_	
77-12	10239-10240	,	_	
77-13	10241-10245	with	_	
77-14	10246-10248	SS	_	
77-15	10249-10251	as	_	
77-16	10252-10255	the	_	
77-17	10256-10265	regressor	_	
77-18	10266-10268	of	_	
77-19	10269-10277	interest	_	
77-20	10277-10278	.	_	

#Text=Voxel-wise P<0.001 combined with a 438-μL clustersize threshold yielded overall P<0.05 based on Monte Carlo simulations.
78-1	10279-10289	Voxel-wise	_	
78-2	10290-10291	P	_	
78-3	10291-10292	<	_	
78-4	10292-10297	0.001	_	
78-5	10298-10306	combined	_	
78-6	10307-10311	with	_	
78-7	10312-10313	a	_	
78-8	10314-10317	438	_	
78-9	10317-10318	-	_	
78-10	10318-10320	μL	_	
78-11	10321-10332	clustersize	_	
78-12	10333-10342	threshold	_	
78-13	10343-10350	yielded	_	
78-14	10351-10358	overall	_	
78-15	10359-10360	P	_	
78-16	10360-10361	<	_	
78-17	10361-10365	0.05	_	
78-18	10366-10371	based	_	
78-19	10372-10374	on	_	
78-20	10375-10380	Monte	_	
78-21	10381-10386	Carlo	_	
78-22	10387-10398	simulations	_	
78-23	10398-10399	.	_	

#Text=For direct statistical groups comparisons based on pre-defined regions of interest (ROIs), a 10-mm RMS kernel was applied to minimize the impact of morphological differences between PSZ and HCS (e.g.,) and reduce the risk of group differences in regional activation resulting from comparing non-corresponding anatomical areas.
79-1	10400-10403	For	_	
79-2	10404-10410	direct	_	
79-3	10411-10422	statistical	_	
79-4	10423-10429	groups	_	
79-5	10430-10441	comparisons	_	
79-6	10442-10447	based	_	
79-7	10448-10450	on	_	
79-8	10451-10462	pre-defined	_	
79-9	10463-10470	regions	_	
79-10	10471-10473	of	_	
79-11	10474-10482	interest	_	
79-12	10483-10484	(	_	
79-13	10484-10488	ROIs	_	
79-14	10488-10489	)	_	
79-15	10489-10490	,	_	
79-16	10491-10492	a	_	
79-17	10493-10495	10	_	
79-18	10495-10496	-	_	
79-19	10496-10498	mm	_	
79-20	10499-10502	RMS	_	
79-21	10503-10509	kernel	_	
79-22	10510-10513	was	_	
79-23	10514-10521	applied	_	
79-24	10522-10524	to	_	
79-25	10525-10533	minimize	_	
79-26	10534-10537	the	_	
79-27	10538-10544	impact	_	
79-28	10545-10547	of	_	
79-29	10548-10561	morphological	_	
79-30	10562-10573	differences	_	
79-31	10574-10581	between	_	
79-32	10582-10585	PSZ	_	
79-33	10586-10589	and	_	
79-34	10590-10593	HCS	_	
79-35	10594-10595	(	_	
79-36	10595-10598	e.g	_	
79-37	10598-10599	.	_	
79-38	10599-10600	,	_	
79-39	10600-10601	)	_	
79-40	10602-10605	and	_	
79-41	10606-10612	reduce	_	
79-42	10613-10616	the	_	
79-43	10617-10621	risk	_	
79-44	10622-10624	of	_	
79-45	10625-10630	group	_	
79-46	10631-10642	differences	_	
79-47	10643-10645	in	_	
79-48	10646-10654	regional	_	
79-49	10655-10665	activation	_	
79-50	10666-10675	resulting	_	
79-51	10676-10680	from	_	
79-52	10681-10690	comparing	_	
79-53	10691-10708	non-corresponding	_	
79-54	10709-10719	anatomical	_	
79-55	10720-10725	areas	_	
79-56	10725-10726	.	_	

#Text=ROIs were defined by an independent study, to avoid bias through “double dipping”.
80-1	10727-10731	ROIs	_	
80-2	10732-10736	were	_	
80-3	10737-10744	defined	_	
80-4	10745-10747	by	_	
80-5	10748-10750	an	_	
80-6	10751-10762	independent	_	
80-7	10763-10768	study	_	
80-8	10768-10769	,	_	
80-9	10770-10772	to	_	
80-10	10773-10778	avoid	_	
80-11	10779-10783	bias	_	
80-12	10784-10791	through	_	
80-13	10792-10793	“	_	
80-14	10793-10799	double	_	
80-15	10800-10807	dipping	_	
80-16	10807-10808	”	_	
80-17	10808-10809	.	_	

#Text=Seven-mm-diameter spheres were centered on peak foci of the task-positive (16 ROIs) and DMN (13 ROIs) networks identified by; page 9676) based on spontaneous correlations and anticorrelations at rest.
81-1	10810-10827	Seven-mm-diameter	_	
81-2	10828-10835	spheres	_	
81-3	10836-10840	were	_	
81-4	10841-10849	centered	_	
81-5	10850-10852	on	_	
81-6	10853-10857	peak	_	
81-7	10858-10862	foci	_	
81-8	10863-10865	of	_	
81-9	10866-10869	the	_	
81-10	10870-10883	task-positive	_	
81-11	10884-10885	(	_	
81-12	10885-10887	16	_	
81-13	10888-10892	ROIs	_	
81-14	10892-10893	)	_	
81-15	10894-10897	and	_	
81-16	10898-10901	DMN	_	
81-17	10902-10903	(	_	
81-18	10903-10905	13	_	
81-19	10906-10910	ROIs	_	
81-20	10910-10911	)	_	
81-21	10912-10920	networks	_	
81-22	10921-10931	identified	_	
81-23	10932-10934	by	_	
81-24	10934-10935	;	_	
81-25	10936-10940	page	_	
81-26	10941-10945	9676	_	
81-27	10945-10946	)	_	
81-28	10947-10952	based	_	
81-29	10953-10955	on	_	
81-30	10956-10967	spontaneous	_	
81-31	10968-10980	correlations	_	
81-32	10981-10984	and	_	
81-33	10985-11001	anticorrelations	_	
81-34	11002-11004	at	_	
81-35	11005-11009	rest	_	
81-36	11009-11010	.	_	

#Text=Thus, ROI definition was not biased by specific task demands.
82-1	11011-11015	Thus	_	
82-2	11015-11016	,	_	
82-3	11017-11020	ROI	_	
82-4	11021-11031	definition	_	
82-5	11032-11035	was	_	
82-6	11036-11039	not	_	
82-7	11040-11046	biased	_	
82-8	11047-11049	by	_	
82-9	11050-11058	specific	_	
82-10	11059-11063	task	_	
82-11	11064-11071	demands	_	
82-12	11071-11072	.	_	

#Text=Activity was averaged within each ROI.
83-1	11073-11081	Activity	_	
83-2	11082-11085	was	_	
83-3	11086-11094	averaged	_	
83-4	11095-11101	within	_	
83-5	11102-11106	each	_	
83-6	11107-11110	ROI	_	
83-7	11110-11111	.	_	

#Text=Task-positive and DMN ROIs were analyzed by two separate three-factor ANOVAs (group × SS × ROI).
84-1	11112-11125	Task-positive	_	
84-2	11126-11129	and	_	
84-3	11130-11133	DMN	_	
84-4	11134-11138	ROIs	_	
84-5	11139-11143	were	_	
84-6	11144-11152	analyzed	_	
84-7	11153-11155	by	_	
84-8	11156-11159	two	_	
84-9	11160-11168	separate	_	
84-10	11169-11181	three-factor	_	
84-11	11182-11188	ANOVAs	_	
84-12	11189-11190	(	_	
84-13	11190-11195	group	_	
84-14	11196-11197	×	_	
84-15	11198-11200	SS	_	
84-16	11201-11202	×	_	
84-17	11203-11206	ROI	_	
84-18	11206-11207	)	_	
84-19	11207-11208	.	_	

#Text=Results
#Text=CDT performance
#Text=Performance during fMRI (Figure 1B) was analyzed by two-factor ANOVA (group × SS).
85-1	11209-11216	Results	_	
85-2	11217-11220	CDT	_	
85-3	11221-11232	performance	_	
85-4	11233-11244	Performance	_	
85-5	11245-11251	during	_	
85-6	11252-11256	fMRI	_	
85-7	11257-11258	(	_	
85-8	11258-11264	Figure	_	
85-9	11265-11267	1B	_	
85-10	11267-11268	)	_	
85-11	11269-11272	was	_	
85-12	11273-11281	analyzed	_	
85-13	11282-11284	by	_	
85-14	11285-11295	two-factor	_	
85-15	11296-11301	ANOVA	_	
85-16	11302-11303	(	_	
85-17	11303-11308	group	_	
85-18	11309-11310	×	_	
85-19	11311-11313	SS	_	
85-20	11313-11314	)	_	
85-21	11314-11315	.	_	

#Text=Accuracy decreased with increasing SS [main effect of SS: F(2,70)=66.1; P<0.001], but did not differ between PSZ and HCS [main effect of group: F(1,35)=0.69, P>0.4].
86-1	11316-11324	Accuracy	_	
86-2	11325-11334	decreased	_	
86-3	11335-11339	with	_	
86-4	11340-11350	increasing	_	
86-5	11351-11353	SS	_	
86-6	11354-11355	[	_	
86-7	11355-11359	main	_	
86-8	11360-11366	effect	_	
86-9	11367-11369	of	_	
86-10	11370-11372	SS	_	
86-11	11372-11373	:	_	
86-12	11374-11375	F	_	
86-13	11375-11376	(	_	
86-14	11376-11380	2,70	_	
86-15	11380-11381	)	_	
86-16	11381-11382	=	_	
86-17	11382-11386	66.1	_	
86-18	11386-11387	;	_	
86-19	11388-11389	P	_	
86-20	11389-11390	<	_	
86-21	11390-11395	0.001	_	
86-22	11395-11396	]	_	
86-23	11396-11397	,	_	
86-24	11398-11401	but	_	
86-25	11402-11405	did	_	
86-26	11406-11409	not	_	
86-27	11410-11416	differ	_	
86-28	11417-11424	between	_	
86-29	11425-11428	PSZ	_	
86-30	11429-11432	and	_	
86-31	11433-11436	HCS	_	
86-32	11437-11438	[	_	
86-33	11438-11442	main	_	
86-34	11443-11449	effect	_	
86-35	11450-11452	of	_	
86-36	11453-11458	group	_	
86-37	11458-11459	:	_	
86-38	11460-11461	F	_	
86-39	11461-11462	(	_	
86-40	11462-11466	1,35	_	
86-41	11466-11467	)	_	
86-42	11467-11468	=	_	
86-43	11468-11472	0.69	_	
86-44	11472-11473	,	_	
86-45	11474-11475	P	_	
86-46	11475-11476	>	_	
86-47	11476-11479	0.4	_	
86-48	11479-11480	]	_	
86-49	11480-11481	.	_	

#Text=HCS tended to outperform PSZ at SS 4, but the group × SS interaction was not significant [F(2,70)=1.30, P=0.28].
87-1	11482-11485	HCS	_	
87-2	11486-11492	tended	_	
87-3	11493-11495	to	_	
87-4	11496-11506	outperform	_	
87-5	11507-11510	PSZ	_	
87-6	11511-11513	at	_	
87-7	11514-11516	SS	_	
87-8	11517-11518	4	_	
87-9	11518-11519	,	_	
87-10	11520-11523	but	_	
87-11	11524-11527	the	_	
87-12	11528-11533	group	_	
87-13	11534-11535	×	_	
87-14	11536-11538	SS	_	
87-15	11539-11550	interaction	_	
87-16	11551-11554	was	_	
87-17	11555-11558	not	_	
87-18	11559-11570	significant	_	
87-19	11571-11572	[	_	
87-20	11572-11573	F	_	
87-21	11573-11574	(	_	
87-22	11574-11578	2,70	_	
87-23	11578-11579	)	_	
87-24	11579-11580	=	_	
87-25	11580-11584	1.30	_	
87-26	11584-11585	,	_	
87-27	11586-11587	P	_	
87-28	11587-11588	=	_	
87-29	11588-11592	0.28	_	
87-30	11592-11593	]	_	
87-31	11593-11594	.	_	

#Text=Reaction time slowed with increasing SS [F(2,70)=94.3, P<0.001], and was slower in PSZ relative to HCS [F(1,35)=4.61, P=0.039], but there was no interaction [F(2,70)=0.81, P>0.4].
88-1	11595-11603	Reaction	_	
88-2	11604-11608	time	_	
88-3	11609-11615	slowed	_	
88-4	11616-11620	with	_	
88-5	11621-11631	increasing	_	
88-6	11632-11634	SS	_	
88-7	11635-11636	[	_	
88-8	11636-11637	F	_	
88-9	11637-11638	(	_	
88-10	11638-11642	2,70	_	
88-11	11642-11643	)	_	
88-12	11643-11644	=	_	
88-13	11644-11648	94.3	_	
88-14	11648-11649	,	_	
88-15	11650-11651	P	_	
88-16	11651-11652	<	_	
88-17	11652-11657	0.001	_	
88-18	11657-11658	]	_	
88-19	11658-11659	,	_	
88-20	11660-11663	and	_	
88-21	11664-11667	was	_	
88-22	11668-11674	slower	_	
88-23	11675-11677	in	_	
88-24	11678-11681	PSZ	_	
88-25	11682-11690	relative	_	
88-26	11691-11693	to	_	
88-27	11694-11697	HCS	_	
88-28	11698-11699	[	_	
88-29	11699-11700	F	_	
88-30	11700-11701	(	_	
88-31	11701-11705	1,35	_	
88-32	11705-11706	)	_	
88-33	11706-11707	=	_	
88-34	11707-11711	4.61	_	
88-35	11711-11712	,	_	
88-36	11713-11714	P	_	
88-37	11714-11715	=	_	
88-38	11715-11720	0.039	_	
88-39	11720-11721	]	_	
88-40	11721-11722	,	_	
88-41	11723-11726	but	_	
88-42	11727-11732	there	_	
88-43	11733-11736	was	_	
88-44	11737-11739	no	_	
88-45	11740-11751	interaction	_	
88-46	11752-11753	[	_	
88-47	11753-11754	F	_	
88-48	11754-11755	(	_	
88-49	11755-11759	2,70	_	
88-50	11759-11760	)	_	
88-51	11760-11761	=	_	
88-52	11761-11765	0.81	_	
88-53	11765-11766	,	_	
88-54	11767-11768	P	_	
88-55	11768-11769	>	_	
88-56	11769-11772	0.4	_	
88-57	11772-11773	]	_	
88-58	11773-11774	.	_	

#Text=No-response trials displayed no main effects or interaction.
89-1	11775-11786	No-response	_	
89-2	11787-11793	trials	_	
89-3	11794-11803	displayed	_	
89-4	11804-11806	no	_	
89-5	11807-11811	main	_	
89-6	11812-11819	effects	_	
89-7	11820-11822	or	_	
89-8	11823-11834	interaction	_	
89-9	11834-11835	.	_	

#Text=To test whether pretraining had contributed to equating performance between groups, performance in the training session was analyzed and displayed the same patterns: significant main effects of SS on both variables, and a trend toward a group × SS interaction on accuracy [F(2,68)=2.89, P=0.063], with HCS outperforming PSZ at SS 4.
90-1	11836-11838	To	_	
90-2	11839-11843	test	_	
90-3	11844-11851	whether	_	
90-4	11852-11863	pretraining	_	
90-5	11864-11867	had	_	
90-6	11868-11879	contributed	_	
90-7	11880-11882	to	_	
90-8	11883-11891	equating	_	
90-9	11892-11903	performance	_	
90-10	11904-11911	between	_	
90-11	11912-11918	groups	_	
90-12	11918-11919	,	_	
90-13	11920-11931	performance	_	
90-14	11932-11934	in	_	
90-15	11935-11938	the	_	
90-16	11939-11947	training	_	
90-17	11948-11955	session	_	
90-18	11956-11959	was	_	
90-19	11960-11968	analyzed	_	
90-20	11969-11972	and	_	
90-21	11973-11982	displayed	_	
90-22	11983-11986	the	_	
90-23	11987-11991	same	_	
90-24	11992-12000	patterns	_	
90-25	12000-12001	:	_	
90-26	12002-12013	significant	_	
90-27	12014-12018	main	_	
90-28	12019-12026	effects	_	
90-29	12027-12029	of	_	
90-30	12030-12032	SS	_	
90-31	12033-12035	on	_	
90-32	12036-12040	both	_	
90-33	12041-12050	variables	_	
90-34	12050-12051	,	_	
90-35	12052-12055	and	_	
90-36	12056-12057	a	_	
90-37	12058-12063	trend	_	
90-38	12064-12070	toward	_	
90-39	12071-12072	a	_	
90-40	12073-12078	group	_	
90-41	12079-12080	×	_	
90-42	12081-12083	SS	_	
90-43	12084-12095	interaction	_	
90-44	12096-12098	on	_	
90-45	12099-12107	accuracy	_	
90-46	12108-12109	[	_	
90-47	12109-12110	F	_	
90-48	12110-12111	(	_	
90-49	12111-12115	2,68	_	
90-50	12115-12116	)	_	
90-51	12116-12117	=	_	
90-52	12117-12121	2.89	_	
90-53	12121-12122	,	_	
90-54	12123-12124	P	_	
90-55	12124-12125	=	_	
90-56	12125-12130	0.063	_	
90-57	12130-12131	]	_	
90-58	12131-12132	,	_	
90-59	12133-12137	with	_	
90-60	12138-12141	HCS	_	
90-61	12142-12155	outperforming	_	
90-62	12156-12159	PSZ	_	
90-63	12160-12162	at	_	
90-64	12163-12165	SS	_	
90-65	12166-12167	4	_	
90-66	12167-12168	.	_	

#Text=However, PSZ had more no-response trials than HCS during training [group main effect: F(1,34)=9.82, P=0.004], but not in the subsequent MRI session [F(1,35)=0.02, P>0.8].
91-1	12169-12176	However	_	
91-2	12176-12177	,	_	
91-3	12178-12181	PSZ	_	
91-4	12182-12185	had	_	
91-5	12186-12190	more	_	
91-6	12191-12202	no-response	_	
91-7	12203-12209	trials	_	
91-8	12210-12214	than	_	
91-9	12215-12218	HCS	_	
91-10	12219-12225	during	_	
91-11	12226-12234	training	_	
91-12	12235-12236	[	_	
91-13	12236-12241	group	_	
91-14	12242-12246	main	_	
91-15	12247-12253	effect	_	
91-16	12253-12254	:	_	
91-17	12255-12256	F	_	
91-18	12256-12257	(	_	
91-19	12257-12261	1,34	_	
91-20	12261-12262	)	_	
91-21	12262-12263	=	_	
91-22	12263-12267	9.82	_	
91-23	12267-12268	,	_	
91-24	12269-12270	P	_	
91-25	12270-12271	=	_	
91-26	12271-12276	0.004	_	
91-27	12276-12277	]	_	
91-28	12277-12278	,	_	
91-29	12279-12282	but	_	
91-30	12283-12286	not	_	
91-31	12287-12289	in	_	
91-32	12290-12293	the	_	
91-33	12294-12304	subsequent	_	
91-34	12305-12308	MRI	_	
91-35	12309-12316	session	_	
91-36	12317-12318	[	_	
91-37	12318-12319	F	_	
91-38	12319-12320	(	_	
91-39	12320-12324	1,35	_	
91-40	12324-12325	)	_	
91-41	12325-12326	=	_	
91-42	12326-12330	0.02	_	
91-43	12330-12331	,	_	
91-44	12332-12333	P	_	
91-45	12333-12334	>	_	
91-46	12334-12337	0.8	_	
91-47	12337-12338	]	_	
91-48	12338-12339	.	_	

#Text=In a direct comparison of effects between sessions by three-factor ANOVA (group × SS × session), there was indeed a group × session interaction on no-response trials [F(1,34)=8.7, P=0.006].
#Text=fMRI
#Text=Figure 2 visualizes linear effects of SS within each separate group.
92-1	12340-12342	In	_	
92-2	12343-12344	a	_	
92-3	12345-12351	direct	_	
92-4	12352-12362	comparison	_	
92-5	12363-12365	of	_	
92-6	12366-12373	effects	_	
92-7	12374-12381	between	_	
92-8	12382-12390	sessions	_	
92-9	12391-12393	by	_	
92-10	12394-12406	three-factor	_	
92-11	12407-12412	ANOVA	_	
92-12	12413-12414	(	_	
92-13	12414-12419	group	_	
92-14	12420-12421	×	_	
92-15	12422-12424	SS	_	
92-16	12425-12426	×	_	
92-17	12427-12434	session	_	
92-18	12434-12435	)	_	
92-19	12435-12436	,	_	
92-20	12437-12442	there	_	
92-21	12443-12446	was	_	
92-22	12447-12453	indeed	_	
92-23	12454-12455	a	_	
92-24	12456-12461	group	_	
92-25	12462-12463	×	_	
92-26	12464-12471	session	_	
92-27	12472-12483	interaction	_	
92-28	12484-12486	on	_	
92-29	12487-12498	no-response	_	
92-30	12499-12505	trials	_	
92-31	12506-12507	[	_	
92-32	12507-12508	F	_	
92-33	12508-12509	(	_	
92-34	12509-12513	1,34	_	
92-35	12513-12514	)	_	
92-36	12514-12515	=	_	
92-37	12515-12518	8.7	_	
92-38	12518-12519	,	_	
92-39	12520-12521	P	_	
92-40	12521-12522	=	_	
92-41	12522-12527	0.006	_	
92-42	12527-12528	]	_	
92-43	12528-12529	.	_	
92-44	12530-12534	fMRI	_	
92-45	12535-12541	Figure	_	
92-46	12542-12543	2	_	
92-47	12544-12554	visualizes	_	
92-48	12555-12561	linear	_	
92-49	12562-12569	effects	_	
92-50	12570-12572	of	_	
92-51	12573-12575	SS	_	
92-52	12576-12582	within	_	
92-53	12583-12587	each	_	
92-54	12588-12596	separate	_	
92-55	12597-12602	group	_	
92-56	12602-12603	.	_	

#Text=Significant clusters identified within each group are listed in Supplementary Tables S1 and S2.
93-1	12604-12615	Significant	_	
93-2	12616-12624	clusters	_	
93-3	12625-12635	identified	_	
93-4	12636-12642	within	_	
93-5	12643-12647	each	_	
93-6	12648-12653	group	_	
93-7	12654-12657	are	_	
93-8	12658-12664	listed	_	
93-9	12665-12667	in	_	
93-10	12668-12681	Supplementary	_	
93-11	12682-12688	Tables	_	
93-12	12689-12691	S1	_	
93-13	12692-12695	and	_	
93-14	12696-12698	S2	_	
93-15	12698-12699	.	_	

#Text=Regions displaying step-wise more activity with larger SS are represented by warm colors.
94-1	12700-12707	Regions	_	
94-2	12708-12718	displaying	_	
94-3	12719-12728	step-wise	_	
94-4	12729-12733	more	_	
94-5	12734-12742	activity	_	
94-6	12743-12747	with	_	
94-7	12748-12754	larger	_	
94-8	12755-12757	SS	_	
94-9	12758-12761	are	_	
94-10	12762-12773	represented	_	
94-11	12774-12776	by	_	
94-12	12777-12781	warm	_	
94-13	12782-12788	colors	_	
94-14	12788-12789	.	_	

#Text=These regions were without exception task-positive.
95-1	12790-12795	These	_	
95-2	12796-12803	regions	_	
95-3	12804-12808	were	_	
95-4	12809-12816	without	_	
95-5	12817-12826	exception	_	
95-6	12827-12840	task-positive	_	
95-7	12840-12841	.	_	

#Text=Regions displaying step-wise less activity with larger SS are represented by cold colors.
96-1	12842-12849	Regions	_	
96-2	12850-12860	displaying	_	
96-3	12861-12870	step-wise	_	
96-4	12871-12875	less	_	
96-5	12876-12884	activity	_	
96-6	12885-12889	with	_	
96-7	12890-12896	larger	_	
96-8	12897-12899	SS	_	
96-9	12900-12903	are	_	
96-10	12904-12915	represented	_	
96-11	12916-12918	by	_	
96-12	12919-12923	cold	_	
96-13	12924-12930	colors	_	
96-14	12930-12931	.	_	

#Text=These clusters were all task-negative and converged with typical DMN regions.
97-1	12932-12937	These	_	
97-2	12938-12946	clusters	_	
97-3	12947-12951	were	_	
97-4	12952-12955	all	_	
97-5	12956-12969	task-negative	_	
97-6	12970-12973	and	_	
97-7	12974-12983	converged	_	
97-8	12984-12988	with	_	
97-9	12989-12996	typical	_	
97-10	12997-13000	DMN	_	
97-11	13001-13008	regions	_	
97-12	13008-13009	.	_	

#Text=Figure 3 and Table 2 display the spherical ROIs used for statistical comparison of SS-dependent activity between HCS and PSZ.
98-1	13010-13016	Figure	_	
98-2	13017-13018	3	_	
98-3	13019-13022	and	_	
98-4	13023-13028	Table	_	
98-5	13029-13030	2	_	
98-6	13031-13038	display	_	
98-7	13039-13042	the	_	
98-8	13043-13052	spherical	_	
98-9	13053-13057	ROIs	_	
98-10	13058-13062	used	_	
98-11	13063-13066	for	_	
98-12	13067-13078	statistical	_	
98-13	13079-13089	comparison	_	
98-14	13090-13092	of	_	
98-15	13093-13105	SS-dependent	_	
98-16	13106-13114	activity	_	
98-17	13115-13122	between	_	
98-18	13123-13126	HCS	_	
98-19	13127-13130	and	_	
98-20	13131-13134	PSZ	_	
98-21	13134-13135	.	_	

#Text=Task-positive ROIs:
#Text=Consistent with ’s classification, the average activity within most ROIs was task-positive [t(36)>2.03, P<0.05], exceptions being left and right superior occipital gyri and right insula, whose activity did not differ from zero.
99-1	13136-13149	Task-positive	_	
99-2	13150-13154	ROIs	_	
99-3	13154-13155	:	_	
99-4	13156-13166	Consistent	_	
99-5	13167-13171	with	_	
99-6	13172-13173	’	_	
99-7	13173-13174	s	_	
99-8	13175-13189	classification	_	
99-9	13189-13190	,	_	
99-10	13191-13194	the	_	
99-11	13195-13202	average	_	
99-12	13203-13211	activity	_	
99-13	13212-13218	within	_	
99-14	13219-13223	most	_	
99-15	13224-13228	ROIs	_	
99-16	13229-13232	was	_	
99-17	13233-13246	task-positive	_	
99-18	13247-13248	[	_	
99-19	13248-13249	t	_	
99-20	13249-13250	(	_	
99-21	13250-13252	36	_	
99-22	13252-13253	)	_	
99-23	13253-13254	>	_	
99-24	13254-13258	2.03	_	
99-25	13258-13259	,	_	
99-26	13260-13261	P	_	
99-27	13261-13262	<	_	
99-28	13262-13266	0.05	_	
99-29	13266-13267	]	_	
99-30	13267-13268	,	_	
99-31	13269-13279	exceptions	_	
99-32	13280-13285	being	_	
99-33	13286-13290	left	_	
99-34	13291-13294	and	_	
99-35	13295-13300	right	_	
99-36	13301-13309	superior	_	
99-37	13310-13319	occipital	_	
99-38	13320-13324	gyri	_	
99-39	13325-13328	and	_	
99-40	13329-13334	right	_	
99-41	13335-13341	insula	_	
99-42	13341-13342	,	_	
99-43	13343-13348	whose	_	
99-44	13349-13357	activity	_	
99-45	13358-13361	did	_	
99-46	13362-13365	not	_	
99-47	13366-13372	differ	_	
99-48	13373-13377	from	_	
99-49	13378-13382	zero	_	
99-50	13382-13383	.	_	

#Text=These three ROIs were excluded from further analysis.
100-1	13384-13389	These	_	
100-2	13390-13395	three	_	
100-3	13396-13400	ROIs	_	
100-4	13401-13405	were	_	
100-5	13406-13414	excluded	_	
100-6	13415-13419	from	_	
100-7	13420-13427	further	_	
100-8	13428-13436	analysis	_	
100-9	13436-13437	.	_	

#Text=The remaining 13 ROIs were analyzed by three-factor ANOVA (group × SS × ROI).
101-1	13438-13441	The	_	
101-2	13442-13451	remaining	_	
101-3	13452-13454	13	_	
101-4	13455-13459	ROIs	_	
101-5	13460-13464	were	_	
101-6	13465-13473	analyzed	_	
101-7	13474-13476	by	_	
101-8	13477-13489	three-factor	_	
101-9	13490-13495	ANOVA	_	
101-10	13496-13497	(	_	
101-11	13497-13502	group	_	
101-12	13503-13504	×	_	
101-13	13505-13507	SS	_	
101-14	13508-13509	×	_	
101-15	13510-13513	ROI	_	
101-16	13513-13514	)	_	
101-17	13514-13515	.	_	

#Text=A main effect of SS [F(2,70)=14.8, P<0.001] reflected greater activation with larger SS.
102-1	13516-13517	A	_	
102-2	13518-13522	main	_	
102-3	13523-13529	effect	_	
102-4	13530-13532	of	_	
102-5	13533-13535	SS	_	
102-6	13536-13537	[	_	
102-7	13537-13538	F	_	
102-8	13538-13539	(	_	
102-9	13539-13543	2,70	_	
102-10	13543-13544	)	_	
102-11	13544-13545	=	_	
102-12	13545-13549	14.8	_	
102-13	13549-13550	,	_	
102-14	13551-13552	P	_	
102-15	13552-13553	<	_	
102-16	13553-13558	0.001	_	
102-17	13558-13559	]	_	
102-18	13560-13569	reflected	_	
102-19	13570-13577	greater	_	
102-20	13578-13588	activation	_	
102-21	13589-13593	with	_	
102-22	13594-13600	larger	_	
102-23	13601-13603	SS	_	
102-24	13603-13604	.	_	

#Text=The main effect of group narrowly failed significance [F(1,35)=4.05, P=0.052].
103-1	13605-13608	The	_	
103-2	13609-13613	main	_	
103-3	13614-13620	effect	_	
103-4	13621-13623	of	_	
103-5	13624-13629	group	_	
103-6	13630-13638	narrowly	_	
103-7	13639-13645	failed	_	
103-8	13646-13658	significance	_	
103-9	13659-13660	[	_	
103-10	13660-13661	F	_	
103-11	13661-13662	(	_	
103-12	13662-13666	1,35	_	
103-13	13666-13667	)	_	
103-14	13667-13668	=	_	
103-15	13668-13672	4.05	_	
103-16	13672-13673	,	_	
103-17	13674-13675	P	_	
103-18	13675-13676	=	_	
103-19	13676-13681	0.052	_	
103-20	13681-13682	]	_	
103-21	13682-13683	.	_	

#Text=Figure 3 illustrates that PSZ tended to recruit task-positive regions more, especially at SS 1 and 2, resulting in smaller effects of SS relative to HCS.
104-1	13684-13690	Figure	_	
104-2	13691-13692	3	_	
104-3	13693-13704	illustrates	_	
104-4	13705-13709	that	_	
104-5	13710-13713	PSZ	_	
104-6	13714-13720	tended	_	
104-7	13721-13723	to	_	
104-8	13724-13731	recruit	_	
104-9	13732-13745	task-positive	_	
104-10	13746-13753	regions	_	
104-11	13754-13758	more	_	
104-12	13758-13759	,	_	
104-13	13760-13770	especially	_	
104-14	13771-13773	at	_	
104-15	13774-13776	SS	_	
104-16	13777-13778	1	_	
104-17	13779-13782	and	_	
104-18	13783-13784	2	_	
104-19	13784-13785	,	_	
104-20	13786-13795	resulting	_	
104-21	13796-13798	in	_	
104-22	13799-13806	smaller	_	
104-23	13807-13814	effects	_	
104-24	13815-13817	of	_	
104-25	13818-13820	SS	_	
104-26	13821-13829	relative	_	
104-27	13830-13832	to	_	
104-28	13833-13836	HCS	_	
104-29	13836-13837	.	_	

#Text=Supplementary Figure S1, showing graphs for individual ROIs, suggests that this pattern originated in parietal and occipital, but not frontal ROIs.
105-1	13838-13851	Supplementary	_	
105-2	13852-13858	Figure	_	
105-3	13859-13861	S1	_	
105-4	13861-13862	,	_	
105-5	13863-13870	showing	_	
105-6	13871-13877	graphs	_	
105-7	13878-13881	for	_	
105-8	13882-13892	individual	_	
105-9	13893-13897	ROIs	_	
105-10	13897-13898	,	_	
105-11	13899-13907	suggests	_	
105-12	13908-13912	that	_	
105-13	13913-13917	this	_	
105-14	13918-13925	pattern	_	
105-15	13926-13936	originated	_	
105-16	13937-13939	in	_	
105-17	13940-13948	parietal	_	
105-18	13949-13952	and	_	
105-19	13953-13962	occipital	_	
105-20	13962-13963	,	_	
105-21	13964-13967	but	_	
105-22	13968-13971	not	_	
105-23	13972-13979	frontal	_	
105-24	13980-13984	ROIs	_	
105-25	13984-13985	.	_	

#Text=However, neither the group × SS [F(2,70)=1.23, P=0.27] nor the group × SS × ROI interaction [F(24,840)=1.09, P>0.3] was significant.
106-1	13986-13993	However	_	
106-2	13993-13994	,	_	
106-3	13995-14002	neither	_	
106-4	14003-14006	the	_	
106-5	14007-14012	group	_	
106-6	14013-14014	×	_	
106-7	14015-14017	SS	_	
106-8	14018-14019	[	_	
106-9	14019-14020	F	_	
106-10	14020-14021	(	_	
106-11	14021-14025	2,70	_	
106-12	14025-14026	)	_	
106-13	14026-14027	=	_	
106-14	14027-14031	1.23	_	
106-15	14031-14032	,	_	
106-16	14033-14034	P	_	
106-17	14034-14035	=	_	
106-18	14035-14039	0.27	_	
106-19	14039-14040	]	_	
106-20	14041-14044	nor	_	
106-21	14045-14048	the	_	
106-22	14049-14054	group	_	
106-23	14055-14056	×	_	
106-24	14057-14059	SS	_	
106-25	14060-14061	×	_	
106-26	14062-14065	ROI	_	
106-27	14066-14077	interaction	_	
106-28	14078-14079	[	_	
106-29	14079-14080	F	_	
106-30	14080-14081	(	_	
106-31	14081-14087	24,840	_	
106-32	14087-14088	)	_	
106-33	14088-14089	=	_	
106-34	14089-14093	1.09	_	
106-35	14093-14094	,	_	
106-36	14095-14096	P	_	
106-37	14096-14097	>	_	
106-38	14097-14100	0.3	_	
106-39	14100-14101	]	_	
106-40	14102-14105	was	_	
106-41	14106-14117	significant	_	
106-42	14117-14118	.	_	

#Text=DMN ROIs:
#Text=Average activity across groups and SSs was confirmed to be task-negative within each ROI [t(36)<−2.3, P<0.03] except the cerebellar tonsils whose activity did not differ from zero.
107-1	14119-14122	DMN	_	
107-2	14123-14127	ROIs	_	
107-3	14127-14128	:	_	
107-4	14129-14136	Average	_	
107-5	14137-14145	activity	_	
107-6	14146-14152	across	_	
107-7	14153-14159	groups	_	
107-8	14160-14163	and	_	
107-9	14164-14167	SSs	_	
107-10	14168-14171	was	_	
107-11	14172-14181	confirmed	_	
107-12	14182-14184	to	_	
107-13	14185-14187	be	_	
107-14	14188-14201	task-negative	_	
107-15	14202-14208	within	_	
107-16	14209-14213	each	_	
107-17	14214-14217	ROI	_	
107-18	14218-14219	[	_	
107-19	14219-14220	t	_	
107-20	14220-14221	(	_	
107-21	14221-14223	36	_	
107-22	14223-14224	)	_	
107-23	14224-14225	<	_	
107-24	14225-14226	−	_	
107-25	14226-14229	2.3	_	
107-26	14229-14230	,	_	
107-27	14231-14232	P	_	
107-28	14232-14233	<	_	
107-29	14233-14237	0.03	_	
107-30	14237-14238	]	_	
107-31	14239-14245	except	_	
107-32	14246-14249	the	_	
107-33	14250-14260	cerebellar	_	
107-34	14261-14268	tonsils	_	
107-35	14269-14274	whose	_	
107-36	14275-14283	activity	_	
107-37	14284-14287	did	_	
107-38	14288-14291	not	_	
107-39	14292-14298	differ	_	
107-40	14299-14303	from	_	
107-41	14304-14308	zero	_	
107-42	14308-14309	.	_	

#Text=The retrosplenial ROI (BA 29 and 30) displayed large and extremely variable negative values, probably due to its location at the intersection of the Vein of Galen and internal sagittal sinus.
108-1	14310-14313	The	_	
108-2	14314-14327	retrosplenial	_	
108-3	14328-14331	ROI	_	
108-4	14332-14333	(	_	
108-5	14333-14335	BA	_	
108-6	14336-14338	29	_	
108-7	14339-14342	and	_	
108-8	14343-14345	30	_	
108-9	14345-14346	)	_	
108-10	14347-14356	displayed	_	
108-11	14357-14362	large	_	
108-12	14363-14366	and	_	
108-13	14367-14376	extremely	_	
108-14	14377-14385	variable	_	
108-15	14386-14394	negative	_	
108-16	14395-14401	values	_	
108-17	14401-14402	,	_	
108-18	14403-14411	probably	_	
108-19	14412-14415	due	_	
108-20	14416-14418	to	_	
108-21	14419-14422	its	_	
108-22	14423-14431	location	_	
108-23	14432-14434	at	_	
108-24	14435-14438	the	_	
108-25	14439-14451	intersection	_	
108-26	14452-14454	of	_	
108-27	14455-14458	the	_	
108-28	14459-14463	Vein	_	
108-29	14464-14466	of	_	
108-30	14467-14472	Galen	_	
108-31	14473-14476	and	_	
108-32	14477-14485	internal	_	
108-33	14486-14494	sagittal	_	
108-34	14495-14500	sinus	_	
108-35	14500-14501	.	_	

#Text=The cerebellar and retrosplenial ROIs were excluded from further analysis.
109-1	14502-14505	The	_	
109-2	14506-14516	cerebellar	_	
109-3	14517-14520	and	_	
109-4	14521-14534	retrosplenial	_	
109-5	14535-14539	ROIs	_	
109-6	14540-14544	were	_	
109-7	14545-14553	excluded	_	
109-8	14554-14558	from	_	
109-9	14559-14566	further	_	
109-10	14567-14575	analysis	_	
109-11	14575-14576	.	_	

#Text=The remaining 11 ROIs were analyzed by three-factor ANOVA.
110-1	14577-14580	The	_	
110-2	14581-14590	remaining	_	
110-3	14591-14593	11	_	
110-4	14594-14598	ROIs	_	
110-5	14599-14603	were	_	
110-6	14604-14612	analyzed	_	
110-7	14613-14615	by	_	
110-8	14616-14628	three-factor	_	
110-9	14629-14634	ANOVA	_	
110-10	14634-14635	.	_	

#Text=There was a significant group × SS interaction [F(2,70)=3.21, P<0.05], which was followed by one-factor ANOVA within each group.
111-1	14636-14641	There	_	
111-2	14642-14645	was	_	
111-3	14646-14647	a	_	
111-4	14648-14659	significant	_	
111-5	14660-14665	group	_	
111-6	14666-14667	×	_	
111-7	14668-14670	SS	_	
111-8	14671-14682	interaction	_	
111-9	14683-14684	[	_	
111-10	14684-14685	F	_	
111-11	14685-14686	(	_	
111-12	14686-14690	2,70	_	
111-13	14690-14691	)	_	
111-14	14691-14692	=	_	
111-15	14692-14696	3.21	_	
111-16	14696-14697	,	_	
111-17	14698-14699	P	_	
111-18	14699-14700	<	_	
111-19	14700-14704	0.05	_	
111-20	14704-14705	]	_	
111-21	14705-14706	,	_	
111-22	14707-14712	which	_	
111-23	14713-14716	was	_	
111-24	14717-14725	followed	_	
111-25	14726-14728	by	_	
111-26	14729-14739	one-factor	_	
111-27	14740-14745	ANOVA	_	
111-28	14746-14752	within	_	
111-29	14753-14757	each	_	
111-30	14758-14763	group	_	
111-31	14763-14764	.	_	

#Text=As shown in Figure 3, PSZ displayed step-wise greater deactivation with larger SS, supported by a main effect of SS [F(2,40)=6.73, P=0.003].
112-1	14765-14767	As	_	
112-2	14768-14773	shown	_	
112-3	14774-14776	in	_	
112-4	14777-14783	Figure	_	
112-5	14784-14785	3	_	
112-6	14785-14786	,	_	
112-7	14787-14790	PSZ	_	
112-8	14791-14800	displayed	_	
112-9	14801-14810	step-wise	_	
112-10	14811-14818	greater	_	
112-11	14819-14831	deactivation	_	
112-12	14832-14836	with	_	
112-13	14837-14843	larger	_	
112-14	14844-14846	SS	_	
112-15	14846-14847	,	_	
112-16	14848-14857	supported	_	
112-17	14858-14860	by	_	
112-18	14861-14862	a	_	
112-19	14863-14867	main	_	
112-20	14868-14874	effect	_	
112-21	14875-14877	of	_	
112-22	14878-14880	SS	_	
112-23	14881-14882	[	_	
112-24	14882-14883	F	_	
112-25	14883-14884	(	_	
112-26	14884-14888	2,40	_	
112-27	14888-14889	)	_	
112-28	14889-14890	=	_	
112-29	14890-14894	6.73	_	
112-30	14894-14895	,	_	
112-31	14896-14897	P	_	
112-32	14897-14898	=	_	
112-33	14898-14903	0.003	_	
112-34	14903-14904	]	_	
112-35	14904-14905	.	_	

#Text=HCS showed no SS-dependent modulation [F(2,30)=0.18, P>0.8].
113-1	14906-14909	HCS	_	
113-2	14910-14916	showed	_	
113-3	14917-14919	no	_	
113-4	14920-14932	SS-dependent	_	
113-5	14933-14943	modulation	_	
113-6	14944-14945	[	_	
113-7	14945-14946	F	_	
113-8	14946-14947	(	_	
113-9	14947-14951	2,30	_	
113-10	14951-14952	)	_	
113-11	14952-14953	=	_	
113-12	14953-14957	0.18	_	
113-13	14957-14958	,	_	
113-14	14959-14960	P	_	
113-15	14960-14961	>	_	
113-16	14961-14964	0.8	_	
113-17	14964-14965	]	_	
113-18	14965-14966	.	_	

#Text=There was no group × SS × ROI interaction [P>0.5].
114-1	14967-14972	There	_	
114-2	14973-14976	was	_	
114-3	14977-14979	no	_	
114-4	14980-14985	group	_	
114-5	14986-14987	×	_	
114-6	14988-14990	SS	_	
114-7	14991-14992	×	_	
114-8	14993-14996	ROI	_	
114-9	14997-15008	interaction	_	
114-10	15009-15010	[	_	
114-11	15010-15011	P	_	
114-12	15011-15012	>	_	
114-13	15012-15015	0.5	_	
114-14	15015-15016	]	_	
114-15	15016-15017	.	_	

#Text=Graphs for individual ROIs are shown in Supplementary Figure S2.
115-1	15018-15024	Graphs	_	
115-2	15025-15028	for	_	
115-3	15029-15039	individual	_	
115-4	15040-15044	ROIs	_	
115-5	15045-15048	are	_	
115-6	15049-15054	shown	_	
115-7	15055-15057	in	_	
115-8	15058-15071	Supplementary	_	
115-9	15072-15078	Figure	_	
115-10	15079-15081	S2	_	
115-11	15081-15082	.	_	

#Text=The apparent outlier status of activity patterns in inferior temporal ROIs prompted exploratory analyses of individual ROIs (see Supplement).
116-1	15083-15086	The	_	
116-2	15087-15095	apparent	_	
116-3	15096-15103	outlier	_	
116-4	15104-15110	status	_	
116-5	15111-15113	of	_	
116-6	15114-15122	activity	_	
116-7	15123-15131	patterns	_	
116-8	15132-15134	in	_	
116-9	15135-15143	inferior	_	
116-10	15144-15152	temporal	_	
116-11	15153-15157	ROIs	_	
116-12	15158-15166	prompted	_	
116-13	15167-15178	exploratory	_	
116-14	15179-15187	analyses	_	
116-15	15188-15190	of	_	
116-16	15191-15201	individual	_	
116-17	15202-15206	ROIs	_	
116-18	15207-15208	(	_	
116-19	15208-15211	see	_	
116-20	15212-15222	Supplement	_	
116-21	15222-15223	)	_	
116-22	15223-15224	.	_	

#Text=Correlations
#Text=We tested whether recruitment of task-positive ROIs at SS 1 (at which PSZ displayed greater activation as compared with HCS) was associated with cognitive performance, psychiatric symptoms, or antipsychotic medication in PSZ.
117-1	15225-15237	Correlations	_	
117-2	15238-15240	We	_	
117-3	15241-15247	tested	_	
117-4	15248-15255	whether	_	
117-5	15256-15267	recruitment	_	
117-6	15268-15270	of	_	
117-7	15271-15284	task-positive	_	
117-8	15285-15289	ROIs	_	
117-9	15290-15292	at	_	
117-10	15293-15295	SS	_	
117-11	15296-15297	1	_	
117-12	15298-15299	(	_	
117-13	15299-15301	at	_	
117-14	15302-15307	which	_	
117-15	15308-15311	PSZ	_	
117-16	15312-15321	displayed	_	
117-17	15322-15329	greater	_	
117-18	15330-15340	activation	_	
117-19	15341-15343	as	_	
117-20	15344-15352	compared	_	
117-21	15353-15357	with	_	
117-22	15358-15361	HCS	_	
117-23	15361-15362	)	_	
117-24	15363-15366	was	_	
117-25	15367-15377	associated	_	
117-26	15378-15382	with	_	
117-27	15383-15392	cognitive	_	
117-28	15393-15404	performance	_	
117-29	15404-15405	,	_	
117-30	15406-15417	psychiatric	_	
117-31	15418-15426	symptoms	_	
117-32	15426-15427	,	_	
117-33	15428-15430	or	_	
117-34	15431-15444	antipsychotic	_	
117-35	15445-15455	medication	_	
117-36	15456-15458	in	_	
117-37	15459-15462	PSZ	_	
117-38	15462-15463	.	_	

#Text=There were no significant Pearson correlations with BPRS, SANS, or LOFS total scores, chlorpromazine equivalents (Andreasen et al., 2010), or CDT accuracy at SS 4 (as proxy for WM capacity).
118-1	15464-15469	There	_	
118-2	15470-15474	were	_	
118-3	15475-15477	no	_	
118-4	15478-15489	significant	_	
118-5	15490-15497	Pearson	_	
118-6	15498-15510	correlations	_	
118-7	15511-15515	with	_	
118-8	15516-15520	BPRS	_	
118-9	15520-15521	,	_	
118-10	15522-15526	SANS	_	
118-11	15526-15527	,	_	
118-12	15528-15530	or	_	
118-13	15531-15535	LOFS	_	
118-14	15536-15541	total	_	
118-15	15542-15548	scores	_	
118-16	15548-15549	,	_	
118-17	15550-15564	chlorpromazine	_	
118-18	15565-15576	equivalents	_	
118-19	15577-15578	(	_	
118-20	15578-15587	Andreasen	_	
118-21	15588-15590	et	_	
118-22	15591-15593	al	_	
118-23	15593-15594	.	_	
118-24	15594-15595	,	_	
118-25	15596-15600	2010	_	
118-26	15600-15601	)	_	
118-27	15601-15602	,	_	
118-28	15603-15605	or	_	
118-29	15606-15609	CDT	_	
118-30	15610-15618	accuracy	_	
118-31	15619-15621	at	_	
118-32	15622-15624	SS	_	
118-33	15625-15626	4	_	
118-34	15627-15628	(	_	
118-35	15628-15630	as	_	
118-36	15631-15636	proxy	_	
118-37	15637-15640	for	_	
118-38	15641-15643	WM	_	
118-39	15644-15652	capacity	_	
118-40	15652-15653	)	_	
118-41	15653-15654	.	_	

#Text=However, over-recruitment correlated with slower RT at SS 1 (R=0.56, P=0.009) and SS 4 (R=0.61, P=0.004), and with lower MATRICS Consensus Cognitive Battery (MCCB) composite scores (R=−0.51, P=0.017).
119-1	15655-15662	However	_	
119-2	15662-15663	,	_	
119-3	15664-15680	over-recruitment	_	
119-4	15681-15691	correlated	_	
119-5	15692-15696	with	_	
119-6	15697-15703	slower	_	
119-7	15704-15706	RT	_	
119-8	15707-15709	at	_	
119-9	15710-15712	SS	_	
119-10	15713-15714	1	_	
119-11	15715-15716	(	_	
119-12	15716-15717	R	_	
119-13	15717-15718	=	_	
119-14	15718-15722	0.56	_	
119-15	15722-15723	,	_	
119-16	15724-15725	P	_	
119-17	15725-15726	=	_	
119-18	15726-15731	0.009	_	
119-19	15731-15732	)	_	
119-20	15733-15736	and	_	
119-21	15737-15739	SS	_	
119-22	15740-15741	4	_	
119-23	15742-15743	(	_	
119-24	15743-15744	R	_	
119-25	15744-15745	=	_	
119-26	15745-15749	0.61	_	
119-27	15749-15750	,	_	
119-28	15751-15752	P	_	
119-29	15752-15753	=	_	
119-30	15753-15758	0.004	_	
119-31	15758-15759	)	_	
119-32	15759-15760	,	_	
119-33	15761-15764	and	_	
119-34	15765-15769	with	_	
119-35	15770-15775	lower	_	
119-36	15776-15783	MATRICS	_	
119-37	15784-15793	Consensus	_	
119-38	15794-15803	Cognitive	_	
119-39	15804-15811	Battery	_	
119-40	15812-15813	(	_	
119-41	15813-15817	MCCB	_	
119-42	15817-15818	)	_	
119-43	15819-15828	composite	_	
119-44	15829-15835	scores	_	
119-45	15836-15837	(	_	
119-46	15837-15838	R	_	
119-47	15838-15839	=	_	
119-48	15839-15840	−	_	
119-49	15840-15844	0.51	_	
119-50	15844-15845	,	_	
119-51	15846-15847	P	_	
119-52	15847-15848	=	_	
119-53	15848-15853	0.017	_	
119-54	15853-15854	)	_	
119-55	15854-15855	.	_	

#Text=No significant correlations were identified between DMN hyperdeactivation at SS 4 and accuracy or RT at SS 4, MCCB composite scores, BPRS, SANS, LOFS, or chlorpromazine equivalents.
120-1	15856-15858	No	_	
120-2	15859-15870	significant	_	
120-3	15871-15883	correlations	_	
120-4	15884-15888	were	_	
120-5	15889-15899	identified	_	
120-6	15900-15907	between	_	
120-7	15908-15911	DMN	_	
120-8	15912-15929	hyperdeactivation	_	
120-9	15930-15932	at	_	
120-10	15933-15935	SS	_	
120-11	15936-15937	4	_	
120-12	15938-15941	and	_	
120-13	15942-15950	accuracy	_	
120-14	15951-15953	or	_	
120-15	15954-15956	RT	_	
120-16	15957-15959	at	_	
120-17	15960-15962	SS	_	
120-18	15963-15964	4	_	
120-19	15964-15965	,	_	
120-20	15966-15970	MCCB	_	
120-21	15971-15980	composite	_	
120-22	15981-15987	scores	_	
120-23	15987-15988	,	_	
120-24	15989-15993	BPRS	_	
120-25	15993-15994	,	_	
120-26	15995-15999	SANS	_	
120-27	15999-16000	,	_	
120-28	16001-16005	LOFS	_	
120-29	16005-16006	,	_	
120-30	16007-16009	or	_	
120-31	16010-16024	chlorpromazine	_	
120-32	16025-16036	equivalents	_	
120-33	16036-16037	.	_	

#Text=Discussion
#Text=Our aim was to compare WM load-dependent activation of task-positive regions and deactivation of the DMN between PSZ and HCS while minimizing group differences in task engagement.
121-1	16038-16048	Discussion	_	
121-2	16049-16052	Our	_	
121-3	16053-16056	aim	_	
121-4	16057-16060	was	_	
121-5	16061-16063	to	_	
121-6	16064-16071	compare	_	
121-7	16072-16074	WM	_	
121-8	16075-16089	load-dependent	_	
121-9	16090-16100	activation	_	
121-10	16101-16103	of	_	
121-11	16104-16117	task-positive	_	
121-12	16118-16125	regions	_	
121-13	16126-16129	and	_	
121-14	16130-16142	deactivation	_	
121-15	16143-16145	of	_	
121-16	16146-16149	the	_	
121-17	16150-16153	DMN	_	
121-18	16154-16161	between	_	
121-19	16162-16165	PSZ	_	
121-20	16166-16169	and	_	
121-21	16170-16173	HCS	_	
121-22	16174-16179	while	_	
121-23	16180-16190	minimizing	_	
121-24	16191-16196	group	_	
121-25	16197-16208	differences	_	
121-26	16209-16211	in	_	
121-27	16212-16216	task	_	
121-28	16217-16227	engagement	_	
121-29	16227-16228	.	_	

#Text=No-response trials were more frequent in PSZ in the initial training session, but no longer in the MRI session, suggesting that pre-training remediated group differences in task engagement that otherwise would have influenced the fMRI results.
122-1	16229-16240	No-response	_	
122-2	16241-16247	trials	_	
122-3	16248-16252	were	_	
122-4	16253-16257	more	_	
122-5	16258-16266	frequent	_	
122-6	16267-16269	in	_	
122-7	16270-16273	PSZ	_	
122-8	16274-16276	in	_	
122-9	16277-16280	the	_	
122-10	16281-16288	initial	_	
122-11	16289-16297	training	_	
122-12	16298-16305	session	_	
122-13	16305-16306	,	_	
122-14	16307-16310	but	_	
122-15	16311-16313	no	_	
122-16	16314-16320	longer	_	
122-17	16321-16323	in	_	
122-18	16324-16327	the	_	
122-19	16328-16331	MRI	_	
122-20	16332-16339	session	_	
122-21	16339-16340	,	_	
122-22	16341-16351	suggesting	_	
122-23	16352-16356	that	_	
122-24	16357-16369	pre-training	_	
122-25	16370-16380	remediated	_	
122-26	16381-16386	group	_	
122-27	16387-16398	differences	_	
122-28	16399-16401	in	_	
122-29	16402-16406	task	_	
122-30	16407-16417	engagement	_	
122-31	16418-16422	that	_	
122-32	16423-16432	otherwise	_	
122-33	16433-16438	would	_	
122-34	16439-16443	have	_	
122-35	16444-16454	influenced	_	
122-36	16455-16458	the	_	
122-37	16459-16463	fMRI	_	
122-38	16464-16471	results	_	
122-39	16471-16472	.	_	

#Text=As expected, frontoparietal task-positive ROIs displayed increasing activation with greater WM load.
123-1	16473-16475	As	_	
123-2	16476-16484	expected	_	
123-3	16484-16485	,	_	
123-4	16486-16500	frontoparietal	_	
123-5	16501-16514	task-positive	_	
123-6	16515-16519	ROIs	_	
123-7	16520-16529	displayed	_	
123-8	16530-16540	increasing	_	
123-9	16541-16551	activation	_	
123-10	16552-16556	with	_	
123-11	16557-16564	greater	_	
123-12	16565-16567	WM	_	
123-13	16568-16572	load	_	
123-14	16572-16573	.	_	

#Text=A trend suggested greater activation in PSZ, especially at smaller SSs, consistent with findings of increased frontoparietal activation in other WM paradigms at lower load (; 2003).
124-1	16574-16575	A	_	
124-2	16576-16581	trend	_	
124-3	16582-16591	suggested	_	
124-4	16592-16599	greater	_	
124-5	16600-16610	activation	_	
124-6	16611-16613	in	_	
124-7	16614-16617	PSZ	_	
124-8	16617-16618	,	_	
124-9	16619-16629	especially	_	
124-10	16630-16632	at	_	
124-11	16633-16640	smaller	_	
124-12	16641-16644	SSs	_	
124-13	16644-16645	,	_	
124-14	16646-16656	consistent	_	
124-15	16657-16661	with	_	
124-16	16662-16670	findings	_	
124-17	16671-16673	of	_	
124-18	16674-16683	increased	_	
124-19	16684-16698	frontoparietal	_	
124-20	16699-16709	activation	_	
124-21	16710-16712	in	_	
124-22	16713-16718	other	_	
124-23	16719-16721	WM	_	
124-24	16722-16731	paradigms	_	
124-25	16732-16734	at	_	
124-26	16735-16740	lower	_	
124-27	16741-16745	load	_	
124-28	16746-16747	(	_	
124-29	16747-16748	;	_	
124-30	16749-16753	2003	_	
124-31	16753-16754	)	_	
124-32	16754-16755	.	_	

#Text=This supports a leftward shift of the load-dependent inverted U-shaped activation curve in schizophrenia.
125-1	16756-16760	This	_	
125-2	16761-16769	supports	_	
125-3	16770-16771	a	_	
125-4	16772-16780	leftward	_	
125-5	16781-16786	shift	_	
125-6	16787-16789	of	_	
125-7	16790-16793	the	_	
125-8	16794-16808	load-dependent	_	
125-9	16809-16817	inverted	_	
125-10	16818-16826	U-shaped	_	
125-11	16827-16837	activation	_	
125-12	16838-16843	curve	_	
125-13	16844-16846	in	_	
125-14	16847-16860	schizophrenia	_	
125-15	16860-16861	.	_	

#Text=The present study only probed its putative ascending arm, at which task load was clearly manageable for both groups, but was probably more resource-consuming for PSZ due to cognitive impairment associated with the disorder.
126-1	16862-16865	The	_	
126-2	16866-16873	present	_	
126-3	16874-16879	study	_	
126-4	16880-16884	only	_	
126-5	16885-16891	probed	_	
126-6	16892-16895	its	_	
126-7	16896-16904	putative	_	
126-8	16905-16914	ascending	_	
126-9	16915-16918	arm	_	
126-10	16918-16919	,	_	
126-11	16920-16922	at	_	
126-12	16923-16928	which	_	
126-13	16929-16933	task	_	
126-14	16934-16938	load	_	
126-15	16939-16942	was	_	
126-16	16943-16950	clearly	_	
126-17	16951-16961	manageable	_	
126-18	16962-16965	for	_	
126-19	16966-16970	both	_	
126-20	16971-16977	groups	_	
126-21	16977-16978	,	_	
126-22	16979-16982	but	_	
126-23	16983-16986	was	_	
126-24	16987-16995	probably	_	
126-25	16996-17000	more	_	
126-26	17001-17019	resource-consuming	_	
126-27	17020-17023	for	_	
126-28	17024-17027	PSZ	_	
126-29	17028-17031	due	_	
126-30	17032-17034	to	_	
126-31	17035-17044	cognitive	_	
126-32	17045-17055	impairment	_	
126-33	17056-17066	associated	_	
126-34	17067-17071	with	_	
126-35	17072-17075	the	_	
126-36	17076-17084	disorder	_	
126-37	17084-17085	.	_	

#Text=The latter was supported by significant correlations between over-engagement of task-positive ROIs at low load and impaired performance on several cognitive indices.
127-1	17086-17089	The	_	
127-2	17090-17096	latter	_	
127-3	17097-17100	was	_	
127-4	17101-17110	supported	_	
127-5	17111-17113	by	_	
127-6	17114-17125	significant	_	
127-7	17126-17138	correlations	_	
127-8	17139-17146	between	_	
127-9	17147-17162	over-engagement	_	
127-10	17163-17165	of	_	
127-11	17166-17179	task-positive	_	
127-12	17180-17184	ROIs	_	
127-13	17185-17187	at	_	
127-14	17188-17191	low	_	
127-15	17192-17196	load	_	
127-16	17197-17200	and	_	
127-17	17201-17209	impaired	_	
127-18	17210-17221	performance	_	
127-19	17222-17224	on	_	
127-20	17225-17232	several	_	
127-21	17233-17242	cognitive	_	
127-22	17243-17250	indices	_	
127-23	17250-17251	.	_	

#Text=Considering the above studies reporting PFC over-recruitment in PSZ at manageable load, it was perhaps surprising that the middle frontal ROIs displayed little SS-dependent activation and no over-recruitment in PSZ.
128-1	17252-17263	Considering	_	
128-2	17264-17267	the	_	
128-3	17268-17273	above	_	
128-4	17274-17281	studies	_	
128-5	17282-17291	reporting	_	
128-6	17292-17295	PFC	_	
128-7	17296-17312	over-recruitment	_	
128-8	17313-17315	in	_	
128-9	17316-17319	PSZ	_	
128-10	17320-17322	at	_	
128-11	17323-17333	manageable	_	
128-12	17334-17338	load	_	
128-13	17338-17339	,	_	
128-14	17340-17342	it	_	
128-15	17343-17346	was	_	
128-16	17347-17354	perhaps	_	
128-17	17355-17365	surprising	_	
128-18	17366-17370	that	_	
128-19	17371-17374	the	_	
128-20	17375-17381	middle	_	
128-21	17382-17389	frontal	_	
128-22	17390-17394	ROIs	_	
128-23	17395-17404	displayed	_	
128-24	17405-17411	little	_	
128-25	17412-17424	SS-dependent	_	
128-26	17425-17435	activation	_	
128-27	17436-17439	and	_	
128-28	17440-17442	no	_	
128-29	17443-17459	over-recruitment	_	
128-30	17460-17462	in	_	
128-31	17463-17466	PSZ	_	
128-32	17466-17467	.	_	

#Text=Results by suggested significant heterogeneity between prefrontal areas with regard to load-dependent recruitment in PSZ relative to HCS.
129-1	17468-17475	Results	_	
129-2	17476-17478	by	_	
129-3	17479-17488	suggested	_	
129-4	17489-17500	significant	_	
129-5	17501-17514	heterogeneity	_	
129-6	17515-17522	between	_	
129-7	17523-17533	prefrontal	_	
129-8	17534-17539	areas	_	
129-9	17540-17544	with	_	
129-10	17545-17551	regard	_	
129-11	17552-17554	to	_	
129-12	17555-17569	load-dependent	_	
129-13	17570-17581	recruitment	_	
129-14	17582-17584	in	_	
129-15	17585-17588	PSZ	_	
129-16	17589-17597	relative	_	
129-17	17598-17600	to	_	
129-18	17601-17604	HCS	_	
129-19	17604-17605	.	_	

#Text=The present study probed limited PFC regions; the middle frontal ROIs may not have represented the generally more dorsal locations displaying over-recruitment in these previous studies.
130-1	17606-17609	The	_	
130-2	17610-17617	present	_	
130-3	17618-17623	study	_	
130-4	17624-17630	probed	_	
130-5	17631-17638	limited	_	
130-6	17639-17642	PFC	_	
130-7	17643-17650	regions	_	
130-8	17650-17651	;	_	
130-9	17652-17655	the	_	
130-10	17656-17662	middle	_	
130-11	17663-17670	frontal	_	
130-12	17671-17675	ROIs	_	
130-13	17676-17679	may	_	
130-14	17680-17683	not	_	
130-15	17684-17688	have	_	
130-16	17689-17700	represented	_	
130-17	17701-17704	the	_	
130-18	17705-17714	generally	_	
130-19	17715-17719	more	_	
130-20	17720-17726	dorsal	_	
130-21	17727-17736	locations	_	
130-22	17737-17747	displaying	_	
130-23	17748-17764	over-recruitment	_	
130-24	17765-17767	in	_	
130-25	17768-17773	these	_	
130-26	17774-17782	previous	_	
130-27	17783-17790	studies	_	
130-28	17790-17791	.	_	

#Text=However, other studies of WM, controlling for task engagement by limiting analyses to epochs of correct performance, similarly found no difference in load-dependent dorsolateral PFC recruitment between PSZ and HCS.
131-1	17792-17799	However	_	
131-2	17799-17800	,	_	
131-3	17801-17806	other	_	
131-4	17807-17814	studies	_	
131-5	17815-17817	of	_	
131-6	17818-17820	WM	_	
131-7	17820-17821	,	_	
131-8	17822-17833	controlling	_	
131-9	17834-17837	for	_	
131-10	17838-17842	task	_	
131-11	17843-17853	engagement	_	
131-12	17854-17856	by	_	
131-13	17857-17865	limiting	_	
131-14	17866-17874	analyses	_	
131-15	17875-17877	to	_	
131-16	17878-17884	epochs	_	
131-17	17885-17887	of	_	
131-18	17888-17895	correct	_	
131-19	17896-17907	performance	_	
131-20	17907-17908	,	_	
131-21	17909-17918	similarly	_	
131-22	17919-17924	found	_	
131-23	17925-17927	no	_	
131-24	17928-17938	difference	_	
131-25	17939-17941	in	_	
131-26	17942-17956	load-dependent	_	
131-27	17957-17969	dorsolateral	_	
131-28	17970-17973	PFC	_	
131-29	17974-17985	recruitment	_	
131-30	17986-17993	between	_	
131-31	17994-17997	PSZ	_	
131-32	17998-18001	and	_	
131-33	18002-18005	HCS	_	
131-34	18005-18006	.	_	

#Text=In task-negative DMN ROIs, both groups displayed robust task-induced deactivation of the DMN; however, only PSZ displayed increasing deactivation with greater WM load.
132-1	18007-18009	In	_	
132-2	18010-18023	task-negative	_	
132-3	18024-18027	DMN	_	
132-4	18028-18032	ROIs	_	
132-5	18032-18033	,	_	
132-6	18034-18038	both	_	
132-7	18039-18045	groups	_	
132-8	18046-18055	displayed	_	
132-9	18056-18062	robust	_	
132-10	18063-18075	task-induced	_	
132-11	18076-18088	deactivation	_	
132-12	18089-18091	of	_	
132-13	18092-18095	the	_	
132-14	18096-18099	DMN	_	
132-15	18099-18100	;	_	
132-16	18101-18108	however	_	
132-17	18108-18109	,	_	
132-18	18110-18114	only	_	
132-19	18115-18118	PSZ	_	
132-20	18119-18128	displayed	_	
132-21	18129-18139	increasing	_	
132-22	18140-18152	deactivation	_	
132-23	18153-18157	with	_	
132-24	18158-18165	greater	_	
132-25	18166-18168	WM	_	
132-26	18169-18173	load	_	
132-27	18173-18174	.	_	

#Text=In HCS, deactivation did not differ between SSs.
133-1	18175-18177	In	_	
133-2	18178-18181	HCS	_	
133-3	18181-18182	,	_	
133-4	18183-18195	deactivation	_	
133-5	18196-18199	did	_	
133-6	18200-18203	not	_	
133-7	18204-18210	differ	_	
133-8	18211-18218	between	_	
133-9	18219-18222	SSs	_	
133-10	18222-18223	.	_	

#Text=While numerous studies reported load-dependent DMN deactivation in healthy participants (e.g.,), those employing visual CDT paradigms similar to ours, with brief stimulus encoding periods, did not observe effects of SS in typical DMN regions (; Ambrose et al., 2016).
134-1	18224-18229	While	_	
134-2	18230-18238	numerous	_	
134-3	18239-18246	studies	_	
134-4	18247-18255	reported	_	
134-5	18256-18270	load-dependent	_	
134-6	18271-18274	DMN	_	
134-7	18275-18287	deactivation	_	
134-8	18288-18290	in	_	
134-9	18291-18298	healthy	_	
134-10	18299-18311	participants	_	
134-11	18312-18313	(	_	
134-12	18313-18316	e.g	_	
134-13	18316-18317	.	_	
134-14	18317-18318	,	_	
134-15	18318-18319	)	_	
134-16	18319-18320	,	_	
134-17	18321-18326	those	_	
134-18	18327-18336	employing	_	
134-19	18337-18343	visual	_	
134-20	18344-18347	CDT	_	
134-21	18348-18357	paradigms	_	
134-22	18358-18365	similar	_	
134-23	18366-18368	to	_	
134-24	18369-18373	ours	_	
134-25	18373-18374	,	_	
134-26	18375-18379	with	_	
134-27	18380-18385	brief	_	
134-28	18386-18394	stimulus	_	
134-29	18395-18403	encoding	_	
134-30	18404-18411	periods	_	
134-31	18411-18412	,	_	
134-32	18413-18416	did	_	
134-33	18417-18420	not	_	
134-34	18421-18428	observe	_	
134-35	18429-18436	effects	_	
134-36	18437-18439	of	_	
134-37	18440-18442	SS	_	
134-38	18443-18445	in	_	
134-39	18446-18453	typical	_	
134-40	18454-18457	DMN	_	
134-41	18458-18465	regions	_	
134-42	18466-18467	(	_	
134-43	18467-18468	;	_	
134-44	18469-18476	Ambrose	_	
134-45	18477-18479	et	_	
134-46	18480-18482	al	_	
134-47	18482-18483	.	_	
134-48	18483-18484	,	_	
134-49	18485-18489	2016	_	
134-50	18489-18490	)	_	
134-51	18490-18491	.	_	

#Text=The color CDT is by and large not conducive to active rehearsal and is only minimally affected by performance of a secondary attention-demanding task in the retention period as long as the stimulus modality differs (; Woodman and Luck, 2001).
135-1	18492-18495	The	_	
135-2	18496-18501	color	_	
135-3	18502-18505	CDT	_	
135-4	18506-18508	is	_	
135-5	18509-18511	by	_	
135-6	18512-18515	and	_	
135-7	18516-18521	large	_	
135-8	18522-18525	not	_	
135-9	18526-18535	conducive	_	
135-10	18536-18538	to	_	
135-11	18539-18545	active	_	
135-12	18546-18555	rehearsal	_	
135-13	18556-18559	and	_	
135-14	18560-18562	is	_	
135-15	18563-18567	only	_	
135-16	18568-18577	minimally	_	
135-17	18578-18586	affected	_	
135-18	18587-18589	by	_	
135-19	18590-18601	performance	_	
135-20	18602-18604	of	_	
135-21	18605-18606	a	_	
135-22	18607-18616	secondary	_	
135-23	18617-18636	attention-demanding	_	
135-24	18637-18641	task	_	
135-25	18642-18644	in	_	
135-26	18645-18648	the	_	
135-27	18649-18658	retention	_	
135-28	18659-18665	period	_	
135-29	18666-18668	as	_	
135-30	18669-18673	long	_	
135-31	18674-18676	as	_	
135-32	18677-18680	the	_	
135-33	18681-18689	stimulus	_	
135-34	18690-18698	modality	_	
135-35	18699-18706	differs	_	
135-36	18707-18708	(	_	
135-37	18708-18709	;	_	
135-38	18710-18717	Woodman	_	
135-39	18718-18721	and	_	
135-40	18722-18726	Luck	_	
135-41	18726-18727	,	_	
135-42	18728-18732	2001	_	
135-43	18732-18733	)	_	
135-44	18733-18734	.	_	

#Text=Thus, the CDT may vary the number of items stored in WM without significantly varying the engagement of attentional or executive control resources.
136-1	18735-18739	Thus	_	
136-2	18739-18740	,	_	
136-3	18741-18744	the	_	
136-4	18745-18748	CDT	_	
136-5	18749-18752	may	_	
136-6	18753-18757	vary	_	
136-7	18758-18761	the	_	
136-8	18762-18768	number	_	
136-9	18769-18771	of	_	
136-10	18772-18777	items	_	
136-11	18778-18784	stored	_	
136-12	18785-18787	in	_	
136-13	18788-18790	WM	_	
136-14	18791-18798	without	_	
136-15	18799-18812	significantly	_	
136-16	18813-18820	varying	_	
136-17	18821-18824	the	_	
136-18	18825-18835	engagement	_	
136-19	18836-18838	of	_	
136-20	18839-18850	attentional	_	
136-21	18851-18853	or	_	
136-22	18854-18863	executive	_	
136-23	18864-18871	control	_	
136-24	18872-18881	resources	_	
136-25	18881-18882	.	_	

#Text=The SS-dependent DMN deactivation seen in PSZ, then, may reflect an increasing engagement of non-specific vigilance or effort in an attempt to accommodate the increasing WM storage challenges.
137-1	18883-18886	The	_	
137-2	18887-18899	SS-dependent	_	
137-3	18900-18903	DMN	_	
137-4	18904-18916	deactivation	_	
137-5	18917-18921	seen	_	
137-6	18922-18924	in	_	
137-7	18925-18928	PSZ	_	
137-8	18928-18929	,	_	
137-9	18930-18934	then	_	
137-10	18934-18935	,	_	
137-11	18936-18939	may	_	
137-12	18940-18947	reflect	_	
137-13	18948-18950	an	_	
137-14	18951-18961	increasing	_	
137-15	18962-18972	engagement	_	
137-16	18973-18975	of	_	
137-17	18976-18988	non-specific	_	
137-18	18989-18998	vigilance	_	
137-19	18999-19001	or	_	
137-20	19002-19008	effort	_	
137-21	19009-19011	in	_	
137-22	19012-19014	an	_	
137-23	19015-19022	attempt	_	
137-24	19023-19025	to	_	
137-25	19026-19037	accommodate	_	
137-26	19038-19041	the	_	
137-27	19042-19052	increasing	_	
137-28	19053-19055	WM	_	
137-29	19056-19063	storage	_	
137-30	19064-19074	challenges	_	
137-31	19074-19075	.	_	

#Text=Given the absence of correlations, this did not appear to benefit task performance or cognitive ability; therefore, it may not be an adaptive strategy.
138-1	19076-19081	Given	_	
138-2	19082-19085	the	_	
138-3	19086-19093	absence	_	
138-4	19094-19096	of	_	
138-5	19097-19109	correlations	_	
138-6	19109-19110	,	_	
138-7	19111-19115	this	_	
138-8	19116-19119	did	_	
138-9	19120-19123	not	_	
138-10	19124-19130	appear	_	
138-11	19131-19133	to	_	
138-12	19134-19141	benefit	_	
138-13	19142-19146	task	_	
138-14	19147-19158	performance	_	
138-15	19159-19161	or	_	
138-16	19162-19171	cognitive	_	
138-17	19172-19179	ability	_	
138-18	19179-19180	;	_	
138-19	19181-19190	therefore	_	
138-20	19190-19191	,	_	
138-21	19192-19194	it	_	
138-22	19195-19198	may	_	
138-23	19199-19202	not	_	
138-24	19203-19205	be	_	
138-25	19206-19208	an	_	
138-26	19209-19217	adaptive	_	
138-27	19218-19226	strategy	_	
138-28	19226-19227	.	_	

#Text=DMN deactivation in PSZ was never lower than in HCS, consistent with our hypothesis that when minimizing differences in task-engagement by making task-demands manageable, the ability to down-regulate DMN functions is unimpaired in PSZ.
139-1	19228-19231	DMN	_	
139-2	19232-19244	deactivation	_	
139-3	19245-19247	in	_	
139-4	19248-19251	PSZ	_	
139-5	19252-19255	was	_	
139-6	19256-19261	never	_	
139-7	19262-19267	lower	_	
139-8	19268-19272	than	_	
139-9	19273-19275	in	_	
139-10	19276-19279	HCS	_	
139-11	19279-19280	,	_	
139-12	19281-19291	consistent	_	
139-13	19292-19296	with	_	
139-14	19297-19300	our	_	
139-15	19301-19311	hypothesis	_	
139-16	19312-19316	that	_	
139-17	19317-19321	when	_	
139-18	19322-19332	minimizing	_	
139-19	19333-19344	differences	_	
139-20	19345-19347	in	_	
139-21	19348-19363	task-engagement	_	
139-22	19364-19366	by	_	
139-23	19367-19373	making	_	
139-24	19374-19386	task-demands	_	
139-25	19387-19397	manageable	_	
139-26	19397-19398	,	_	
139-27	19399-19402	the	_	
139-28	19403-19410	ability	_	
139-29	19411-19413	to	_	
139-30	19414-19427	down-regulate	_	
139-31	19428-19431	DMN	_	
139-32	19432-19441	functions	_	
139-33	19442-19444	is	_	
139-34	19445-19455	unimpaired	_	
139-35	19456-19458	in	_	
139-36	19459-19462	PSZ	_	
139-37	19462-19463	.	_	

#Text=This speaks against an inability to down-regulate task-independent thought processes as a primary mechanism causative of cognitive impairment in schizophrenia.
140-1	19464-19468	This	_	
140-2	19469-19475	speaks	_	
140-3	19476-19483	against	_	
140-4	19484-19486	an	_	
140-5	19487-19496	inability	_	
140-6	19497-19499	to	_	
140-7	19500-19513	down-regulate	_	
140-8	19514-19530	task-independent	_	
140-9	19531-19538	thought	_	
140-10	19539-19548	processes	_	
140-11	19549-19551	as	_	
140-12	19552-19553	a	_	
140-13	19554-19561	primary	_	
140-14	19562-19571	mechanism	_	
140-15	19572-19581	causative	_	
140-16	19582-19584	of	_	
140-17	19585-19594	cognitive	_	
140-18	19595-19605	impairment	_	
140-19	19606-19608	in	_	
140-20	19609-19622	schizophrenia	_	
140-21	19622-19623	.	_	

#Text=Task-induced DMN deactivation even tended to be greater in PSZ relative to HCS, especially at the largest SS.
141-1	19624-19636	Task-induced	_	
141-2	19637-19640	DMN	_	
141-3	19641-19653	deactivation	_	
141-4	19654-19658	even	_	
141-5	19659-19665	tended	_	
141-6	19666-19668	to	_	
141-7	19669-19671	be	_	
141-8	19672-19679	greater	_	
141-9	19680-19682	in	_	
141-10	19683-19686	PSZ	_	
141-11	19687-19695	relative	_	
141-12	19696-19698	to	_	
141-13	19699-19702	HCS	_	
141-14	19702-19703	,	_	
141-15	19704-19714	especially	_	
141-16	19715-19717	at	_	
141-17	19718-19721	the	_	
141-18	19722-19729	largest	_	
141-19	19730-19732	SS	_	
141-20	19732-19733	.	_	

#Text=Given that greater processing demands are associated with greater DMN deactivation, this phenomenon may reflect more effortful processing in PSZ.
142-1	19734-19739	Given	_	
142-2	19740-19744	that	_	
142-3	19745-19752	greater	_	
142-4	19753-19763	processing	_	
142-5	19764-19771	demands	_	
142-6	19772-19775	are	_	
142-7	19776-19786	associated	_	
142-8	19787-19791	with	_	
142-9	19792-19799	greater	_	
142-10	19800-19803	DMN	_	
142-11	19804-19816	deactivation	_	
142-12	19816-19817	,	_	
142-13	19818-19822	this	_	
142-14	19823-19833	phenomenon	_	
142-15	19834-19837	may	_	
142-16	19838-19845	reflect	_	
142-17	19846-19850	more	_	
142-18	19851-19860	effortful	_	
142-19	19861-19871	processing	_	
142-20	19872-19874	in	_	
142-21	19875-19878	PSZ	_	
142-22	19878-19879	.	_	

#Text=A previous study employing a stimulus detection paradigm of low difficulty with task pre-training reported DMN hyperdeactivation in PSZ in response to cue-induced attentional focusing, not accompanied by over-recruitment of task-positive regions.
143-1	19880-19881	A	_	
143-2	19882-19890	previous	_	
143-3	19891-19896	study	_	
143-4	19897-19906	employing	_	
143-5	19907-19908	a	_	
143-6	19909-19917	stimulus	_	
143-7	19918-19927	detection	_	
143-8	19928-19936	paradigm	_	
143-9	19937-19939	of	_	
143-10	19940-19943	low	_	
143-11	19944-19954	difficulty	_	
143-12	19955-19959	with	_	
143-13	19960-19964	task	_	
143-14	19965-19977	pre-training	_	
143-15	19978-19986	reported	_	
143-16	19987-19990	DMN	_	
143-17	19991-20008	hyperdeactivation	_	
143-18	20009-20011	in	_	
143-19	20012-20015	PSZ	_	
143-20	20016-20018	in	_	
143-21	20019-20027	response	_	
143-22	20028-20030	to	_	
143-23	20031-20042	cue-induced	_	
143-24	20043-20054	attentional	_	
143-25	20055-20063	focusing	_	
143-26	20063-20064	,	_	
143-27	20065-20068	not	_	
143-28	20069-20080	accompanied	_	
143-29	20081-20083	by	_	
143-30	20084-20100	over-recruitment	_	
143-31	20101-20103	of	_	
143-32	20104-20117	task-positive	_	
143-33	20118-20125	regions	_	
143-34	20125-20126	.	_	

#Text=This prompted the suggestion that DMN hyperdeactivation reflected greater non-specific effort.
144-1	20127-20131	This	_	
144-2	20132-20140	prompted	_	
144-3	20141-20144	the	_	
144-4	20145-20155	suggestion	_	
144-5	20156-20160	that	_	
144-6	20161-20164	DMN	_	
144-7	20165-20182	hyperdeactivation	_	
144-8	20183-20192	reflected	_	
144-9	20193-20200	greater	_	
144-10	20201-20213	non-specific	_	
144-11	20214-20220	effort	_	
144-12	20220-20221	.	_	

#Text=In the present study, a trend towards hyperdeactivation was seen at higher load, again in the absence of group differences in task-positive ROI engagement.
145-1	20222-20224	In	_	
145-2	20225-20228	the	_	
145-3	20229-20236	present	_	
145-4	20237-20242	study	_	
145-5	20242-20243	,	_	
145-6	20244-20245	a	_	
145-7	20246-20251	trend	_	
145-8	20252-20259	towards	_	
145-9	20260-20277	hyperdeactivation	_	
145-10	20278-20281	was	_	
145-11	20282-20286	seen	_	
145-12	20287-20289	at	_	
145-13	20290-20296	higher	_	
145-14	20297-20301	load	_	
145-15	20301-20302	,	_	
145-16	20303-20308	again	_	
145-17	20309-20311	in	_	
145-18	20312-20315	the	_	
145-19	20316-20323	absence	_	
145-20	20324-20326	of	_	
145-21	20327-20332	group	_	
145-22	20333-20344	differences	_	
145-23	20345-20347	in	_	
145-24	20348-20361	task-positive	_	
145-25	20362-20365	ROI	_	
145-26	20366-20376	engagement	_	
145-27	20376-20377	.	_	

#Text=This adds to the notion that exaggerated down-regulation of DMN function in PSZ may constitute an independent mechanism of attempting to deal with challenging (but not unmanageable) task demands.
146-1	20378-20382	This	_	
146-2	20383-20387	adds	_	
146-3	20388-20390	to	_	
146-4	20391-20394	the	_	
146-5	20395-20401	notion	_	
146-6	20402-20406	that	_	
146-7	20407-20418	exaggerated	_	
146-8	20419-20434	down-regulation	_	
146-9	20435-20437	of	_	
146-10	20438-20441	DMN	_	
146-11	20442-20450	function	_	
146-12	20451-20453	in	_	
146-13	20454-20457	PSZ	_	
146-14	20458-20461	may	_	
146-15	20462-20472	constitute	_	
146-16	20473-20475	an	_	
146-17	20476-20487	independent	_	
146-18	20488-20497	mechanism	_	
146-19	20498-20500	of	_	
146-20	20501-20511	attempting	_	
146-21	20512-20514	to	_	
146-22	20515-20519	deal	_	
146-23	20520-20524	with	_	
146-24	20525-20536	challenging	_	
146-25	20537-20538	(	_	
146-26	20538-20541	but	_	
146-27	20542-20545	not	_	
146-28	20546-20558	unmanageable	_	
146-29	20558-20559	)	_	
146-30	20560-20564	task	_	
146-31	20565-20572	demands	_	
146-32	20572-20573	.	_	

#Text=The use of a block-design did not allow dissociating activity related to WM encoding and maintenance vs. retrieval and decision-related processes.
147-1	20574-20577	The	_	
147-2	20578-20581	use	_	
147-3	20582-20584	of	_	
147-4	20585-20586	a	_	
147-5	20587-20599	block-design	_	
147-6	20600-20603	did	_	
147-7	20604-20607	not	_	
147-8	20608-20613	allow	_	
147-9	20614-20626	dissociating	_	
147-10	20627-20635	activity	_	
147-11	20636-20643	related	_	
147-12	20644-20646	to	_	
147-13	20647-20649	WM	_	
147-14	20650-20658	encoding	_	
147-15	20659-20662	and	_	
147-16	20663-20674	maintenance	_	
147-17	20675-20677	vs	_	
147-18	20677-20678	.	_	
147-19	20679-20688	retrieval	_	
147-20	20689-20692	and	_	
147-21	20693-20709	decision-related	_	
147-22	20710-20719	processes	_	
147-23	20719-20720	.	_	

#Text=Future studies will aim at expanding the present findings by employing an event-related design and larger sample.
148-1	20721-20727	Future	_	
148-2	20728-20735	studies	_	
148-3	20736-20740	will	_	
148-4	20741-20744	aim	_	
148-5	20745-20747	at	_	
148-6	20748-20757	expanding	_	
148-7	20758-20761	the	_	
148-8	20762-20769	present	_	
148-9	20770-20778	findings	_	
148-10	20779-20781	by	_	
148-11	20782-20791	employing	_	
148-12	20792-20794	an	_	
148-13	20795-20808	event-related	_	
148-14	20809-20815	design	_	
148-15	20816-20819	and	_	
148-16	20820-20826	larger	_	
148-17	20827-20833	sample	_	
148-18	20833-20834	.	_	

#Text=Future studies will also test a wider range of SSs that includes WM load conditions that far exceed participants’ capacity and may result in task-engagement “breaking off”.
149-1	20835-20841	Future	_	
149-2	20842-20849	studies	_	
149-3	20850-20854	will	_	
149-4	20855-20859	also	_	
149-5	20860-20864	test	_	
149-6	20865-20866	a	_	
149-7	20867-20872	wider	_	
149-8	20873-20878	range	_	
149-9	20879-20881	of	_	
149-10	20882-20885	SSs	_	
149-11	20886-20890	that	_	
149-12	20891-20899	includes	_	
149-13	20900-20902	WM	_	
149-14	20903-20907	load	_	
149-15	20908-20918	conditions	_	
149-16	20919-20923	that	_	
149-17	20924-20927	far	_	
149-18	20928-20934	exceed	_	
149-19	20935-20947	participants	_	
149-20	20947-20948	’	_	
149-21	20949-20957	capacity	_	
149-22	20958-20961	and	_	
149-23	20962-20965	may	_	
149-24	20966-20972	result	_	
149-25	20973-20975	in	_	
149-26	20976-20991	task-engagement	_	
149-27	20992-20993	“	_	
149-28	20993-21001	breaking	_	
149-29	21002-21005	off	_	
149-30	21005-21006	”	_	
149-31	21006-21007	.	_	

#Text=This will enable conclusions about modulation of task-positive regions on the descending arm of the putative load - activation dose-response curve, and may help reconcile reports of DMN hypodeactivation in schizophrenia with the hyperdeactivation found by our group.
150-1	21008-21012	This	_	
150-2	21013-21017	will	_	
150-3	21018-21024	enable	_	
150-4	21025-21036	conclusions	_	
150-5	21037-21042	about	_	
150-6	21043-21053	modulation	_	
150-7	21054-21056	of	_	
150-8	21057-21070	task-positive	_	
150-9	21071-21078	regions	_	
150-10	21079-21081	on	_	
150-11	21082-21085	the	_	
150-12	21086-21096	descending	_	
150-13	21097-21100	arm	_	
150-14	21101-21103	of	_	
150-15	21104-21107	the	_	
150-16	21108-21116	putative	_	
150-17	21117-21121	load	_	
150-18	21122-21123	-	_	
150-19	21124-21134	activation	_	
150-20	21135-21148	dose-response	_	
150-21	21149-21154	curve	_	
150-22	21154-21155	,	_	
150-23	21156-21159	and	_	
150-24	21160-21163	may	_	
150-25	21164-21168	help	_	
150-26	21169-21178	reconcile	_	
150-27	21179-21186	reports	_	
150-28	21187-21189	of	_	
150-29	21190-21193	DMN	_	
150-30	21194-21210	hypodeactivation	_	
150-31	21211-21213	in	_	
150-32	21214-21227	schizophrenia	_	
150-33	21228-21232	with	_	
150-34	21233-21236	the	_	
150-35	21237-21254	hyperdeactivation	_	
150-36	21255-21260	found	_	
150-37	21261-21263	by	_	
150-38	21264-21267	our	_	
150-39	21268-21273	group	_	
150-40	21273-21274	.	_	

#Text=We expect hypodeactivation exclusively at supra-capacity SSs, accompanied by significant performance deficits in PSZ relative to HCS.
151-1	21275-21277	We	_	
151-2	21278-21284	expect	_	
151-3	21285-21301	hypodeactivation	_	
151-4	21302-21313	exclusively	_	
151-5	21314-21316	at	_	
151-6	21317-21331	supra-capacity	_	
151-7	21332-21335	SSs	_	
151-8	21335-21336	,	_	
151-9	21337-21348	accompanied	_	
151-10	21349-21351	by	_	
151-11	21352-21363	significant	_	
151-12	21364-21375	performance	_	
151-13	21376-21384	deficits	_	
151-14	21385-21387	in	_	
151-15	21388-21391	PSZ	_	
151-16	21392-21400	relative	_	
151-17	21401-21403	to	_	
151-18	21404-21407	HCS	_	
151-19	21407-21408	.	_	

#Text=Supplementary Material
#Text=References
#Text=
#Text=Working memory encoding and maintenance deficits in schizophrenia: neural evidence for activation and deactivation abnormalities
#Text=The brain’s default network: anatomy, function, and relevance to disease
#Text=Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited
#Text=Physiological characteristics of capacity constraints in working memory as revealed by functional MRI
#Text=Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down
#Text=Is a responsive default mode network required for successful working memory task performance?
152-1	21409-21422	Supplementary	_	
152-2	21423-21431	Material	_	
152-3	21432-21442	References	_	
152-4	21444-21451	Working	_	
152-5	21452-21458	memory	_	
152-6	21459-21467	encoding	_	
152-7	21468-21471	and	_	
152-8	21472-21483	maintenance	_	
152-9	21484-21492	deficits	_	
152-10	21493-21495	in	_	
152-11	21496-21509	schizophrenia	_	
152-12	21509-21510	:	_	
152-13	21511-21517	neural	_	
152-14	21518-21526	evidence	_	
152-15	21527-21530	for	_	
152-16	21531-21541	activation	_	
152-17	21542-21545	and	_	
152-18	21546-21558	deactivation	_	
152-19	21559-21572	abnormalities	_	
152-20	21573-21576	The	_	
152-21	21577-21582	brain	_	
152-22	21582-21583	’	_	
152-23	21583-21584	s	_	
152-24	21585-21592	default	_	
152-25	21593-21600	network	_	
152-26	21600-21601	:	_	
152-27	21602-21609	anatomy	_	
152-28	21609-21610	,	_	
152-29	21611-21619	function	_	
152-30	21619-21620	,	_	
152-31	21621-21624	and	_	
152-32	21625-21634	relevance	_	
152-33	21635-21637	to	_	
152-34	21638-21645	disease	_	
152-35	21646-21659	Physiological	_	
152-36	21660-21671	dysfunction	_	
152-37	21672-21674	of	_	
152-38	21675-21678	the	_	
152-39	21679-21691	dorsolateral	_	
152-40	21692-21702	prefrontal	_	
152-41	21703-21709	cortex	_	
152-42	21710-21712	in	_	
152-43	21713-21726	schizophrenia	_	
152-44	21727-21736	revisited	_	
152-45	21737-21750	Physiological	_	
152-46	21751-21766	characteristics	_	
152-47	21767-21769	of	_	
152-48	21770-21778	capacity	_	
152-49	21779-21790	constraints	_	
152-50	21791-21793	in	_	
152-51	21794-21801	working	_	
152-52	21802-21808	memory	_	
152-53	21809-21811	as	_	
152-54	21812-21820	revealed	_	
152-55	21821-21823	by	_	
152-56	21824-21834	functional	_	
152-57	21835-21838	MRI	_	
152-58	21839-21849	Complexity	_	
152-59	21850-21852	of	_	
152-60	21853-21863	prefrontal	_	
152-61	21864-21872	cortical	_	
152-62	21873-21884	dysfunction	_	
152-63	21885-21887	in	_	
152-64	21888-21901	schizophrenia	_	
152-65	21901-21902	:	_	
152-66	21903-21907	More	_	
152-67	21908-21912	than	_	
152-68	21913-21915	up	_	
152-69	21916-21918	or	_	
152-70	21919-21923	down	_	
152-71	21924-21926	Is	_	
152-72	21927-21928	a	_	
152-73	21929-21939	responsive	_	
152-74	21940-21947	default	_	
152-75	21948-21952	mode	_	
152-76	21953-21960	network	_	
152-77	21961-21969	required	_	
152-78	21970-21973	for	_	
152-79	21974-21984	successful	_	
152-80	21985-21992	working	_	
152-81	21993-21999	memory	_	
152-82	22000-22004	task	_	
152-83	22005-22016	performance	_	
152-84	22016-22017	?	_	

#Text=AFNI: software for analysis and visualization of functional magnetic resonance neuroimages
#Text=When less means more: deactivations during encoding that predict subsequent memory
#Text=Common and differential pathophysiological features accompany comparable cognitive impairments in medication-free patients with schizophrenia and in healthy aging subjects
#Text=Prediction of human errors by maladaptive changes in event-related brain networks
#Text=Towards a functional organization of the medial temporal lobe memory system: role of the parahippocampal and medial entorhinal cortical areas
#Text=Disrupted working memory circuitry in schizophrenia: disentangling fMRI markers of core pathology vs other aspects of impaired performance
#Text=Functional magnetic resonance imaging of a parametric working memory task in schizophrenia: relationship with performance and effects of antipsychotic treatment
#Text=Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence
#Text=The human brain is intrinsically organized into dynamic, anticorrelated functional networks
#Text=Deficient suppression of default mode regions during working memory in individuals with early psychosis and at clinical high-risk for psychosis
#Text=Intact attentional control of working memory encoding in schizophrenia
#Text=Uncoupling cognitive workload and prefrontal cortical physiology: A PET rCBF study
#Text=Searching for a baseline: functional imaging and the resting human brain
#Text=Reduced load-dependent default mode network deactivation across executive tasks in schizophrenia spectrum disorders
#Text=Hyperdeactivation of the default mode network in people with schizophrenia when focusing attention in space.
153-1	22018-22022	AFNI	_	
153-2	22022-22023	:	_	
153-3	22024-22032	software	_	
153-4	22033-22036	for	_	
153-5	22037-22045	analysis	_	
153-6	22046-22049	and	_	
153-7	22050-22063	visualization	_	
153-8	22064-22066	of	_	
153-9	22067-22077	functional	_	
153-10	22078-22086	magnetic	_	
153-11	22087-22096	resonance	_	
153-12	22097-22108	neuroimages	_	
153-13	22109-22113	When	_	
153-14	22114-22118	less	_	
153-15	22119-22124	means	_	
153-16	22125-22129	more	_	
153-17	22129-22130	:	_	
153-18	22131-22144	deactivations	_	
153-19	22145-22151	during	_	
153-20	22152-22160	encoding	_	
153-21	22161-22165	that	_	
153-22	22166-22173	predict	_	
153-23	22174-22184	subsequent	_	
153-24	22185-22191	memory	_	
153-25	22192-22198	Common	_	
153-26	22199-22202	and	_	
153-27	22203-22215	differential	_	
153-28	22216-22234	pathophysiological	_	
153-29	22235-22243	features	_	
153-30	22244-22253	accompany	_	
153-31	22254-22264	comparable	_	
153-32	22265-22274	cognitive	_	
153-33	22275-22286	impairments	_	
153-34	22287-22289	in	_	
153-35	22290-22305	medication-free	_	
153-36	22306-22314	patients	_	
153-37	22315-22319	with	_	
153-38	22320-22333	schizophrenia	_	
153-39	22334-22337	and	_	
153-40	22338-22340	in	_	
153-41	22341-22348	healthy	_	
153-42	22349-22354	aging	_	
153-43	22355-22363	subjects	_	
153-44	22364-22374	Prediction	_	
153-45	22375-22377	of	_	
153-46	22378-22383	human	_	
153-47	22384-22390	errors	_	
153-48	22391-22393	by	_	
153-49	22394-22405	maladaptive	_	
153-50	22406-22413	changes	_	
153-51	22414-22416	in	_	
153-52	22417-22430	event-related	_	
153-53	22431-22436	brain	_	
153-54	22437-22445	networks	_	
153-55	22446-22453	Towards	_	
153-56	22454-22455	a	_	
153-57	22456-22466	functional	_	
153-58	22467-22479	organization	_	
153-59	22480-22482	of	_	
153-60	22483-22486	the	_	
153-61	22487-22493	medial	_	
153-62	22494-22502	temporal	_	
153-63	22503-22507	lobe	_	
153-64	22508-22514	memory	_	
153-65	22515-22521	system	_	
153-66	22521-22522	:	_	
153-67	22523-22527	role	_	
153-68	22528-22530	of	_	
153-69	22531-22534	the	_	
153-70	22535-22550	parahippocampal	_	
153-71	22551-22554	and	_	
153-72	22555-22561	medial	_	
153-73	22562-22572	entorhinal	_	
153-74	22573-22581	cortical	_	
153-75	22582-22587	areas	_	
153-76	22588-22597	Disrupted	_	
153-77	22598-22605	working	_	
153-78	22606-22612	memory	_	
153-79	22613-22622	circuitry	_	
153-80	22623-22625	in	_	
153-81	22626-22639	schizophrenia	_	
153-82	22639-22640	:	_	
153-83	22641-22654	disentangling	_	
153-84	22655-22659	fMRI	_	
153-85	22660-22667	markers	_	
153-86	22668-22670	of	_	
153-87	22671-22675	core	_	
153-88	22676-22685	pathology	_	
153-89	22686-22688	vs	_	
153-90	22689-22694	other	_	
153-91	22695-22702	aspects	_	
153-92	22703-22705	of	_	
153-93	22706-22714	impaired	_	
153-94	22715-22726	performance	_	
153-95	22727-22737	Functional	_	
153-96	22738-22746	magnetic	_	
153-97	22747-22756	resonance	_	
153-98	22757-22764	imaging	_	
153-99	22765-22767	of	_	
153-100	22768-22769	a	_	
153-101	22770-22780	parametric	_	
153-102	22781-22788	working	_	
153-103	22789-22795	memory	_	
153-104	22796-22800	task	_	
153-105	22801-22803	in	_	
153-106	22804-22817	schizophrenia	_	
153-107	22817-22818	:	_	
153-108	22819-22831	relationship	_	
153-109	22832-22836	with	_	
153-110	22837-22848	performance	_	
153-111	22849-22852	and	_	
153-112	22853-22860	effects	_	
153-113	22861-22863	of	_	
153-114	22864-22877	antipsychotic	_	
153-115	22878-22887	treatment	_	
153-116	22888-22897	Cognitive	_	
153-117	22898-22906	deficits	_	
153-118	22907-22909	in	_	
153-119	22910-22923	schizophrenia	_	
153-120	22923-22924	:	_	
153-121	22925-22927	an	_	
153-122	22928-22935	updated	_	
153-123	22936-22947	metanalysis	_	
153-124	22948-22950	of	_	
153-125	22951-22954	the	_	
153-126	22955-22965	scientific	_	
153-127	22966-22974	evidence	_	
153-128	22975-22978	The	_	
153-129	22979-22984	human	_	
153-130	22985-22990	brain	_	
153-131	22991-22993	is	_	
153-132	22994-23007	intrinsically	_	
153-133	23008-23017	organized	_	
153-134	23018-23022	into	_	
153-135	23023-23030	dynamic	_	
153-136	23030-23031	,	_	
153-137	23032-23046	anticorrelated	_	
153-138	23047-23057	functional	_	
153-139	23058-23066	networks	_	
153-140	23067-23076	Deficient	_	
153-141	23077-23088	suppression	_	
153-142	23089-23091	of	_	
153-143	23092-23099	default	_	
153-144	23100-23104	mode	_	
153-145	23105-23112	regions	_	
153-146	23113-23119	during	_	
153-147	23120-23127	working	_	
153-148	23128-23134	memory	_	
153-149	23135-23137	in	_	
153-150	23138-23149	individuals	_	
153-151	23150-23154	with	_	
153-152	23155-23160	early	_	
153-153	23161-23170	psychosis	_	
153-154	23171-23174	and	_	
153-155	23175-23177	at	_	
153-156	23178-23186	clinical	_	
153-157	23187-23196	high-risk	_	
153-158	23197-23200	for	_	
153-159	23201-23210	psychosis	_	
153-160	23211-23217	Intact	_	
153-161	23218-23229	attentional	_	
153-162	23230-23237	control	_	
153-163	23238-23240	of	_	
153-164	23241-23248	working	_	
153-165	23249-23255	memory	_	
153-166	23256-23264	encoding	_	
153-167	23265-23267	in	_	
153-168	23268-23281	schizophrenia	_	
153-169	23282-23292	Uncoupling	_	
153-170	23293-23302	cognitive	_	
153-171	23303-23311	workload	_	
153-172	23312-23315	and	_	
153-173	23316-23326	prefrontal	_	
153-174	23327-23335	cortical	_	
153-175	23336-23346	physiology	_	
153-176	23346-23347	:	_	
153-177	23348-23349	A	_	
153-178	23350-23353	PET	_	
153-179	23354-23358	rCBF	_	
153-180	23359-23364	study	_	
153-181	23365-23374	Searching	_	
153-182	23375-23378	for	_	
153-183	23379-23380	a	_	
153-184	23381-23389	baseline	_	
153-185	23389-23390	:	_	
153-186	23391-23401	functional	_	
153-187	23402-23409	imaging	_	
153-188	23410-23413	and	_	
153-189	23414-23417	the	_	
153-190	23418-23425	resting	_	
153-191	23426-23431	human	_	
153-192	23432-23437	brain	_	
153-193	23438-23445	Reduced	_	
153-194	23446-23460	load-dependent	_	
153-195	23461-23468	default	_	
153-196	23469-23473	mode	_	
153-197	23474-23481	network	_	
153-198	23482-23494	deactivation	_	
153-199	23495-23501	across	_	
153-200	23502-23511	executive	_	
153-201	23512-23517	tasks	_	
153-202	23518-23520	in	_	
153-203	23521-23534	schizophrenia	_	
153-204	23535-23543	spectrum	_	
153-205	23544-23553	disorders	_	
153-206	23554-23571	Hyperdeactivation	_	
153-207	23572-23574	of	_	
153-208	23575-23578	the	_	
153-209	23579-23586	default	_	
153-210	23587-23591	mode	_	
153-211	23592-23599	network	_	
153-212	23600-23602	in	_	
153-213	23603-23609	people	_	
153-214	23610-23614	with	_	
153-215	23615-23628	schizophrenia	_	
153-216	23629-23633	when	_	
153-217	23634-23642	focusing	_	
153-218	23643-23652	attention	_	
153-219	23653-23655	in	_	
153-220	23656-23661	space	_	
153-221	23661-23662	.	_	

#Text=Schizophr
#Text=Task-induced deactivation of midline cortical regions in schizophrenia assessed with fMRI
#Text=Altered engagement of attention and default networks during target detection in schizophrenia
#Text=Diagnostic criteria and five-year outcome in schizophrenia.
154-1	23663-23672	Schizophr	_	
154-2	23673-23685	Task-induced	_	
154-3	23686-23698	deactivation	_	
154-4	23699-23701	of	_	
154-5	23702-23709	midline	_	
154-6	23710-23718	cortical	_	
154-7	23719-23726	regions	_	
154-8	23727-23729	in	_	
154-9	23730-23743	schizophrenia	_	
154-10	23744-23752	assessed	_	
154-11	23753-23757	with	_	
154-12	23758-23762	fMRI	_	
154-13	23763-23770	Altered	_	
154-14	23771-23781	engagement	_	
154-15	23782-23784	of	_	
154-16	23785-23794	attention	_	
154-17	23795-23798	and	_	
154-18	23799-23806	default	_	
154-19	23807-23815	networks	_	
154-20	23816-23822	during	_	
154-21	23823-23829	target	_	
154-22	23830-23839	detection	_	
154-23	23840-23842	in	_	
154-24	23843-23856	schizophrenia	_	
154-25	23857-23867	Diagnostic	_	
154-26	23868-23876	criteria	_	
154-27	23877-23880	and	_	
154-28	23881-23890	five-year	_	
154-29	23891-23898	outcome	_	
154-30	23899-23901	in	_	
154-31	23902-23915	schizophrenia	_	
154-32	23915-23916	.	_	

#Text=A report from the International Pilot Study of schizophrenia
#Text=Cognitive control signals in posterior cingulate cortex
#Text=The Fagerstrom Test for Nicotine Dependence - A Revision of the Fagerstrom Tolerance Questionnaire
#Text=A functional magnetic resonance imaging study of working memory abnormalities in schizophrenia
#Text=Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: Evidence from a working memory task
#Text=Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study
#Text=Circular analysis in systems neuroscience: the dangers of double dipping
#Text=Working memory impairments in schizophrenia: A meta-analysis
#Text=The capacity of visual working memory for features and onjunctions
#Text=Brain functional abnormality in schizo-affective disorder: an fMRI study
#Text=Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings
#Text=Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI
#Text=Interrupting the “stream of consciousness”: An fMRI investigation
#Text=A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging
#Text=Decreased efficiency of task-positive and task-negative networks during working memory in schizophrenia.
155-1	23917-23918	A	_	
155-2	23919-23925	report	_	
155-3	23926-23930	from	_	
155-4	23931-23934	the	_	
155-5	23935-23948	International	_	
155-6	23949-23954	Pilot	_	
155-7	23955-23960	Study	_	
155-8	23961-23963	of	_	
155-9	23964-23977	schizophrenia	_	
155-10	23978-23987	Cognitive	_	
155-11	23988-23995	control	_	
155-12	23996-24003	signals	_	
155-13	24004-24006	in	_	
155-14	24007-24016	posterior	_	
155-15	24017-24026	cingulate	_	
155-16	24027-24033	cortex	_	
155-17	24034-24037	The	_	
155-18	24038-24048	Fagerstrom	_	
155-19	24049-24053	Test	_	
155-20	24054-24057	for	_	
155-21	24058-24066	Nicotine	_	
155-22	24067-24077	Dependence	_	
155-23	24078-24079	-	_	
155-24	24080-24081	A	_	
155-25	24082-24090	Revision	_	
155-26	24091-24093	of	_	
155-27	24094-24097	the	_	
155-28	24098-24108	Fagerstrom	_	
155-29	24109-24118	Tolerance	_	
155-30	24119-24132	Questionnaire	_	
155-31	24133-24134	A	_	
155-32	24135-24145	functional	_	
155-33	24146-24154	magnetic	_	
155-34	24155-24164	resonance	_	
155-35	24165-24172	imaging	_	
155-36	24173-24178	study	_	
155-37	24179-24181	of	_	
155-38	24182-24189	working	_	
155-39	24190-24196	memory	_	
155-40	24197-24210	abnormalities	_	
155-41	24211-24213	in	_	
155-42	24214-24227	schizophrenia	_	
155-43	24228-24239	Inefficient	_	
155-44	24240-24246	neural	_	
155-45	24247-24255	activity	_	
155-46	24256-24258	in	_	
155-47	24259-24267	patients	_	
155-48	24268-24272	with	_	
155-49	24273-24286	schizophrenia	_	
155-50	24287-24290	and	_	
155-51	24291-24303	nonpsychotic	_	
155-52	24304-24313	relatives	_	
155-53	24314-24316	of	_	
155-54	24317-24330	schizophrenic	_	
155-55	24331-24339	patients	_	
155-56	24339-24340	:	_	
155-57	24341-24349	Evidence	_	
155-58	24350-24354	from	_	
155-59	24355-24356	a	_	
155-60	24357-24364	working	_	
155-61	24365-24371	memory	_	
155-62	24372-24376	task	_	
155-63	24377-24390	Dysregulation	_	
155-64	24391-24393	of	_	
155-65	24394-24401	working	_	
155-66	24402-24408	memory	_	
155-67	24409-24412	and	_	
155-68	24413-24425	default-mode	_	
155-69	24426-24434	networks	_	
155-70	24435-24437	in	_	
155-71	24438-24451	schizophrenia	_	
155-72	24452-24457	using	_	
155-73	24458-24469	independent	_	
155-74	24470-24479	component	_	
155-75	24480-24488	analysis	_	
155-76	24488-24489	,	_	
155-77	24490-24492	an	_	
155-78	24493-24498	fBIRN	_	
155-79	24499-24502	and	_	
155-80	24503-24507	MCIC	_	
155-81	24508-24513	study	_	
155-82	24514-24522	Circular	_	
155-83	24523-24531	analysis	_	
155-84	24532-24534	in	_	
155-85	24535-24542	systems	_	
155-86	24543-24555	neuroscience	_	
155-87	24555-24556	:	_	
155-88	24557-24560	the	_	
155-89	24561-24568	dangers	_	
155-90	24569-24571	of	_	
155-91	24572-24578	double	_	
155-92	24579-24586	dipping	_	
155-93	24587-24594	Working	_	
155-94	24595-24601	memory	_	
155-95	24602-24613	impairments	_	
155-96	24614-24616	in	_	
155-97	24617-24630	schizophrenia	_	
155-98	24630-24631	:	_	
155-99	24632-24633	A	_	
155-100	24634-24647	meta-analysis	_	
155-101	24648-24651	The	_	
155-102	24652-24660	capacity	_	
155-103	24661-24663	of	_	
155-104	24664-24670	visual	_	
155-105	24671-24678	working	_	
155-106	24679-24685	memory	_	
155-107	24686-24689	for	_	
155-108	24690-24698	features	_	
155-109	24699-24702	and	_	
155-110	24703-24714	onjunctions	_	
155-111	24715-24720	Brain	_	
155-112	24721-24731	functional	_	
155-113	24732-24743	abnormality	_	
155-114	24744-24746	in	_	
155-115	24747-24763	schizo-affective	_	
155-116	24764-24772	disorder	_	
155-117	24772-24773	:	_	
155-118	24774-24776	an	_	
155-119	24777-24781	fMRI	_	
155-120	24782-24787	study	_	
155-121	24788-24798	Prefrontal	_	
155-122	24799-24805	cortex	_	
155-123	24806-24817	dysfunction	_	
155-124	24818-24824	during	_	
155-125	24825-24832	working	_	
155-126	24833-24839	memory	_	
155-127	24840-24851	performance	_	
155-128	24852-24854	in	_	
155-129	24855-24868	schizophrenia	_	
155-130	24868-24869	:	_	
155-131	24870-24881	reconciling	_	
155-132	24882-24892	discrepant	_	
155-133	24893-24901	findings	_	
155-134	24902-24915	Schizophrenic	_	
155-135	24916-24924	subjects	_	
155-136	24925-24933	activate	_	
155-137	24934-24946	dorsolateral	_	
155-138	24947-24957	prefrontal	_	
155-139	24958-24964	cortex	_	
155-140	24965-24971	during	_	
155-141	24972-24973	a	_	
155-142	24974-24981	working	_	
155-143	24982-24988	memory	_	
155-144	24989-24993	task	_	
155-145	24993-24994	,	_	
155-146	24995-24997	as	_	
155-147	24998-25006	measured	_	
155-148	25007-25009	by	_	
155-149	25010-25014	fMRI	_	
155-150	25015-25027	Interrupting	_	
155-151	25028-25031	the	_	
155-152	25032-25033	“	_	
155-153	25033-25039	stream	_	
155-154	25040-25042	of	_	
155-155	25043-25056	consciousness	_	
155-156	25056-25057	”	_	
155-157	25057-25058	:	_	
155-158	25059-25061	An	_	
155-159	25062-25066	fMRI	_	
155-160	25067-25080	investigation	_	
155-161	25081-25082	A	_	
155-162	25083-25093	parametric	_	
155-163	25094-25106	manipulation	_	
155-164	25107-25109	of	_	
155-165	25110-25117	factors	_	
155-166	25118-25127	affecting	_	
155-167	25128-25140	task-induced	_	
155-168	25141-25153	deactivation	_	
155-169	25154-25156	in	_	
155-170	25157-25167	functional	_	
155-171	25168-25180	neuroimaging	_	
155-172	25181-25190	Decreased	_	
155-173	25191-25201	efficiency	_	
155-174	25202-25204	of	_	
155-175	25205-25218	task-positive	_	
155-176	25219-25222	and	_	
155-177	25223-25236	task-negative	_	
155-178	25237-25245	networks	_	
155-179	25246-25252	during	_	
155-180	25253-25260	working	_	
155-181	25261-25267	memory	_	
155-182	25268-25270	in	_	
155-183	25271-25284	schizophrenia	_	
155-184	25284-25285	.	_	

#Text=Schizophr
#Text=Functional and structural MR imaging in neuropsychiatric disorders, Part 2: Application in Schizophrenia and Autism
#Text=On the use of caffeine as a contrast booster for BOLD fMRI studies
#Text=
#Text=Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: an fMRI study using an ICA analysis approach
#Text=The Brief Psychiatric Rating Scale
#Text=The neuroanatomy of psychotic diathesis: A meta-analytic review
#Text=Cognitive and emotional modulation of brain default operation
#Text=The default mode network and the working memory network are not anti-correlated during all phases of a working memory task
#Text=Failure to deactivate in the prefrontal cortex in schizophrenia: dysfunction of the default mode network?
156-1	25286-25295	Schizophr	_	
156-2	25296-25306	Functional	_	
156-3	25307-25310	and	_	
156-4	25311-25321	structural	_	
156-5	25322-25324	MR	_	
156-6	25325-25332	imaging	_	
156-7	25333-25335	in	_	
156-8	25336-25352	neuropsychiatric	_	
156-9	25353-25362	disorders	_	
156-10	25362-25363	,	_	
156-11	25364-25368	Part	_	
156-12	25369-25370	2	_	
156-13	25370-25371	:	_	
156-14	25372-25383	Application	_	
156-15	25384-25386	in	_	
156-16	25387-25400	Schizophrenia	_	
156-17	25401-25404	and	_	
156-18	25405-25411	Autism	_	
156-19	25412-25414	On	_	
156-20	25415-25418	the	_	
156-21	25419-25422	use	_	
156-22	25423-25425	of	_	
156-23	25426-25434	caffeine	_	
156-24	25435-25437	as	_	
156-25	25438-25439	a	_	
156-26	25440-25448	contrast	_	
156-27	25449-25456	booster	_	
156-28	25457-25460	for	_	
156-29	25461-25465	BOLD	_	
156-30	25466-25470	fMRI	_	
156-31	25471-25478	studies	_	
156-32	25480-25488	Patients	_	
156-33	25489-25493	with	_	
156-34	25494-25507	schizophrenia	_	
156-35	25508-25512	fail	_	
156-36	25513-25515	to	_	
156-37	25516-25527	up-regulate	_	
156-38	25528-25541	task-positive	_	
156-39	25542-25545	and	_	
156-40	25546-25559	down-regulate	_	
156-41	25560-25573	task-negative	_	
156-42	25574-25579	brain	_	
156-43	25580-25588	networks	_	
156-44	25588-25589	:	_	
156-45	25590-25592	an	_	
156-46	25593-25597	fMRI	_	
156-47	25598-25603	study	_	
156-48	25604-25609	using	_	
156-49	25610-25612	an	_	
156-50	25613-25616	ICA	_	
156-51	25617-25625	analysis	_	
156-52	25626-25634	approach	_	
156-53	25635-25638	The	_	
156-54	25639-25644	Brief	_	
156-55	25645-25656	Psychiatric	_	
156-56	25657-25663	Rating	_	
156-57	25664-25669	Scale	_	
156-58	25670-25673	The	_	
156-59	25674-25686	neuroanatomy	_	
156-60	25687-25689	of	_	
156-61	25690-25699	psychotic	_	
156-62	25700-25709	diathesis	_	
156-63	25709-25710	:	_	
156-64	25711-25712	A	_	
156-65	25713-25726	meta-analytic	_	
156-66	25727-25733	review	_	
156-67	25734-25743	Cognitive	_	
156-68	25744-25747	and	_	
156-69	25748-25757	emotional	_	
156-70	25758-25768	modulation	_	
156-71	25769-25771	of	_	
156-72	25772-25777	brain	_	
156-73	25778-25785	default	_	
156-74	25786-25795	operation	_	
156-75	25796-25799	The	_	
156-76	25800-25807	default	_	
156-77	25808-25812	mode	_	
156-78	25813-25820	network	_	
156-79	25821-25824	and	_	
156-80	25825-25828	the	_	
156-81	25829-25836	working	_	
156-82	25837-25843	memory	_	
156-83	25844-25851	network	_	
156-84	25852-25855	are	_	
156-85	25856-25859	not	_	
156-86	25860-25875	anti-correlated	_	
156-87	25876-25882	during	_	
156-88	25883-25886	all	_	
156-89	25887-25893	phases	_	
156-90	25894-25896	of	_	
156-91	25897-25898	a	_	
156-92	25899-25906	working	_	
156-93	25907-25913	memory	_	
156-94	25914-25918	task	_	
156-95	25919-25926	Failure	_	
156-96	25927-25929	to	_	
156-97	25930-25940	deactivate	_	
156-98	25941-25943	in	_	
156-99	25944-25947	the	_	
156-100	25948-25958	prefrontal	_	
156-101	25959-25965	cortex	_	
156-102	25966-25968	in	_	
156-103	25969-25982	schizophrenia	_	
156-104	25982-25983	:	_	
156-105	25984-25995	dysfunction	_	
156-106	25996-25998	of	_	
156-107	25999-26002	the	_	
156-108	26003-26010	default	_	
156-109	26011-26015	mode	_	
156-110	26016-26023	network	_	
156-111	26023-26024	?	_	

#Text=Neuroimaging of cognitive disability in schizophrenia: Search for a pathophysiological mechanism
#Text=Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patients
#Text=The global cognitive impairment in schizophrenia: Consistent over decades and around the world
#Text=Modulation of the default mode network is task-dependant in chronic schizophrenia patients
#Text=
#Text=Capacity limit of visual short-term memory in human posterior parietal cortex
#Text=Posterior parietal cortex activity predicts individual differences in visual short-term memory capacity
#Text=Functional neuroimaging of working memory in schizpohrenia: task performance as a moderating variable
#Text=Working memory dysfunction in schizophrenia compared to healthy controls and patients with depression: Evidence from event-related fMRI
#Text=Transient blood pressure changes affect the functional magnetic resonance imaging detection of cerebral activation
#Text=
#Text=
#Text=The neural bases of momentary lapses in attention
#Text=Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia
#Text=
#Text=Visual search is slowed when visuospatial working memory is occupied
#Text=Visual search remains efficient when visual working memory is full
#Text=Task display and performance
#Text=(A) Screen shot of a change detection task encoding array with SS 4.
157-1	26025-26037	Neuroimaging	_	
157-2	26038-26040	of	_	
157-3	26041-26050	cognitive	_	
157-4	26051-26061	disability	_	
157-5	26062-26064	in	_	
157-6	26065-26078	schizophrenia	_	
157-7	26078-26079	:	_	
157-8	26080-26086	Search	_	
157-9	26087-26090	for	_	
157-10	26091-26092	a	_	
157-11	26093-26111	pathophysiological	_	
157-12	26112-26121	mechanism	_	
157-13	26122-26132	Correlated	_	
157-14	26133-26143	structural	_	
157-15	26144-26147	and	_	
157-16	26148-26158	functional	_	
157-17	26159-26164	brain	_	
157-18	26165-26178	abnormalities	_	
157-19	26179-26181	in	_	
157-20	26182-26185	the	_	
157-21	26186-26193	default	_	
157-22	26194-26198	mode	_	
157-23	26199-26206	network	_	
157-24	26207-26209	in	_	
157-25	26210-26223	schizophrenia	_	
157-26	26224-26232	patients	_	
157-27	26233-26236	The	_	
157-28	26237-26243	global	_	
157-29	26244-26253	cognitive	_	
157-30	26254-26264	impairment	_	
157-31	26265-26267	in	_	
157-32	26268-26281	schizophrenia	_	
157-33	26281-26282	:	_	
157-34	26283-26293	Consistent	_	
157-35	26294-26298	over	_	
157-36	26299-26306	decades	_	
157-37	26307-26310	and	_	
157-38	26311-26317	around	_	
157-39	26318-26321	the	_	
157-40	26322-26327	world	_	
157-41	26328-26338	Modulation	_	
157-42	26339-26341	of	_	
157-43	26342-26345	the	_	
157-44	26346-26353	default	_	
157-45	26354-26358	mode	_	
157-46	26359-26366	network	_	
157-47	26367-26369	is	_	
157-48	26370-26384	task-dependant	_	
157-49	26385-26387	in	_	
157-50	26388-26395	chronic	_	
157-51	26396-26409	schizophrenia	_	
157-52	26410-26418	patients	_	
157-53	26420-26428	Capacity	_	
157-54	26429-26434	limit	_	
157-55	26435-26437	of	_	
157-56	26438-26444	visual	_	
157-57	26445-26455	short-term	_	
157-58	26456-26462	memory	_	
157-59	26463-26465	in	_	
157-60	26466-26471	human	_	
157-61	26472-26481	posterior	_	
157-62	26482-26490	parietal	_	
157-63	26491-26497	cortex	_	
157-64	26498-26507	Posterior	_	
157-65	26508-26516	parietal	_	
157-66	26517-26523	cortex	_	
157-67	26524-26532	activity	_	
157-68	26533-26541	predicts	_	
157-69	26542-26552	individual	_	
157-70	26553-26564	differences	_	
157-71	26565-26567	in	_	
157-72	26568-26574	visual	_	
157-73	26575-26585	short-term	_	
157-74	26586-26592	memory	_	
157-75	26593-26601	capacity	_	
157-76	26602-26612	Functional	_	
157-77	26613-26625	neuroimaging	_	
157-78	26626-26628	of	_	
157-79	26629-26636	working	_	
157-80	26637-26643	memory	_	
157-81	26644-26646	in	_	
157-82	26647-26660	schizpohrenia	_	
157-83	26660-26661	:	_	
157-84	26662-26666	task	_	
157-85	26667-26678	performance	_	
157-86	26679-26681	as	_	
157-87	26682-26683	a	_	
157-88	26684-26694	moderating	_	
157-89	26695-26703	variable	_	
157-90	26704-26711	Working	_	
157-91	26712-26718	memory	_	
157-92	26719-26730	dysfunction	_	
157-93	26731-26733	in	_	
157-94	26734-26747	schizophrenia	_	
157-95	26748-26756	compared	_	
157-96	26757-26759	to	_	
157-97	26760-26767	healthy	_	
157-98	26768-26776	controls	_	
157-99	26777-26780	and	_	
157-100	26781-26789	patients	_	
157-101	26790-26794	with	_	
157-102	26795-26805	depression	_	
157-103	26805-26806	:	_	
157-104	26807-26815	Evidence	_	
157-105	26816-26820	from	_	
157-106	26821-26834	event-related	_	
157-107	26835-26839	fMRI	_	
157-108	26840-26849	Transient	_	
157-109	26850-26855	blood	_	
157-110	26856-26864	pressure	_	
157-111	26865-26872	changes	_	
157-112	26873-26879	affect	_	
157-113	26880-26883	the	_	
157-114	26884-26894	functional	_	
157-115	26895-26903	magnetic	_	
157-116	26904-26913	resonance	_	
157-117	26914-26921	imaging	_	
157-118	26922-26931	detection	_	
157-119	26932-26934	of	_	
157-120	26935-26943	cerebral	_	
157-121	26944-26954	activation	_	
157-122	26957-26960	The	_	
157-123	26961-26967	neural	_	
157-124	26968-26973	bases	_	
157-125	26974-26976	of	_	
157-126	26977-26986	momentary	_	
157-127	26987-26993	lapses	_	
157-128	26994-26996	in	_	
157-129	26997-27006	attention	_	
157-130	27007-27020	Hyperactivity	_	
157-131	27021-27024	and	_	
157-132	27025-27042	hyperconnectivity	_	
157-133	27043-27045	of	_	
157-134	27046-27049	the	_	
157-135	27050-27057	default	_	
157-136	27058-27065	network	_	
157-137	27066-27068	in	_	
157-138	27069-27082	schizophrenia	_	
157-139	27083-27086	and	_	
157-140	27087-27089	in	_	
157-141	27090-27102	first-degree	_	
157-142	27103-27112	relatives	_	
157-143	27113-27115	of	_	
157-144	27116-27123	persons	_	
157-145	27124-27128	with	_	
157-146	27129-27142	schizophrenia	_	
157-147	27144-27150	Visual	_	
157-148	27151-27157	search	_	
157-149	27158-27160	is	_	
157-150	27161-27167	slowed	_	
157-151	27168-27172	when	_	
157-152	27173-27185	visuospatial	_	
157-153	27186-27193	working	_	
157-154	27194-27200	memory	_	
157-155	27201-27203	is	_	
157-156	27204-27212	occupied	_	
157-157	27213-27219	Visual	_	
157-158	27220-27226	search	_	
157-159	27227-27234	remains	_	
157-160	27235-27244	efficient	_	
157-161	27245-27249	when	_	
157-162	27250-27256	visual	_	
157-163	27257-27264	working	_	
157-164	27265-27271	memory	_	
157-165	27272-27274	is	_	
157-166	27275-27279	full	_	
157-167	27280-27284	Task	_	
157-168	27285-27292	display	_	
157-169	27293-27296	and	_	
157-170	27297-27308	performance	_	
157-171	27309-27310	(	_	
157-172	27310-27311	A	_	
157-173	27311-27312	)	_	
157-174	27313-27319	Screen	_	
157-175	27320-27324	shot	_	
157-176	27325-27327	of	_	
157-177	27328-27329	a	_	
157-178	27330-27336	change	_	
157-179	27337-27346	detection	_	
157-180	27347-27351	task	_	
157-181	27352-27360	encoding	_	
157-182	27361-27366	array	_	
157-183	27367-27371	with	_	
157-184	27372-27374	SS	_	
157-185	27375-27376	4	_	
157-186	27376-27377	.	_	

#Text=(B) Average (±SEM) accuracy and reaction time in people with schizophrenia (PSZ) and healthy control subjects (HCS).
158-1	27378-27379	(	_	
158-2	27379-27380	B	_	
158-3	27380-27381	)	_	
158-4	27382-27389	Average	_	
158-5	27390-27391	(	_	
158-6	27391-27392	±	_	
158-7	27392-27395	SEM	_	
158-8	27395-27396	)	_	
158-9	27397-27405	accuracy	_	
158-10	27406-27409	and	_	
158-11	27410-27418	reaction	_	
158-12	27419-27423	time	_	
158-13	27424-27426	in	_	
158-14	27427-27433	people	_	
158-15	27434-27438	with	_	
158-16	27439-27452	schizophrenia	_	
158-17	27453-27454	(	_	
158-18	27454-27457	PSZ	_	
158-19	27457-27458	)	_	
158-20	27459-27462	and	_	
158-21	27463-27470	healthy	_	
158-22	27471-27478	control	_	
158-23	27479-27487	subjects	_	
158-24	27488-27489	(	_	
158-25	27489-27492	HCS	_	
158-26	27492-27493	)	_	
158-27	27493-27494	.	_	

#Text=Within-group effects
#Text=Brain regions responding to working memory load in healthy control subjects (HCS) and in participants with schizophrenia (PSZ).
159-1	27495-27507	Within-group	_	
159-2	27508-27515	effects	_	
159-3	27516-27521	Brain	_	
159-4	27522-27529	regions	_	
159-5	27530-27540	responding	_	
159-6	27541-27543	to	_	
159-7	27544-27551	working	_	
159-8	27552-27558	memory	_	
159-9	27559-27563	load	_	
159-10	27564-27566	in	_	
159-11	27567-27574	healthy	_	
159-12	27575-27582	control	_	
159-13	27583-27591	subjects	_	
159-14	27592-27593	(	_	
159-15	27593-27596	HCS	_	
159-16	27596-27597	)	_	
159-17	27598-27601	and	_	
159-18	27602-27604	in	_	
159-19	27605-27617	participants	_	
159-20	27618-27622	with	_	
159-21	27623-27636	schizophrenia	_	
159-22	27637-27638	(	_	
159-23	27638-27641	PSZ	_	
159-24	27641-27642	)	_	
159-25	27642-27643	.	_	

#Text=Regions displaying increased BOLD signal with larger SS are drawn in warm colors.
160-1	27644-27651	Regions	_	
160-2	27652-27662	displaying	_	
160-3	27663-27672	increased	_	
160-4	27673-27677	BOLD	_	
160-5	27678-27684	signal	_	
160-6	27685-27689	with	_	
160-7	27690-27696	larger	_	
160-8	27697-27699	SS	_	
160-9	27700-27703	are	_	
160-10	27704-27709	drawn	_	
160-11	27710-27712	in	_	
160-12	27713-27717	warm	_	
160-13	27718-27724	colors	_	
160-14	27724-27725	.	_	

#Text=Region displaying decreased signal with larger SS are drawn in cold colors.
161-1	27726-27732	Region	_	
161-2	27733-27743	displaying	_	
161-3	27744-27753	decreased	_	
161-4	27754-27760	signal	_	
161-5	27761-27765	with	_	
161-6	27766-27772	larger	_	
161-7	27773-27775	SS	_	
161-8	27776-27779	are	_	
161-9	27780-27785	drawn	_	
161-10	27786-27788	in	_	
161-11	27789-27793	cold	_	
161-12	27794-27800	colors	_	
161-13	27800-27801	.	_	

#Text=Group activation maps are overlaid onto anatomical scans in Talairach space, averaged separately over all 16 HCS, and over all 21 PSZ.
162-1	27802-27807	Group	_	
162-2	27808-27818	activation	_	
162-3	27819-27823	maps	_	
162-4	27824-27827	are	_	
162-5	27828-27836	overlaid	_	
162-6	27837-27841	onto	_	
162-7	27842-27852	anatomical	_	
162-8	27853-27858	scans	_	
162-9	27859-27861	in	_	
162-10	27862-27871	Talairach	_	
162-11	27872-27877	space	_	
162-12	27877-27878	,	_	
162-13	27879-27887	averaged	_	
162-14	27888-27898	separately	_	
162-15	27899-27903	over	_	
162-16	27904-27907	all	_	
162-17	27908-27910	16	_	
162-18	27911-27914	HCS	_	
162-19	27914-27915	,	_	
162-20	27916-27919	and	_	
162-21	27920-27924	over	_	
162-22	27925-27928	all	_	
162-23	27929-27931	21	_	
162-24	27932-27935	PSZ	_	
162-25	27935-27936	.	_	

#Text=ROI-based group comparison
#Text=7-mm diameter spheres centered on peak foci of the task-positive (red) and default mode (blue) networks identified by, overlaid onto the average of all 37 anatomical scans in Talairach space.
163-1	27937-27946	ROI-based	_	
163-2	27947-27952	group	_	
163-3	27953-27963	comparison	_	
163-4	27964-27965	7	_	
163-5	27965-27966	-	_	
163-6	27966-27968	mm	_	
163-7	27969-27977	diameter	_	
163-8	27978-27985	spheres	_	
163-9	27986-27994	centered	_	
163-10	27995-27997	on	_	
163-11	27998-28002	peak	_	
163-12	28003-28007	foci	_	
163-13	28008-28010	of	_	
163-14	28011-28014	the	_	
163-15	28015-28028	task-positive	_	
163-16	28029-28030	(	_	
163-17	28030-28033	red	_	
163-18	28033-28034	)	_	
163-19	28035-28038	and	_	
163-20	28039-28046	default	_	
163-21	28047-28051	mode	_	
163-22	28052-28053	(	_	
163-23	28053-28057	blue	_	
163-24	28057-28058	)	_	
163-25	28059-28067	networks	_	
163-26	28068-28078	identified	_	
163-27	28079-28081	by	_	
163-28	28081-28082	,	_	
163-29	28083-28091	overlaid	_	
163-30	28092-28096	onto	_	
163-31	28097-28100	the	_	
163-32	28101-28108	average	_	
163-33	28109-28111	of	_	
163-34	28112-28115	all	_	
163-35	28116-28118	37	_	
163-36	28119-28129	anatomical	_	
163-37	28130-28135	scans	_	
163-38	28136-28138	in	_	
163-39	28139-28148	Talairach	_	
163-40	28149-28154	space	_	
163-41	28154-28155	.	_	

#Text=The numbering corresponds to ROIs in Table 2.
164-1	28156-28159	The	_	
164-2	28160-28169	numbering	_	
164-3	28170-28181	corresponds	_	
164-4	28182-28184	to	_	
164-5	28185-28189	ROIs	_	
164-6	28190-28192	in	_	
164-7	28193-28198	Table	_	
164-8	28199-28200	2	_	
164-9	28200-28201	.	_	

#Text=The graphs display average (±SEM) BOLD activity over task-positive and over default mode network ROIs in healthy controls subjects (HCS) and people with schizophrenia (PSZ) for each SS.
165-1	28202-28205	The	_	
165-2	28206-28212	graphs	_	
165-3	28213-28220	display	_	
165-4	28221-28228	average	_	
165-5	28229-28230	(	_	
165-6	28230-28231	±	_	
165-7	28231-28234	SEM	_	
165-8	28234-28235	)	_	
165-9	28236-28240	BOLD	_	
165-10	28241-28249	activity	_	
165-11	28250-28254	over	_	
165-12	28255-28268	task-positive	_	
165-13	28269-28272	and	_	
165-14	28273-28277	over	_	
165-15	28278-28285	default	_	
165-16	28286-28290	mode	_	
165-17	28291-28298	network	_	
165-18	28299-28303	ROIs	_	
165-19	28304-28306	in	_	
165-20	28307-28314	healthy	_	
165-21	28315-28323	controls	_	
165-22	28324-28332	subjects	_	
165-23	28333-28334	(	_	
165-24	28334-28337	HCS	_	
165-25	28337-28338	)	_	
165-26	28339-28342	and	_	
165-27	28343-28349	people	_	
165-28	28350-28354	with	_	
165-29	28355-28368	schizophrenia	_	
165-30	28369-28370	(	_	
165-31	28370-28373	PSZ	_	
165-32	28373-28374	)	_	
165-33	28375-28378	for	_	
165-34	28379-28383	each	_	
165-35	28384-28386	SS	_	
165-36	28386-28387	.	_	

#Text=*P<0.05 in independent-samples t-test.
166-1	28388-28389	*	_	
166-2	28389-28390	P	_	
166-3	28390-28391	<	_	
166-4	28391-28395	0.05	_	
166-5	28396-28398	in	_	
166-6	28399-28418	independent-samples	_	
166-7	28419-28425	t-test	_	
166-8	28425-28426	.	_	

#Text=PSZ (N=21)\tHCS (N=16)\tStatisticP-value\t \tAge\t36.2 ± 11.0(range 20–53)\t36.5 ± 14.5(range 19–53)\tt(35)=.06P=0.95\t \tMale : Female\t13 : 8\t11 : 5\tχ2=0.19P=0.67\t \tAfr Am : Cauc : Other\t6 : 14 : 1\t4 : 11 : 1\tχ2=0.09P=0.96\t \tEducation (years)\t12.8 ± 2.7\t14.1 ± 1.7\tt(35)=1.76P=0.088\t \tParental Education (yrs)a\t13.1 ± 3.0\t14.3 ± 2.0\tt(35)=1.40P=0.17\t \tEstimated IQbf\t104.1 ± 13.2\t115.6 ± 7.3\tt(35)=3.12P<0.005\t \tMCCBcf\t37.9 ± 13.1\t53.2 ± 6.2\tt(35)=4.30P<0.001\t \tWRAT 4df\t97.8 ± 14.8\t110.3 ± 13.0\tt(35)=2.67P<0.02\t \tWTARe\t101.0 ± 18.7\t111.6 ± 9.7\tt(35)=2.06P<0.05\t \tSmokers : Non-smokers\t6 : 15\t2 : 14\tχ2=1.38P>0.2\t \tFTND of current smokersf\t3.5 ± 2.4\t3.5 ± 2.8\tt(6)=0.24P>0.8\t \tSystolic blood pressure (mm Hg)g\t125.2 ± 12.0\t122.9 ± 15.9\tt(35)=0.49P>0.6\t \tDiastolic blood pressure (mm Hg)g\t76.2 ± 7.6\t73.8 ± 9.8\tt(35)=0.87P>0.3\t \t
#Text=Average over maternal and paternal education
#Text=Based on vocabulary and matrix reasoning subscales of the Wechsler Abbreviated Scale of Intelligence 
#Text=Composite score on the MATRICS Consensus Cognitive Battery 
#Text=Wide Range Achievement Test 
#Text=Wechsler Test of Adult Reading 
#Text=Fagerstrom Test for Nicotine Dependence 
#Text=taken during screening
#Text=ROIs representing 7-mm-diameter spheres centered on peak foci of the task-positive and task-negative/default mode networks identified by 
#Text=\tRegion\tSide\tCenter of Mass (mm)\t \tLR\tPA\tIS\t \tTask-positive\t \t1\tSuperior parietal lobule, intraparietal sulcus\tL\t−23\t−66\t46\t \t2\tSuperior parietal lobule, intraparietal sulcus\tR\t25\t−58\t52\t \t3\tInferior parietal lobule, intraparietal sulcus\tL\t−42\t−44\t49\t \t4\tInferior parietal lobule, intraparietal sulcus\tR\t47\t−37\t52\t \t5\tSuperior occipital gyrus, cuneus\tL\t−26\t−80\t26\t \t6\tSuperior occipital gyrus, cuneus\tR\t35\t−81\t29\t \t7\tSuperior precentral gyrus (frontal eye field)\tL\t−24\t−12\t61\t \t8\tSuperior precentral gyrus (frontal eye field)\tR\t28\t−7\t54\t \t9\tInferior precentral gyrus\tL\t−54\t0\t35\t \t10\tMedial frontal gyrus (supplementary motor area)\tL/R\t−2\t1\t51\t \t11\tMiddle frontal gyrus\tL\t−40\t39\t26\t \t12\tMiddle frontal gyrus\tR\t38\t41\t22\t \t13\tMiddle occipital gyrus\tL\t−47\t−69\t−3\t \t14\tMiddle occipital gyrus\tR\t54\t−63\t−8\t \t15\tInsula\tL\t−45\t5\t8\t \t16\tInsula\tR\t45\t4\t14\t \tTask-negative / default mode network\t \t1\tPosterior cingulate gyrus\tL/R\t−2\t−36\t37\t \t2\tRetrosplenial cortex\tL/R\t3\t−51\t8\t \t3\tAngular gyrus\tL\t−47\t−67\t36\t \t4\tAngular gyrus\tR\t53\t−67\t36\t \t5\tRostral anterior cingulate gyrus\tL/R\t−3\t39\t−2\t \t6\tMedial prefrontal gyrus\tL/R\t1\t54\t21\t \t7\tSuperior frontal gyrus\tL\t−14\t38\t52\t \t8\tSuperior frontal gyrus\tR\t17\t37\t52\t \t9\tMiddle & inferior temporal gyrus\tL\t−61\t−33\t−15\t \t10\tMiddle & inferior temporal gyrus\tR\t65\t−17\t−15\t \t11\tParahippocampal gyrus\tL\t−22\t−26\t−16\t \t12\tParahippocampal gyrus\tR\t25\t−26\t−14\t \t13\tCerebellar tonsils\tL/R\t7\t−52\t−44
167-1	28428-28431	PSZ	_	
167-2	28432-28433	(	_	
167-3	28433-28434	N	_	
167-4	28434-28435	=	_	
167-5	28435-28437	21	_	
167-6	28437-28438	)	_	
167-7	28439-28442	HCS	_	
167-8	28443-28444	(	_	
167-9	28444-28445	N	_	
167-10	28445-28446	=	_	
167-11	28446-28448	16	_	
167-12	28448-28449	)	_	
167-13	28450-28466	StatisticP-value	_	
167-14	28469-28472	Age	_	
167-15	28473-28477	36.2	_	
167-16	28478-28479	±	_	
167-17	28480-28484	11.0	_	
167-18	28484-28485	(	_	
167-19	28485-28490	range	_	
167-20	28491-28493	20	_	
167-21	28493-28494	–	_	
167-22	28494-28496	53	_	
167-23	28496-28497	)	_	
167-24	28498-28502	36.5	_	
167-25	28503-28504	±	_	
167-26	28505-28509	14.5	_	
167-27	28509-28510	(	_	
167-28	28510-28515	range	_	
167-29	28516-28518	19	_	
167-30	28518-28519	–	_	
167-31	28519-28521	53	_	
167-32	28521-28522	)	_	
167-33	28523-28524	t	_	
167-34	28524-28525	(	_	
167-35	28525-28527	35	_	
167-36	28527-28528	)	_	
167-37	28528-28529	=	_	
167-38	28529-28533	.06P	_	
167-39	28533-28534	=	_	
167-40	28534-28538	0.95	_	
167-41	28541-28545	Male	_	
167-42	28546-28547	:	_	
167-43	28548-28554	Female	_	
167-44	28555-28557	13	_	
167-45	28558-28559	:	_	
167-46	28560-28561	8	_	
167-47	28562-28564	11	_	
167-48	28565-28566	:	_	
167-49	28567-28568	5	_	
167-50	28569-28571	χ2	_	
167-51	28571-28572	=	_	
167-52	28572-28577	0.19P	_	
167-53	28577-28578	=	_	
167-54	28578-28582	0.67	_	
167-55	28585-28588	Afr	_	
167-56	28589-28591	Am	_	
167-57	28592-28593	:	_	
167-58	28594-28598	Cauc	_	
167-59	28599-28600	:	_	
167-60	28601-28606	Other	_	
167-61	28607-28608	6	_	
167-62	28609-28610	:	_	
167-63	28611-28613	14	_	
167-64	28614-28615	:	_	
167-65	28616-28617	1	_	
167-66	28618-28619	4	_	
167-67	28620-28621	:	_	
167-68	28622-28624	11	_	
167-69	28625-28626	:	_	
167-70	28627-28628	1	_	
167-71	28629-28631	χ2	_	
167-72	28631-28632	=	_	
167-73	28632-28637	0.09P	_	
167-74	28637-28638	=	_	
167-75	28638-28642	0.96	_	
167-76	28645-28654	Education	_	
167-77	28655-28656	(	_	
167-78	28656-28661	years	_	
167-79	28661-28662	)	_	
167-80	28663-28667	12.8	_	
167-81	28668-28669	±	_	
167-82	28670-28673	2.7	_	
167-83	28674-28678	14.1	_	
167-84	28679-28680	±	_	
167-85	28681-28684	1.7	_	
167-86	28685-28686	t	_	
167-87	28686-28687	(	_	
167-88	28687-28689	35	_	
167-89	28689-28690	)	_	
167-90	28690-28691	=	_	
167-91	28691-28696	1.76P	_	
167-92	28696-28697	=	_	
167-93	28697-28702	0.088	_	
167-94	28705-28713	Parental	_	
167-95	28714-28723	Education	_	
167-96	28724-28725	(	_	
167-97	28725-28728	yrs	_	
167-98	28728-28729	)	_	
167-99	28729-28730	a	_	
167-100	28731-28735	13.1	_	
167-101	28736-28737	±	_	
167-102	28738-28741	3.0	_	
167-103	28742-28746	14.3	_	
167-104	28747-28748	±	_	
167-105	28749-28752	2.0	_	
167-106	28753-28754	t	_	
167-107	28754-28755	(	_	
167-108	28755-28757	35	_	
167-109	28757-28758	)	_	
167-110	28758-28759	=	_	
167-111	28759-28764	1.40P	_	
167-112	28764-28765	=	_	
167-113	28765-28769	0.17	_	
167-114	28772-28781	Estimated	_	
167-115	28782-28786	IQbf	_	
167-116	28787-28792	104.1	_	
167-117	28793-28794	±	_	
167-118	28795-28799	13.2	_	
167-119	28800-28805	115.6	_	
167-120	28806-28807	±	_	
167-121	28808-28811	7.3	_	
167-122	28812-28813	t	_	
167-123	28813-28814	(	_	
167-124	28814-28816	35	_	
167-125	28816-28817	)	_	
167-126	28817-28818	=	_	
167-127	28818-28823	3.12P	_	
167-128	28823-28824	<	_	
167-129	28824-28829	0.005	_	
167-130	28832-28838	MCCBcf	_	
167-131	28839-28843	37.9	_	
167-132	28844-28845	±	_	
167-133	28846-28850	13.1	_	
167-134	28851-28855	53.2	_	
167-135	28856-28857	±	_	
167-136	28858-28861	6.2	_	
167-137	28862-28863	t	_	
167-138	28863-28864	(	_	
167-139	28864-28866	35	_	
167-140	28866-28867	)	_	
167-141	28867-28868	=	_	
167-142	28868-28873	4.30P	_	
167-143	28873-28874	<	_	
167-144	28874-28879	0.001	_	
167-145	28882-28886	WRAT	_	
167-146	28887-28890	4df	_	
167-147	28891-28895	97.8	_	
167-148	28896-28897	±	_	
167-149	28898-28902	14.8	_	
167-150	28903-28908	110.3	_	
167-151	28909-28910	±	_	
167-152	28911-28915	13.0	_	
167-153	28916-28917	t	_	
167-154	28917-28918	(	_	
167-155	28918-28920	35	_	
167-156	28920-28921	)	_	
167-157	28921-28922	=	_	
167-158	28922-28927	2.67P	_	
167-159	28927-28928	<	_	
167-160	28928-28932	0.02	_	
167-161	28935-28940	WTARe	_	
167-162	28941-28946	101.0	_	
167-163	28947-28948	±	_	
167-164	28949-28953	18.7	_	
167-165	28954-28959	111.6	_	
167-166	28960-28961	±	_	
167-167	28962-28965	9.7	_	
167-168	28966-28967	t	_	
167-169	28967-28968	(	_	
167-170	28968-28970	35	_	
167-171	28970-28971	)	_	
167-172	28971-28972	=	_	
167-173	28972-28977	2.06P	_	
167-174	28977-28978	<	_	
167-175	28978-28982	0.05	_	
167-176	28985-28992	Smokers	_	
167-177	28993-28994	:	_	
167-178	28995-29006	Non-smokers	_	
167-179	29007-29008	6	_	
167-180	29009-29010	:	_	
167-181	29011-29013	15	_	
167-182	29014-29015	2	_	
167-183	29016-29017	:	_	
167-184	29018-29020	14	_	
167-185	29021-29023	χ2	_	
167-186	29023-29024	=	_	
167-187	29024-29029	1.38P	_	
167-188	29029-29030	>	_	
167-189	29030-29033	0.2	_	
167-190	29036-29040	FTND	_	
167-191	29041-29043	of	_	
167-192	29044-29051	current	_	
167-193	29052-29060	smokersf	_	
167-194	29061-29064	3.5	_	
167-195	29065-29066	±	_	
167-196	29067-29070	2.4	_	
167-197	29071-29074	3.5	_	
167-198	29075-29076	±	_	
167-199	29077-29080	2.8	_	
167-200	29081-29082	t	_	
167-201	29082-29083	(	_	
167-202	29083-29084	6	_	
167-203	29084-29085	)	_	
167-204	29085-29086	=	_	
167-205	29086-29091	0.24P	_	
167-206	29091-29092	>	_	
167-207	29092-29095	0.8	_	
167-208	29098-29106	Systolic	_	
167-209	29107-29112	blood	_	
167-210	29113-29121	pressure	_	
167-211	29122-29123	(	_	
167-212	29123-29125	mm	_	
167-213	29126-29128	Hg	_	
167-214	29128-29129	)	_	
167-215	29129-29130	g	_	
167-216	29131-29136	125.2	_	
167-217	29137-29138	±	_	
167-218	29139-29143	12.0	_	
167-219	29144-29149	122.9	_	
167-220	29150-29151	±	_	
167-221	29152-29156	15.9	_	
167-222	29157-29158	t	_	
167-223	29158-29159	(	_	
167-224	29159-29161	35	_	
167-225	29161-29162	)	_	
167-226	29162-29163	=	_	
167-227	29163-29168	0.49P	_	
167-228	29168-29169	>	_	
167-229	29169-29172	0.6	_	
167-230	29175-29184	Diastolic	_	
167-231	29185-29190	blood	_	
167-232	29191-29199	pressure	_	
167-233	29200-29201	(	_	
167-234	29201-29203	mm	_	
167-235	29204-29206	Hg	_	
167-236	29206-29207	)	_	
167-237	29207-29208	g	_	
167-238	29209-29213	76.2	_	
167-239	29214-29215	±	_	
167-240	29216-29219	7.6	_	
167-241	29220-29224	73.8	_	
167-242	29225-29226	±	_	
167-243	29227-29230	9.8	_	
167-244	29231-29232	t	_	
167-245	29232-29233	(	_	
167-246	29233-29235	35	_	
167-247	29235-29236	)	_	
167-248	29236-29237	=	_	
167-249	29237-29242	0.87P	_	
167-250	29242-29243	>	_	
167-251	29243-29246	0.3	_	
167-252	29250-29257	Average	_	
167-253	29258-29262	over	_	
167-254	29263-29271	maternal	_	
167-255	29272-29275	and	_	
167-256	29276-29284	paternal	_	
167-257	29285-29294	education	_	
167-258	29295-29300	Based	_	
167-259	29301-29303	on	_	
167-260	29304-29314	vocabulary	_	
167-261	29315-29318	and	_	
167-262	29319-29325	matrix	_	
167-263	29326-29335	reasoning	_	
167-264	29336-29345	subscales	_	
167-265	29346-29348	of	_	
167-266	29349-29352	the	_	
167-267	29353-29361	Wechsler	_	
167-268	29362-29373	Abbreviated	_	
167-269	29374-29379	Scale	_	
167-270	29380-29382	of	_	
167-271	29383-29395	Intelligence	_	
167-272	29397-29406	Composite	_	
167-273	29407-29412	score	_	
167-274	29413-29415	on	_	
167-275	29416-29419	the	_	
167-276	29420-29427	MATRICS	_	
167-277	29428-29437	Consensus	_	
167-278	29438-29447	Cognitive	_	
167-279	29448-29455	Battery	_	
167-280	29457-29461	Wide	_	
167-281	29462-29467	Range	_	
167-282	29468-29479	Achievement	_	
167-283	29480-29484	Test	_	
167-284	29486-29494	Wechsler	_	
167-285	29495-29499	Test	_	
167-286	29500-29502	of	_	
167-287	29503-29508	Adult	_	
167-288	29509-29516	Reading	_	
167-289	29518-29528	Fagerstrom	_	
167-290	29529-29533	Test	_	
167-291	29534-29537	for	_	
167-292	29538-29546	Nicotine	_	
167-293	29547-29557	Dependence	_	
167-294	29559-29564	taken	_	
167-295	29565-29571	during	_	
167-296	29572-29581	screening	_	
167-297	29582-29586	ROIs	_	
167-298	29587-29599	representing	_	
167-299	29600-29601	7	_	
167-300	29601-29602	-	_	
167-301	29602-29613	mm-diameter	_	
167-302	29614-29621	spheres	_	
167-303	29622-29630	centered	_	
167-304	29631-29633	on	_	
167-305	29634-29638	peak	_	
167-306	29639-29643	foci	_	
167-307	29644-29646	of	_	
167-308	29647-29650	the	_	
167-309	29651-29664	task-positive	_	
167-310	29665-29668	and	_	
167-311	29669-29682	task-negative	_	
167-312	29682-29683	/	_	
167-313	29683-29690	default	_	
167-314	29691-29695	mode	_	
167-315	29696-29704	networks	_	
167-316	29705-29715	identified	_	
167-317	29716-29718	by	_	
167-318	29721-29727	Region	_	
167-319	29728-29732	Side	_	
167-320	29733-29739	Center	_	
167-321	29740-29742	of	_	
167-322	29743-29747	Mass	_	
167-323	29748-29749	(	_	
167-324	29749-29751	mm	_	
167-325	29751-29752	)	_	
167-326	29755-29757	LR	_	
167-327	29758-29760	PA	_	
167-328	29761-29763	IS	_	
167-329	29766-29779	Task-positive	_	
167-330	29782-29783	1	_	
167-331	29784-29792	Superior	_	
167-332	29793-29801	parietal	_	
167-333	29802-29808	lobule	_	
167-334	29808-29809	,	_	
167-335	29810-29823	intraparietal	_	
167-336	29824-29830	sulcus	_	
167-337	29831-29832	L	_	
167-338	29833-29834	−	_	
167-339	29834-29836	23	_	
167-340	29837-29838	−	_	
167-341	29838-29840	66	_	
167-342	29841-29843	46	_	
167-343	29846-29847	2	_	
167-344	29848-29856	Superior	_	
167-345	29857-29865	parietal	_	
167-346	29866-29872	lobule	_	
167-347	29872-29873	,	_	
167-348	29874-29887	intraparietal	_	
167-349	29888-29894	sulcus	_	
167-350	29895-29896	R	_	
167-351	29897-29899	25	_	
167-352	29900-29901	−	_	
167-353	29901-29903	58	_	
167-354	29904-29906	52	_	
167-355	29909-29910	3	_	
167-356	29911-29919	Inferior	_	
167-357	29920-29928	parietal	_	
167-358	29929-29935	lobule	_	
167-359	29935-29936	,	_	
167-360	29937-29950	intraparietal	_	
167-361	29951-29957	sulcus	_	
167-362	29958-29959	L	_	
167-363	29960-29961	−	_	
167-364	29961-29963	42	_	
167-365	29964-29965	−	_	
167-366	29965-29967	44	_	
167-367	29968-29970	49	_	
167-368	29973-29974	4	_	
167-369	29975-29983	Inferior	_	
167-370	29984-29992	parietal	_	
167-371	29993-29999	lobule	_	
167-372	29999-30000	,	_	
167-373	30001-30014	intraparietal	_	
167-374	30015-30021	sulcus	_	
167-375	30022-30023	R	_	
167-376	30024-30026	47	_	
167-377	30027-30028	−	_	
167-378	30028-30030	37	_	
167-379	30031-30033	52	_	
167-380	30036-30037	5	_	
167-381	30038-30046	Superior	_	
167-382	30047-30056	occipital	_	
167-383	30057-30062	gyrus	_	
167-384	30062-30063	,	_	
167-385	30064-30070	cuneus	_	
167-386	30071-30072	L	_	
167-387	30073-30074	−	_	
167-388	30074-30076	26	_	
167-389	30077-30078	−	_	
167-390	30078-30080	80	_	
167-391	30081-30083	26	_	
167-392	30086-30087	6	_	
167-393	30088-30096	Superior	_	
167-394	30097-30106	occipital	_	
167-395	30107-30112	gyrus	_	
167-396	30112-30113	,	_	
167-397	30114-30120	cuneus	_	
167-398	30121-30122	R	_	
167-399	30123-30125	35	_	
167-400	30126-30127	−	_	
167-401	30127-30129	81	_	
167-402	30130-30132	29	_	
167-403	30135-30136	7	_	
167-404	30137-30145	Superior	_	
167-405	30146-30156	precentral	_	
167-406	30157-30162	gyrus	_	
167-407	30163-30164	(	_	
167-408	30164-30171	frontal	_	
167-409	30172-30175	eye	_	
167-410	30176-30181	field	_	
167-411	30181-30182	)	_	
167-412	30183-30184	L	_	
167-413	30185-30186	−	_	
167-414	30186-30188	24	_	
167-415	30189-30190	−	_	
167-416	30190-30192	12	_	
167-417	30193-30195	61	_	
167-418	30198-30199	8	_	
167-419	30200-30208	Superior	_	
167-420	30209-30219	precentral	_	
167-421	30220-30225	gyrus	_	
167-422	30226-30227	(	_	
167-423	30227-30234	frontal	_	
167-424	30235-30238	eye	_	
167-425	30239-30244	field	_	
167-426	30244-30245	)	_	
167-427	30246-30247	R	_	
167-428	30248-30250	28	_	
167-429	30251-30252	−	_	
167-430	30252-30253	7	_	
167-431	30254-30256	54	_	
167-432	30259-30260	9	_	
167-433	30261-30269	Inferior	_	
167-434	30270-30280	precentral	_	
167-435	30281-30286	gyrus	_	
167-436	30287-30288	L	_	
167-437	30289-30290	−	_	
167-438	30290-30292	54	_	
167-439	30293-30294	0	_	
167-440	30295-30297	35	_	
167-441	30300-30302	10	_	
167-442	30303-30309	Medial	_	
167-443	30310-30317	frontal	_	
167-444	30318-30323	gyrus	_	
167-445	30324-30325	(	_	
167-446	30325-30338	supplementary	_	
167-447	30339-30344	motor	_	
167-448	30345-30349	area	_	
167-449	30349-30350	)	_	
167-450	30351-30352	L	_	
167-451	30352-30353	/	_	
167-452	30353-30354	R	_	
167-453	30355-30356	−	_	
167-454	30356-30357	2	_	
167-455	30358-30359	1	_	
167-456	30360-30362	51	_	
167-457	30365-30367	11	_	
167-458	30368-30374	Middle	_	
167-459	30375-30382	frontal	_	
167-460	30383-30388	gyrus	_	
167-461	30389-30390	L	_	
167-462	30391-30392	−	_	
167-463	30392-30394	40	_	
167-464	30395-30397	39	_	
167-465	30398-30400	26	_	
167-466	30403-30405	12	_	
167-467	30406-30412	Middle	_	
167-468	30413-30420	frontal	_	
167-469	30421-30426	gyrus	_	
167-470	30427-30428	R	_	
167-471	30429-30431	38	_	
167-472	30432-30434	41	_	
167-473	30435-30437	22	_	
167-474	30440-30442	13	_	
167-475	30443-30449	Middle	_	
167-476	30450-30459	occipital	_	
167-477	30460-30465	gyrus	_	
167-478	30466-30467	L	_	
167-479	30468-30469	−	_	
167-480	30469-30471	47	_	
167-481	30472-30473	−	_	
167-482	30473-30475	69	_	
167-483	30476-30477	−	_	
167-484	30477-30478	3	_	
167-485	30481-30483	14	_	
167-486	30484-30490	Middle	_	
167-487	30491-30500	occipital	_	
167-488	30501-30506	gyrus	_	
167-489	30507-30508	R	_	
167-490	30509-30511	54	_	
167-491	30512-30513	−	_	
167-492	30513-30515	63	_	
167-493	30516-30517	−	_	
167-494	30517-30518	8	_	
167-495	30521-30523	15	_	
167-496	30524-30530	Insula	_	
167-497	30531-30532	L	_	
167-498	30533-30534	−	_	
167-499	30534-30536	45	_	
167-500	30537-30538	5	_	
167-501	30539-30540	8	_	
167-502	30543-30545	16	_	
167-503	30546-30552	Insula	_	
167-504	30553-30554	R	_	
167-505	30555-30557	45	_	
167-506	30558-30559	4	_	
167-507	30560-30562	14	_	
167-508	30565-30578	Task-negative	_	
167-509	30579-30580	/	_	
167-510	30581-30588	default	_	
167-511	30589-30593	mode	_	
167-512	30594-30601	network	_	
167-513	30604-30605	1	_	
167-514	30606-30615	Posterior	_	
167-515	30616-30625	cingulate	_	
167-516	30626-30631	gyrus	_	
167-517	30632-30633	L	_	
167-518	30633-30634	/	_	
167-519	30634-30635	R	_	
167-520	30636-30637	−	_	
167-521	30637-30638	2	_	
167-522	30639-30640	−	_	
167-523	30640-30642	36	_	
167-524	30643-30645	37	_	
167-525	30648-30649	2	_	
167-526	30650-30663	Retrosplenial	_	
167-527	30664-30670	cortex	_	
167-528	30671-30672	L	_	
167-529	30672-30673	/	_	
167-530	30673-30674	R	_	
167-531	30675-30676	3	_	
167-532	30677-30678	−	_	
167-533	30678-30680	51	_	
167-534	30681-30682	8	_	
167-535	30685-30686	3	_	
167-536	30687-30694	Angular	_	
167-537	30695-30700	gyrus	_	
167-538	30701-30702	L	_	
167-539	30703-30704	−	_	
167-540	30704-30706	47	_	
167-541	30707-30708	−	_	
167-542	30708-30710	67	_	
167-543	30711-30713	36	_	
167-544	30716-30717	4	_	
167-545	30718-30725	Angular	_	
167-546	30726-30731	gyrus	_	
167-547	30732-30733	R	_	
167-548	30734-30736	53	_	
167-549	30737-30738	−	_	
167-550	30738-30740	67	_	
167-551	30741-30743	36	_	
167-552	30746-30747	5	_	
167-553	30748-30755	Rostral	_	
167-554	30756-30764	anterior	_	
167-555	30765-30774	cingulate	_	
167-556	30775-30780	gyrus	_	
167-557	30781-30782	L	_	
167-558	30782-30783	/	_	
167-559	30783-30784	R	_	
167-560	30785-30786	−	_	
167-561	30786-30787	3	_	
167-562	30788-30790	39	_	
167-563	30791-30792	−	_	
167-564	30792-30793	2	_	
167-565	30796-30797	6	_	
167-566	30798-30804	Medial	_	
167-567	30805-30815	prefrontal	_	
167-568	30816-30821	gyrus	_	
167-569	30822-30823	L	_	
167-570	30823-30824	/	_	
167-571	30824-30825	R	_	
167-572	30826-30827	1	_	
167-573	30828-30830	54	_	
167-574	30831-30833	21	_	
167-575	30836-30837	7	_	
167-576	30838-30846	Superior	_	
167-577	30847-30854	frontal	_	
167-578	30855-30860	gyrus	_	
167-579	30861-30862	L	_	
167-580	30863-30864	−	_	
167-581	30864-30866	14	_	
167-582	30867-30869	38	_	
167-583	30870-30872	52	_	
167-584	30875-30876	8	_	
167-585	30877-30885	Superior	_	
167-586	30886-30893	frontal	_	
167-587	30894-30899	gyrus	_	
167-588	30900-30901	R	_	
167-589	30902-30904	17	_	
167-590	30905-30907	37	_	
167-591	30908-30910	52	_	
167-592	30913-30914	9	_	
167-593	30915-30921	Middle	_	
167-594	30922-30923	&	_	
167-595	30924-30932	inferior	_	
167-596	30933-30941	temporal	_	
167-597	30942-30947	gyrus	_	
167-598	30948-30949	L	_	
167-599	30950-30951	−	_	
167-600	30951-30953	61	_	
167-601	30954-30955	−	_	
167-602	30955-30957	33	_	
167-603	30958-30959	−	_	
167-604	30959-30961	15	_	
167-605	30964-30966	10	_	
167-606	30967-30973	Middle	_	
167-607	30974-30975	&	_	
167-608	30976-30984	inferior	_	
167-609	30985-30993	temporal	_	
167-610	30994-30999	gyrus	_	
167-611	31000-31001	R	_	
167-612	31002-31004	65	_	
167-613	31005-31006	−	_	
167-614	31006-31008	17	_	
167-615	31009-31010	−	_	
167-616	31010-31012	15	_	
167-617	31015-31017	11	_	
167-618	31018-31033	Parahippocampal	_	
167-619	31034-31039	gyrus	_	
167-620	31040-31041	L	_	
167-621	31042-31043	−	_	
167-622	31043-31045	22	_	
167-623	31046-31047	−	_	
167-624	31047-31049	26	_	
167-625	31050-31051	−	_	
167-626	31051-31053	16	_	
167-627	31056-31058	12	_	
167-628	31059-31074	Parahippocampal	_	
167-629	31075-31080	gyrus	_	
167-630	31081-31082	R	_	
167-631	31083-31085	25	_	
167-632	31086-31087	−	_	
167-633	31087-31089	26	_	
167-634	31090-31091	−	_	
167-635	31091-31093	14	_	
167-636	31096-31098	13	_	
167-637	31099-31109	Cerebellar	_	
167-638	31110-31117	tonsils	_	
167-639	31118-31119	L	_	
167-640	31119-31120	/	_	
167-641	31120-31121	R	_	
167-642	31122-31123	7	_	
167-643	31124-31125	−	_	
167-644	31125-31127	52	_	
167-645	31128-31129	−	_	
167-646	31129-31131	44	_	
